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Welcome 
TO THE LATEST EDITION OF DRUGS OF ABUSE 
Education plays a critical role in preventing substance abuse. Drugs of Abuse, A DEA 
Resource Guide, is designed to be a reliable resource on the most commonly abused 
and misused drugs in the United States. This comprehensive guide provides important 
information about the harms and consequences of drug use by describing a drug’s effects 
on the body and mind, overdose potential, origin, legal status, and other key facts. 
Drugs of Abuse also offers a list of additional drug education and prevention resources, 
including the DEA websites: 
www.DEA.gov; www.JustThinkTwice.com, aimed at teenagers; 
www.GetSmartAboutDrugs.com, designed for parents, educators, and 
caregivers; www.CampusDrugPrevention.gov, for higher education, and 
www.OperationPrevention.com for opioid curricula.
I. Controlled Substances Act
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CONTROLLING DRUGS OR OTHER 
SUBSTANCES THROUGH FORMAL 
SCHEDULING 
The Controlled Substances Act (CSA) places all 
substances which were in some manner regulated 
under existing federal law into one of five schedules. 
This placement is based upon the substance’s 
accepted medical use, potential for abuse, and 
safety or dependence liability. The Act also provides 
a mechanism for substances to be controlled (added 
to or transferred between schedules) or decontrolled 
(removed from control). The procedure for these 
actions is found in Section 201 of the Act (21U.S.C. 
§811). 
Proceedings to add, delete, or change the 
schedule of a drug or other substance may be 
initiated by the Drug Enforcement Administration 
(DEA), the Department of Health and Human 
Services (HHS), or by petition from any interested 
party, including: 
• The manufacturer of a drug 
• A medical society or  association 
• A  pharmacy association 
• A public interest group concerned with drug abuse 
• A state or local government agency 
• An individual citizen 
When a petition is received by the DEA, the 
agency begins its own investigation of the drug. 
The DEA also may begin an investigation of a drug 
at any time based upon information received from 
law enforcement laboratories, state and local law 
enforcement and regulatory agencies, or other 
sources of information. 
Once the DEA has collected the necessary data, 
the DEA Administrator, by authority of the Attorney 
I. Controlled Substances Act 
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General, requests from HHS a scientific and 
medical evaluation and recommendation as to 
whether the drug or other substance should be 
controlled or removed from control. This request 
is sent to  the Assistant Secretary for Health of 
HHS. 
The Assistant Secretary, by authority of the 
Secretary, compiles the information and transmits 
back to the DEA: a medical and scientific 
evaluation regarding the drug or other substance, 
a recommendation as to whether the drug should 
be controlled, and in what schedule it should be 
placed. 
The medical and scientific evaluations are 
binding on the DEA with respect to scientific and 
medical matters and form a part of the scheduling 
decision. 
Once the DEA has received the scientific and 
medical evaluation from HHS, the Administrator 
will evaluate all available data and make a final 
decision whether to propose that a drug or other 
substance should be removed or controlled and 
into which schedule it should be placed. 
If a drug does not have a potential for abuse, it 
cannot be controlled. Although the term “potential 
for abuse” is not defined in the CSA, there is 
much discussion of the term in the legislative 
history of the Act. The following items are 
indicators that a drug or other substance has a 
potential for abuse: 
(1) There is evidence that individuals are taking 
the drug or other substance in amounts sufficient 
to create a hazard to their health or to the safety 
of other individuals or to the community. 
(2) There is significant diversion of the drug or 
other substance from legitimate drug channels. 
(3) Individuals are taking the drug or other 
substance on their own initiative rather than on 
the basis of medical advice from a practitioner. 
(4) The drug is a new drug so related in its 
action to a drug or other substance already listed 
as having a potential for abuse to make it likely 
that the drug will have the same potential for 
abuse as such drugs, thus making it reasonable 
to assume that there may be significant diversions 
from legitimate channels, significant use contrary 
to or without medical advice, or that it has a 
substantial capability of creating hazards to 
the health of the user or to the safety of the 
community. Of course, evidence of actual abuse 
of a substance is indicative that a drug has a 
potential for abuse. 
In determining into which schedule a drug or 
other substance should be placed, or whether a 
substance should be decontrolled or rescheduled, 
certain factors are required to be considered. 
These factors are listed in Section 201 (c), [21 
U.S.C. § 811 (c)] of the CSA as follows: 
(1) The drug’s actual or relative potential for 
abuse. 
(2) Scientific evidence of the drug’s 
pharmacological effect, if known. The state of 
knowledge with respect to the effects of a specific 
drug is, of course, a major consideration. For 
example, it is vital to know whether or not a drug 
has a hallucinogenic effect if it is to be controlled 
due to that effect. 
The best available knowledge of the 
pharmacological properties of a drug should be 
considered. 
(3) The state of current scientific knowledge 
regarding the substance. Criteria (2) and (3) 
are closely related. However, (2) is primarily 
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concerned with pharmacological effects and (3) 
deals with all scientific knowledge with respect to 
the substance. 
(4) Its history and current pattern of abuse. 
To determine whether or not a drug should be 
controlled, it is important to know the pattern of 
abuse of that substance. 
(5) The scope, duration, and significance of 
abuse. In evaluating existing abuse, the DEA 
Administrator must know not only the pattern of 
abuse, but also whether the abuse is widespread. 
(6) What, if any, risk there is to the public health. 
If a drug creates dangers to the public health, in 
addition to or because of its abuse potential, then 
these dangers must also be considered by the 
Administrator. 
(7) The drug’s psychic or physiological 
dependence liability. There must be an assessment 
of the extent to which a drug is physically addictive 
or psychologically habit forming. 
(8) Whether the substance is an immediate 
precursor of a substance already controlled. The 
CSA allows inclusion of immediate precursors on 
this basis alone into the appropriate schedule and 
thus safeguards against possibilities of clandestine 
manufacture. After considering the above listed 
factors, the Administrator must make specific 
findings concerning the drug or other substance. 
This will determine into which schedule the drug or 
other substance will be placed. These schedules are 
established by the CSA. They are as follows: 
Schedule I 
• The drug or other substance has a high potential for  
abuse. 
• The drug or other substance has no currently accepted 
medical use in treatment in the United States. 
• There is a lack of accepted safety for use of the drug 
or other substance under medical supervision. 
• Examples of Schedule I substances include heroin, 
gamma hydroxybutyric acid (GHB), lysergic acid 
diethylamide (LSD), marijuana, and methaqualone. 
Schedule II 
• The drug or other substance has a high potential for   
abuse. 
• The drug or other substance has a currently accepted 
medical use in treatment in the United States or 
a currently accepted medical use with severe 
restrictions. 
• Abuse of the drug or other substance may lead to 
severe psychological or physical dependence. 
• Examples of Schedule II substances include 
morphine, phencyclidine (PCP), cocaine, methadone, 
hydrocodone, fentanyl, and methamphetamine. 
Schedule III 
• The drug or other substance has less potential 
for abuse than the drugs or other substances in 
Schedules I and II. 
• The drug or other substance has a currently accepted 
medical use in treatment in the United States. 
• Abuse of the drug or other substance may lead 
to moderate or low physical dependence or high 
psychological dependence. 
• Anabolic steroids, codeine products with aspirin or 
acetaminophen, and some barbiturates are examples 
of Schedule III substances.
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Schedule IV 
• The drug or other substance has a low potential for 
abuse relative to the drugs or other substances in 
Schedule III. 
• The drug or other substance has a currently accepted 
medical use in treatment in the United States. 
• Abuse of the drug or other substance may lead 
to limited physical dependence or psychological 
dependence relative to the drugs or other substances 
in Schedule III. 
• Examples of drugs included in Schedule IV are 
alprazolam, clonazepam, and diazepam. 
Schedule V 
• The drug or other substance has a low potential for 
abuse relative to the drugs or other substances in 
Schedule IV. 
• The drug or other substance has a currently accepted 
medical use in treatment in the United States. 
• Abuse of the drug or other substances may lead 
to limited physical dependence or psychological 
dependence relative to the drugs or other substances 
in Schedule IV. 
• Cough medicines with codeine are examples of 
Schedule V drugs. 
When the DEA Administrator has determined 
that a drug or other substance should be 
controlled, decontrolled, or rescheduled, a 
proposal to take action is published in the Federal 
Register. The proposal invites all interested 
persons to file comments with the DEA and may 
also request a hearing with the DEA. If no hearing 
is requested, the DEA will evaluate all comments 
received and publish a final order in the Federal 
Register, controlling the drug as proposed or with 
modifications based upon the written comments 
filed. This order will set the effective dates for 
imposing the various requirements of the CSA. 
If a hearing is requested, the DEA will enter into 
discussions with the party or parties requesting 
a hearing in an attempt to narrow the issue for 
litigation. If necessary, a hearing will then be 
held before an Administrative Law Judge. The 
judge will take evidence on factual issues and 
hear arguments on legal questions regarding 
the control of the drug. Depending on the scope 
and complexity of the issues, the hearing may 
be brief or quite extensive. The Administrative 
Law Judge, at the close of the hearing, prepares 
findings of fact and conclusions of law and a 
recommended decision that is submitted to the 
DEA Administrator. The DEA Administrator will 
review these documents, as well as the underlying 
material, and prepare his/her own findings of fact 
and conclusions of law (which may or may not be 
the same as those drafted by the Administrative 
Law Judge). The DEA Administrator then 
publishes a final order in the Federal Register 
either scheduling the drug or other substance or 
declining to do so. 
Once the final order is published in the Federal 
Register, interested parties have 30 days to 
appeal to a U.S. Court of Appeals to challenge 
the order. Findings of fact by the Administrator are 
deemed conclusive if supported by “substantial 
evidence.” The order imposing controls is not 
stayed during the appeal, however, unless so 
ordered by the Court. 
Emergency or Temporary Scheduling 
The CSA was amended by the Comprehensive 
Crime Control Act of 1984. This Act included a 
provision which allows the DEA Administrator to 
place a substance, on a temporary basis, into 
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Schedule I, when necessary, to avoid an imminent 
hazard to public safety. 
This emergency scheduling authority permits the 
scheduling of a substance which is not currently 
controlled, is being abused, and is a risk to public 
health while the formal rulemaking procedures 
described in the CSA are being conducted. This 
emergency scheduling applies only to substances 
with no accepted medical use. 
A temporary scheduling order may be issued 
for two years with a possible extension of up to 
one year if formal scheduling procedures have 
been initiated. The notice of intent and order are 
published in the Federal Register, as are the 
proposals and orders for formal scheduling. [21 
U.S.C. § 811 (h)] 
Controlled Substance analogues 
Controlled substance analogues are substances 
that are not formally controlled substances, 
but may be found in illicit trafficking. They are 
structurally or pharmacologically similar to 
Schedule I or II controlled substances and have 
no legitimate medical use. A substance that meets 
the definition of a controlled substance analogue 
and is intended for human consumption may be 
treated under the CSA as if it were a controlled 
substance in Schedule I. [21 U.S.C. § 802(32), 21 
U.S.C. § 813] 
International treaty obligations 
United States treaty obligations may require 
that a drug or other substance be controlled under 
the CSA, or rescheduled if existing controls are 
less stringent than those required by a treaty. The 
procedures for these scheduling actions are found 
in Section 201 (d)of the Act. [21 U.S.C. § 811 (d)] 
The United States is a party to the Single 
Convention on Narcotic Drugs of 1961, which 
was designed to establish effective control over 
international and domestic traffic in narcotics, coca 
leaf, cocaine, and cannabis. A second treaty, the 
Convention on Psychotropic Substances of 1971, 
which entered into force in 1976 and was ratified 
by Congress in 1980, is designed to establish 
comparable control over stimulants, depressants, 
and hallucinogens. 
REGULATION 
The CSA creates a closed system of distribution 
for controlled substances. The cornerstone of this 
system is the registration of all those authorized 
by DEA to handle controlled substances. All 
individuals and firms that are registered are 
required to maintain complete and accurate 
inventories, and records of all transactions 
involving controlled substances, as well as 
security for the storage of controlled substances. 
Registration 
Any person who handles or intends to handle 
controlled substances must obtain a registration 
issued by DEA. A unique number is assigned to 
each legitimate handler of controlled drugs such 
as importer, exporter, manufacturer, distributor, 
hospital, pharmacy, practitioner, and researcher. 
This number must be made available to the 
supplier by the customer prior to the purchase 
of a controlled substance, and its validity can 
be verified online through the Diversion Control 
Division website at www.DEAdiversion.usdoj. 
gov. Thus, the opportunity for unauthorized 
transactions is greatly diminished.
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Recordkeeping and Reporting 
The CSA requires that complete and accurate 
records be kept of all quantities of controlled 
substances manufactured, imported, exported, 
received, delivered, distributed, dispensed, 
or otherwise disposed. Each substance must 
be physically inventoried every two years. 
Some limited exceptions to the recordkeeping 
requirements apply to certain categories of 
registrants. 
From these records it is possible to trace the 
flow of any drug from the time it is first imported or 
manufactured, through the distribution level, to the 
pharmacy or hospital that dispensed it, and then 
to the actual patient who received the drug. The 
mere existence of this requirement is sufficient to 
discourage many forms of diversion. It actually 
serves large drug corporations as an internal 
check to uncover diversion, such as pilferage by 
employees. 
There is one distinction between scheduled 
items for record keeping requirements. Records 
for Schedule I and II drugs must be kept separate 
from all other records maintained by the registrant. 
Records for Schedule III, IV, and V substances 
must be kept in a “readily retrievable” form, or 
maintained separately from all other records. 
Distribution 
Maintaining records is required for distribution of 
a controlled substance from one manufacturer to 
another, from manufacturer to distributor, and from 
distributor to dispenser. In the case of Schedule 
I and II drugs, the supplier must first receive a 
special order from the customer. This order form 
(DEA Form 222) is issued by DEA only to persons 
who are properly registered to handle Schedule I 
and II controlled substances. 
The form is preprinted with the name and 
address of the customer. The drugs must be 
shipped to this name and address. The use of this 
form is a special reinforcement of the registration 
requirement; it ensures that only authorized 
individuals may obtain Schedule I and II drugs. 
Controlled Substance Ordering System (CSOS) 
– Electronic Order Forms 
Any registrant permitted to order Schedule II 
controlled substances may do so electronically via 
the DEA Controlled Substance Ordering System 
(CSOS). The use of electronic orders is optional; 
registrants may continue to issue orders on a 
paper DEA Form 222. CSOS allows for secure 
electronic transmission of controlled substance 
orders without the supporting paper DEA Form 
222. The adoption of the CSOS standards is the 
only allowance for the electronic transmission of 
Schedule II controlled substance orders between 
controlled substance manufacturers, distributors, 
pharmacies, and other DEA authorized entities. 
CSOS uses Public Key Infrastructure (PKI) 
technology, which requires CSOS users to obtain 
a CSOS digital certificate for electronic ordering. 
The electronic orders must be signed using a 
digital signature issued by a Certification Authority 
(CA) operated by DEA. 
Digital certificates can be obtained only by 
registrants and individuals granted power of 
attorney by registrants to sign orders. A registrant 
must appoint a CSOS coordinator who will serve 
as that registrant’s recognized agent regarding 
issues pertaining to issuance of, revocation 
of, and changes to, digital certificates issued 
under that registrant’s DEA registration. A CSOS 
digital certificate will be valid until the DEA 
registration under which it is issued expires or 
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until the CSOS CA is notified that the certificate 
should be revoked. Certificates will be revoked 
if the certificate holder is no longer authorized 
to sign Schedule II orders for the registrant, if 
the information on which the certificate is based 
changes, or if the digital certificate used to sign 
electronic orders has been compromised, stolen, 
or lost. 
One benefit of using the CSOS system is that 
participants who are registered in other schedules 
in addition to Schedule II can then use this same 
system to also order those other controlled 
substances. 
Another benefit of the DEA Form 222 is the 
special monitoring it permits. The form is issued 
in triplicate: the customer keeps one copy; two 
copies go to the supplier, who, after filling the 
order, keeps a copy and forwards the third copy to 
the nearest DEA office. 
For drugs in Schedules III, IV, and V, no order 
form is necessary, but both the supplier and 
the purchaser must still maintain records of all 
transactions involving these controlled substances 
and those records must contain specific 
information required by DEA regulation. 
The supplier in each case, however, is under 
an obligation to verify the authenticity of the 
customer. The supplier is held fully accountable 
for any drugs that are shipped to a purchaser who 
does not have a valid registration. Manufacturers 
must submit periodic reports of the Schedule I and 
II controlled substances they produce in bulk and 
dosage forms. 
They also report the manufactured quantity 
and form of each narcotic substance listed 
in Schedule III. Distributors of controlled 
substances must report the quantity and form of 
all their transactions of controlled drugs listed in 
Schedules I and II, narcotics listed in Schedule 
III, and GHB. Both manufacturers and distributors 
are required to provide reports of their annual 
inventories of these controlled substances. This 
data is entered into a system called the Automated 
Reports and Consolidated Orders System 
(ARCOS). It enables the DEA to monitor the 
distribution of controlled substances throughout 
the country, and to identify retail level registrants 
that receive unusual quantities of controlled 
substances. 
Dispensing to Patients 
The dispensing of a controlled substance is 
the delivery by a practitioner of the controlled 
substance to the ultimate user, who may be 
a patient or research subject. Special control 
mechanisms operate here as well. Schedule I 
drugs are those that have no currently accepted 
medical use in the United States; therefore, they 
may be used in the United States only in research 
situations. 
They generally are supplied by only a limited 
number of firms to properly registered and 
qualified researchers. Controlled substances 
may be dispensed by a practitioner by direct 
administration, by prescription, or by dispensing. 
Records must be maintained by the practitioner 
of all dispensing of controlled substances and of 
certain administrations. 
The CSA does not require the practitioner to 
maintain copies of prescriptions unless such 
substances are prescribed in the course of 
maintenance or detoxification treatment of an 
individual. Certain states require the use of 
multiple-copy prescriptions for Schedule II and 
other specified controlled substances. 
The determination to place drugs on prescription 
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is within the jurisdiction of the FDA. Unlike 
other prescription drugs, however, controlled 
substances are subject to additional restrictions. 
Schedule II prescription orders must be written 
and signed by the practitioner; they may not 
be telephoned into the pharmacy except in an 
emergency. In addition, a prescription for a 
Schedule II drug may not be refilled. For Schedule 
III and IV drugs, the prescription order may 
be either written or oral (that is, by telephone 
to the pharmacy). In addition, the patient may 
(if authorized by the practitioner) have the 
prescription refilled up to five times and at any time 
within six months from the date the prescription 
was issued. 
Schedule V includes some prescription drugs 
and many narcotic preparations, including 
antitussives and antidiarrheals. Even here, 
however, the law imposes restrictions beyond 
those normally required for the over-the-counter 
sales; for example, the patient must be at least 18 
years of age, must offer some form of identification, 
and have his or her name entered into a special 
log maintained by the pharmacist as part of a 
special record. 
Electronic Prescriptions 
On March 31, 2010, DEA published in the 
Federal Register the Electronic Prescriptions for 
Controlled Substances interim final rule which 
became effective June 1, 2010. The rule provides 
practitioners with the option of writing prescriptions 
for controlled substances electronically and also 
permits pharmacies to receive, dispense, and 
archive these electronic prescriptions. 
Persons who wish to dispense controlled 
substances using electronic prescriptions must 
select software that meets the requirements of 
this rule. As of June 1, 2010, only those electronic 
applications that comply with all of DEA’s 
requirements as set forth in 21 C.F.R. §1311 may 
be used to electronically create, transmit, receive/ 
archive controlled substances prescriptions, and 
dispense controlled substances based on those 
prescriptions. 
Ryan Haight Online Pharmacy Consumer 
Protection Act of 2008 
On October 15, 2008, the President signed into 
law the Ryan Haight Online Pharmacy Consumer 
Protection Act of 2008, often referred to as the 
Ryan Haight Act. This law amends the CSA by 
adding a series of new regulatory requirements 
and criminal provisions designed to combat the 
proliferation of so-called “rogue Internet sites” 
that unlawfully dispense controlled substances 
by means of the Internet. The Ryan Haight 
Act applies  to all controlled substances in all 
schedules. An online pharmacy is a person, entity, 
or Internet site, whether in the United States or 
abroad, that knowingly or intentionally delivers, 
distributes, or dispenses, or offers or attempts 
to deliver, distribute, or dispense, a controlled 
substance by means of the Internet. 
This law became effective April 13, 2009. As of 
that date, it is illegal under federal law to deliver, 
distribute, or dispense a controlled substance 
by means of the Internet unless the online 
pharmacy holds a modification of DEA registration 
authorizing it to operate as an online pharmacy. 
Quotas 
DEA limits the quantity of Schedule I and 
II controlled substances and specific List I 
chemicals (pseudoephedrine, ephedrine, and 
phenylpropanolamine) that may be produced in 
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the United States in any given calendar year for 
legitimate medical, scientific and research needs, 
inventory, and lawful exports. By utilizing available 
data on sales and inventories of these controlled 
substances, and taking into account estimates 
of drug usage provided by the FDA, the DEA 
establishes annual aggregate production quotas 
for Schedule I and II controlled substances and 
the List I chemicals pseudoephedrine, ephedrine, 
and phenylpropanolamine. 
The aggregate production quotas and the 
assessment of annual needs are allocated among 
the various manufacturers who are registered 
to manufacture the specific substance or listed 
chemical. DEA also allocates the amount of 
bulk material that may be procured by those 
DEA registered manufacturers that prepare the 
substances into dosage units. 
Security 
DEA registrants are required by regulation 
to maintain certain security for the storage 
and distribution of controlled substances. 
Manufacturers and distributors of Schedule I and 
II substances must store controlled substances in 
specially constructed vaults or highly rated safes, 
and maintain electronic security for all storage 
areas. Lesser physical security requirements 
apply to retail level registrants such as hospitals 
and pharmacies. All registrants are required 
to make every effort to ensure that controlled 
substances in their possession are not diverted 
into the illicit market. This requires operational 
as well as physical security. For example, 
registrants are responsible for ensuring that 
controlled substances are distributed only to other 
registrants that are authorized to receive them, or 
to legitimate patients. 
Controlled Substance Theft or Significant Loss 
Should a theft or significant loss of any controlled 
substance occur, a registrant must implement the 
following procedures within one business day of 
the discovery of the theft or loss. 
A. Notify DEA and Local Police 
The theft of controlled substances from a 
registrant is a criminal act and a source of 
diversion that requires notification to DEA. 
A registrant must notify in writing the local 
DEA Diversion Field Office within one business 
day of discovery of a theft or significant loss of 
a controlled substance. Although not specifically 
required by federal law or regulations, the 
registrant should also notify local law enforcement 
and state regulatory agencies. 
Prompt notification to enforcement agencies 
will allow them to investigate the incident and 
prosecute those responsible for the diversion. 
If there is a question as to whether a theft has 
occurred or a loss is significant, a registrant 
should err on the side of caution and report it to 
DEA and local law enforcement authorities. 
DEA must be notified directly. This requirement 
is not satisfied by reporting the theft or significant 
loss in any other manner. For example, a 
corporation which owns or operates multiple 
registered sites and wishes to channel all 
notifications through corporate management or 
any other internal department responsible for 
security, must still provide notice directly to DEA 
in writing within one business day upon discovery 
and keep a copy of that notice for its records. The 
notice must be signed by an authorized individual 
of the registrant.
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B. Complete DEA Form 106 
A registrant must also complete a DEA Form 
106 (Report of Theft or Loss of Controlled 
Substances) which can be found online at www. 
DEAdiversion.usdoj.gov under the Quick Links 
section. The DEA Form 106 is used to document 
the actual circumstances of the theft or significant 
loss and the quantities of controlled substances 
involved. A paper version of the form may also 
be obtained by writing to the Drug Enforcement 
Administration. If completing the paper version, 
the registrant should send the original DEA Form 
106 to the local DEA Diversion Field Office and 
keep a copy for its records. 
PENALTIES 
The CSA provides penalties for unlawful 
manufacturing, distribution, and dispensing of 
controlled substances. The penalties are basically 
determined by the schedule of the drug or other 
substance, and sometimes are specified by drug 
name, as in the case of marijuana. As the statute 
has been amended since its initial passage 
in 1970, the penalties have been altered by 
Congress. The following charts are an overview of 
the penalties for trafficking or unlawful distribution 
of controlled substances. This is not inclusive of 
the penalties provided under the CSA. 
User Accountability/Personal Use Penalties 
On November 19, 1988, Congress passed the 
Anti-Drug Abuse Act of 1988, P. L. 100-690. 
Two sections of this Act represent the U.S. 
Government’s attempt to reduce drug abuse by 
dealing not just with the person who sells the 
illegal drug, but also with the person who buys it. 
The first new section is titled “User Accountability,” 
and is codified at 21 U.S.C. § 862 and various 
sections of Title 42, U.S.C. The second involves 
“personal use amounts” of illegal drugs, and is 
codified at 21 U.S.C. § 844a. 
User Accountability 
The purpose of User Accountability is to not 
only make the public aware of the federal 
government’s position on drug abuse, but to 
describe new programs intended to decrease 
drug abuse by holding drug users personally 
responsible for their illegal activities, and 
imposing civil penalties on those who violate drug 
laws. 
It is important to remember that these penalties 
are in addition to the criminal penalties drug 
users are already given, and do not replace those 
criminal penalties. 
The new User Accountability programs call for 
more instruction in schools, kindergarten through 
senior high, to educate children on the dangers 
of drug abuse. These programs will include 
participation by students, parents, teachers, 
local businesses and the local, state, and federal 
government. 
User Accountability also targets businesses 
interested in doing business with the federal 
government. This program requires those 
businesses to maintain a drug-free workplace, 
principally through educating employees on 
the dangers of drug abuse, and by informing 
employees of the penalties they face if they 
engage in illegal drug activity on company 
property. There is also a provision in the law 
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that makes public housing projects drug-free by 
evicting those residents who allow their units to 
be used for illegal drug activity, and denies federal 
benefits, such as housing assistance and student 
loans, to individuals convicted of illegal drug 
activity. Depending on the offense, an individual 
may be prohibited from ever receiving any benefit 
provided by the federal government. 
Personal Use Amounts 
This section of the 1988 Act allows the 
government to punish drug offenders with minor 
infractions without giving the offender a criminal 
record if the offender is in possession of only a 
small amount of drugs. 
This law is designed to impact the “user” of 
illicit drugs, while simultaneously saving the 
government the costs of a full-blown criminal 
investigation. Under this section, the government 
has the option of imposing only a civil fine on 
individuals possessing only a small quantity of 
an illegal drug. Possession of this small quantity, 
identified as a “personal use amount,” carries a 
civil fine of up to $10,000. 
In determining the amount of the fine in a 
particular case, the drug offender’s income and 
assets will be considered. This is accomplished 
through an administrative proceeding rather than 
a criminal trial, thus reducing the exposure of 
the offender to the entire criminal justice system, 
and reducing the costs to the offender and the 
government. 
The value of this section is that it allows the 
government to punish a minor drug offender, 
gives the drug offender the opportunity to fully 
redeem himself or herself, and have all public 
record of the proceeding destroyed. If this was 
the drug offender’s first offense, and the offender 
has paid all fines, can pass a drug test, and has 
not been convicted of a crime after three years, 
the offender can request that all proceedings be 
dismissed. 
If the proceeding is dismissed, the drug offender 
can lawfully say he or she had never been 
prosecuted, either criminally or civilly, for a drug 
offense. 
The law has imposed two limitations on this 
section’s use. It may not be used if (1) the drug 
offender has been previously convicted of a 
federal or state drug offense; or (2) the offender 
has already been fined twice under this section.
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This document is a general reference and not a comprehensive list. This list describes the basic or 
parent chemical and does not describe the salts, isomers and salts of isomers, esters, ethers, and 
derivatives which may also be controlled substances. While some positional isomers have been identified 
here, they are shown as examples, and the chart does not include every potential positional isomer. 
Cannabimimetic agents as defined under the Food and Drug Administration Safety and Innovation Act 
were placed into Schedule I even though they are not included in this particular list. Please visit https:// 
go.usa.gov/59 for the most recent updates to the list. 
SUBSTANCE DEA NUMBER NARCOTIC OTHER NAMES 
(1-(4-Fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-te-
tramethylcyclopropyl)methanone 7014 N FUB-144 
1-(1-Phenylcyclohexyl)pyrrolidine 7458 N PCPy, PHP, rolicyclidine 
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine 9663 Y PEPAP, synthetic heroin 
1-(5-Fluoropentyl)-N-(2-phenylpro-
pan-2-yl)-1H-indazole-3-carboxamide 7083 N 5F-CUMYL-PINACA; SGT-25 
1-[1-(2-Thienyl)cyclohexyl]piperidine 7470 N TCP, tenocyclidine 
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine 7473 N TCPy 
1-Methyl-4-phenyl-4-propionoxypiperidine 9661 Y MPPP, synthetic heroin 
2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethana-
mine  (2C-P) 7524 N 2C-P 
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine  
(2C-E ) 7509 N
2C-E (Positional Isomer: 2,5-Dimethoxy-3,4-di-
methylphenethylamine (2C-G)) 
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine  
(2C-D) 7508 N 2C-D 
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine  
(2C-N) 7521 N 2C-N 
2-(2,5-Dimethoxyphenyl) ethanamine  (2C-H) 7517 N 2C-H 
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxy-
benzyl) ethanamine  (25B-NBOMe) 7536 N 25B-NBOMe, 2C-B-NBOMe, 25B, Cimbi-36 
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine  
(2C-C) 7519 N 2C-C 
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxy-
benzyl) ethanamine  (25C-NBOMe) 7537 N 25C-NBOMe, 2C-C-NBOMe, 25C, Cimbi-82 
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine  
(2C-T-2 ) 7385 N 2C-T-2 
2-(4-iodo-2,5-dimethoxyphenyl) ethanamine  
(2C-I) 7518 N 2C-I 
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxy-
benzyl) ethanamine  (25I-NBOMe) 7538 N 25I-NBOMe, 2C-I-NBOMe, 25I, Cimbi-5 
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethan-
amine  (2C-T-4 ) 7532 N
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2,5-Dimethoxy-4-ethylamphetamine 7399 N DOET 
2,5-Dimethoxyamphetamine 7396 N DMA, 2,5-DMA 
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phe-
nylacetamide 9825 Y Methoxyacetyl fentanyl 
3,4,5-Trimethoxyamphetamine 7390 N 
TMA (Positional Isomers:  2,4,5-Trimethoxy-am-
phetamine (TMA-5), 2,4,6-Trimethoxy-amphet-
amine (TMA-6), Escaline) 
3,4-Methylenedioxyamphetamine 7400 N MDA, Love Drug 
3,4-Methylenedioxymethamphetamine 7405 N MDMA, Ecstasy, XTC 
3,4-Methylenedioxy-N-ethylamphetamine 7404 N N-ethyl MDA, MDE, MDEA 
3-Fluoro-N-methylcathinone  (3-FMC) 1233 N 1-(3-fluorophenyl)-2-(methylamino)propan-1-one) (Positional isomer: 2-FMC) 
3-Methylfentanyl 9813 Y China White, fentanyl 
3-Methylthiofentanyl 9833 Y China White, fentanyl 
4´-methyl-alpha-pyrrolidinohexiophenone 
(MPHP) 7446 N MPHP 
4-Bromo-2,5-dimethoxyamphetamine 7391 N DOB, 4-bromo-DMA 
4-Bromo-2,5-dimethoxyphenethylamine 7392 N 2C-B, Nexus, has been sold as Ecstasy, i.e. MDMA 
4-chloro-alpha-pyrrolidinovalerophenone 








9824 Y Para-fluoroisobutyryl fentanyl 
4-Fluoro-N-methylcathinone  (4-FMC) 1238 N flephedrone; 1-(4-fluorophenyl)-2-(methylamino) propan-1-one)  (Positional isomer: 2-FMC) 
4-Methoxyamphetamine 7411 N PMA 
4-Methyl-2,5-dimethoxyamphetamine 7395 N DOM, STP  (Positional Isomer: 2,5-Dime-thoxy-3,4-dimethylphenethylamine (2C-G)) 
4-methyl-alpha-ethylaminopentiophenone (4-
MEAP) 7245 N 4-MEAP 
4-Methyl-alphapyrrolidinopropiophenone 




4-Methylaminorex (cis isomer) 1590 N U4Euh, McN-422 
4-Methyl-N-ethylcathinone  (4-MEC) 1249 N 
2-(ethylamino)-1-(4-methylphenyl)propan-1-one) 
(Positional Isomers:3-methylethcathinone (3-









SUBSTANCE DEA NUMBER NARCOTIC OTHER NAMES
20   Drugs of Abuse | A DEA Resource Guide: 2020 EDITION
SCHEDULE I
5F–ADB; 5F–MDMB–PINACA (Methyl 
2-(1-(5-fluoropentyl)-1H-indazole-3-carboxam-
ido)-3,3-dimethylbutanoate) 
7034 N 5F-ADB, 5F-MDMB-PINACA 
5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-inda-









5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pen-
tyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl) 
methanone 
7011 N 5-Fluoro-UR-144, XLR-11 and XLR11 
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-in-
dole-3-carboxylate) 7225 N 5-Fluoro-PB-22; 5F-PB-22 
5-Methoxy-3,4-methylenedioxyamphetamine 7401 N MMDA 
5-Methoxy-N,N-diisopropyltryptamine 7439 N 5-MeO-DIPT (Positional Isomer: 5-Me-thoxy-N,N-dipropyltryptamine (5-MeO-DPT)) 
5-Methoxy-N-N-dimethyltryptamine 7431 N 5-MeO-DMT (Positional Isomer: 4-Me-thoxy-N,N-dimethyltryptamine (4-MeO-DMT)) 
AB-CHMINACA  (N-(1-amino-3-methyl-1- 
oxobutan-2-yl)-1-(cyclohexylmethyl)- 
1H-indazole-3-carboxamide 




7012 N AB-FUBINACA 
AB-PINACA  (N-(1-amino-3-methyl- 
1-oxobutan-2-yl)-1-pentyl-1H-indazole- 
3-carboxamide) 
7023 N AB-PINACA 
Acetorphine 9319 Y 
Acetyl Fentanyl  (N-(1-phenethylpiperi-
din-4-yl)-N-phenylacetamide) 9821 Y 
Acetyl-alpha-methylfentanyl 9815 Y 
Acetyldihydrocodeine 9051 Y Acetylcodone 
Acetylmethadol 9601 Y Methadyl acetate 
Acryl fentanyl  (N-(1-phenethylpiperi-








7035 N ADB-PINACA 
AH-7921 (3,4-dichloro-N-[(1-dimethylamino) 
cyclohexylmethyl]benzamide)) 9551 Y AH-7921 
Allylprodine 9602 Y 
Alphacetylmethadol except levo-alphacetylmeth-
adol 9603 Y
SUBSTANCE DEA NUMBER NARCOTIC OTHER NAMES
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SCHEDULE I
Alpha-ethyltryptamine 7249 N ET, Trip 
Alphameprodine 9604 Y 
Alphamethadol 9605 Y 
Alpha-methylfentanyl 9814 Y China White, fentanyl 
Alpha-methylthiofentanyl 9832 Y China White, fentanyl 
Alpha-methyltryptamine 7432 N AMT (Positional Isomer: N-Methyltryptamine) 
alpha-pyrrolidinobutiophenone  (α-PBP) 7546 N 1-phenyl-2-(pyrrolidin-1-yl)butan-1-one) 
alpha-pyrrolidinoheptaphenone (PV8) 7548 N PV8 
alpha-pyrrolidinohexanophenone (a-PHP) 7544 N a-PHP 






indole) 7201 N AM2201 
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) 
indole) 7694 N AM-694 
Aminorex 1585 N has been sold as methamphetamine 
APINACA and AKB48  N-(1-Adamantyl)-1-pen-
tyl-1H-indazole-3-carboxamide 7048 N APINACA and AKB48 
Benzethidine 9606 Y 
Benzylmorphine 9052 Y 
Betacetylmethadol 9607 Y 
Beta-hydroxy-3-methylfentanyl 9831 Y China White, fentanyl 
Beta-hydroxyfentanyl 9830 Y China White, fentanyl 





Betameprodine 9608 Y 
Betamethadol 9609 Y 
Betaprodine 9611 Y 
Bufotenine 7433 N Mappine, N,N-dimethylserotonin 
Butylone 7541 N 
bk-MBDB; 1-(1,3-benzodioxol-5-yl)-2-(methyl-
amino)butan-1-one) (Positional Isomers:  
ethylone (bk-MDEA; MDEC), dimethylone (bk-
MDDMA; MDDMC)) 




Cathinone 1235 N Constituent of “Khat” plant 
Clonitazene 9612 Y 
Codeine methylbromide 9070 Y 
Codeine-N-oxide 9053 Y
SUBSTANCE DEA NUMBER NARCOTIC OTHER NAMES
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SCHEDULE I
CP-47,497 (5-(1,1-Dimethylhepty-
l)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) 7297 N CP-47,497 
CP-47,497 C8 Homologue (5-(1,1-Dimethyloc-
tyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) 7298 N CP-47,497 C8 Homologue 
Cyclopentyl fentanyl 9847 Y N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopen-tanecarboxamide 
Cyclopropyl Fentanyl 9845 Y N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopro-panecarboxamide 
Cyprenorphine 9054 Y 
Desomorphine 9055 Y 
Dextromoramide 9613 Y Palfium, Jetrium, Narcolo 
Diampromide 9615 Y 
Diethylthiambutene 9616 Y 
Diethyltryptamine 7434 N DET, N,N-Diethyltryptamine (Positional Isomer: N-Methyl-N-isopropyltryptamine (MiPT)) 
Difenoxin 9168 Y Lyspafen 
Dihydromorphine 9145 Y 
Dimenoxadol 9617 Y 
Dimepheptanol 9618 Y 
Dimethylthiambutene 9619 Y 
Dimethyltryptamine 7435 N DMT 
Dioxaphetyl butyrate 9621 Y 
Dipipanone 9622 Y Dipipan, phenylpiperone HCl, Diconal, Wellconal 
Drotebanol 9335 Y Metebanyl, oxymethebanol 
Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carbox-
amido)-3,3-dimethylbutanoate 7036 N 5F-EDMB-PINACA 
Ethylmethylthiambutene 9623 Y 
Etonitazene 9624 Y 
Etorphine (except HCl) 9056 Y 
Etoxeridine 9625 Y 
Fenethylline 1503 N Captagon,amfetyline,ethyltheophylline amphet-amine 
Fentanyl related-substances as defined in 21 
CFR 1308.11(h) 9850 Y 
Furanyl fentanyl   (N-(1-phenethylpiperi-
din-4-yl)-N-phenylfuran-2-carboxamide) 9834 Y 
Furethidine 9626 Y 
Gamma Hydroxybutyric Acid 2010 N GHB, gamma hydroxybutyrate, sodium oxybate 
Heroin 9200 Y Diacetylmorphine, diamorphine 
Hydromorphinol 9301 Y 
Hydroxypethidine 9627 Y 
Ibogaine 7260 N Constituent of “Tabernanthe iboga” plant
SUBSTANCE DEA NUMBER NARCOTIC OTHER NAMES
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Isobutyryl fentanyl 9827 Y N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyr-amide 
JWH-018 (also known as AM678) (1-Pentyl-3-(1-
naphthoyl)indole) 7118 N JWH-018 and AM-678 
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) 7019 N JWH-019 
JWH-073 (1-Butyl-3-(1-naphthoyl)indole) 7173 N JWH-073 
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) 
indole) 7081 N JWH-081 
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) 
indole) 7122 N JWH-122 
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naph-
thoyl)indole) 7200 N JWH-200 
JWH-203  (1-Pentyl-3-(2-chlorophenylacetyl) 
indole) 7203 N JWH-203 
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) 
indole) 6250 N JWH-250 
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) 
indole) 7398 N JWH-398 
Ketobemidone 9628 Y Cliradon 
Levomoramide 9629 Y 
Levophenacylmorphan 9631 Y 




7032 N MAB-CHMINACA and ADB-CHMINACA 
Marihuana 7360 N Cannabis, marijuana 
Marihuana Extract 7350 N 
MDMB–CHMICA, MMB–CHMINACA (Methyl 
2-(1-(cyclohexylmethyl)-1H-indole-3-carboxam-
ido)-3,3-dimethylbutanoate) 




7020 N MDMB-FUBINACA 
MDPV (3,4-Methylenedioxypyrovalerone) 7535 N MDPV 
Mecloqualone 2572 N Nubarene 
Mephedrone (4-Methyl-N-methylcathinone) 1248 N 
(Positional Isomers: 3-Methyl-methcathinone, 
Buphedrone, Ethcathinone, N,N-Dimethyl-cathi-
none) 
Mescaline 7381 N Constituent of “Peyote” cacti 
Methaqualone 2565 N Quaalude, Parest, Somnafac, Opitimil, Mandrax 
Methcathinone 1237 N N-Methylcathinone, “cat” 
Methyl 2-(1-(4-fluorobenzyl)-1Hindazole-3-car-
boxamido)-3- methylbutanoate 7021 N FUB–AMB, MMB– FUBINACA, AMB–FUBINACA 
Methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carbox-
amido)-3,3-dimethylbutanoate 7041 N 5F-MDMB-PICA 
Methyldesorphine 9302 Y
SCHEDULE I
SUBSTANCE DEA NUMBER NARCOTIC OTHER NAMES
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SCHEDULE I
Methyldihydromorphine 9304 Y 
Methylone (3,4-Methylenedioxy-N-methylcathi-
none) 7540 N 
(Positional Isomer:  2,3-methylenedioxymeth-
cathinone (2,3-MDMC, 1-(benzo[d][1,3]diox-
ol-4-yl)-2-(methylamino)propan-1-one)) 




Morpheridine 9632 Y 
Morphine methylbromide 9305 Y 
Morphine methylsulfonate 9306 Y 
Morphine-N-oxide 9307 Y 
MT-45  (1-cyclohexyl-4-(1,2-diphenylethyl) 
piperazine)) 9560 Y MT-45 
Myrophine 9308 Y 
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahy-
drofuran-2-carboxamide 9843 Y Tetrahydrofuranyl fentanyl 
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl) 
propionamide 9816 Y Ortho-fluorofentanyl or 2-fluorofentanyl 
N-(Adamantan-1-yl)-1-(4-fluorobenzyl)-1H-inda-
zole-3-carboxamide 7047 N
FUB-AKB48; FUB-APINACA; AKB48 N-(4-FLU-
OROBENZYL) 
N,N-Dimethylamphetamine 1480 N 
Naphyrone 1258 N 
naphthylpyrovalerone; 1-(naphthalen-2-yl)-2-
(pyrrolidin-1-yl)pentan-1-one) (Positional Isomer:  
α-naphyrone) 
N-Benzylpiperazine 7493 N BZP, 1-benzylpiperazine 
N-Ethyl-1-phenylcyclohexylamine 7455 N PCE 
N-Ethyl-3-piperidyl benzilate 7482 N JB 323 
N-Ethylamphetamine 1475 N NEA 
N-ethylhexedrone 7246 N 
N-Ethylpentylone  (1-(1,3-benzodiox-
ol-5-yl)-2-(ethylamino)-pentan-1-one) 7543 N Ephylone 
N-Hydroxy-3,4-methylenedioxyamphetamine 7402 N N-hydroxy MDA 
Nicocodeine 9309 Y 
Nicomorphine 9312 Y Vilan 
NM2201; CBL2201 (Naphthalen-1-yl 1-(5-fluoro-
pentyl)-1 H-indole-3-carboxylate) 7221 N 
N-Methyl-3-piperidyl benzilate 7484 N JB 336 
Noracymethadol 9633 Y 
Norlevorphanol 9634 Y 
Normethadone 9635 Y Phenyldimazone 
Normorphine 9313 Y 
Norpipanone 9636 Y 
Ocfentanil 9838 Y N-(2-fluorophenyl)-2-methoxy-N-(1-pheneth-ylpiperidin-4-yl)acetamide
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Para-chloroisobutyryl fentanyl 9826 Y N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl) isobutyramide 
Para-fluorobutyryl fentanyl 9823 Y N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl) butyramide 
Para-Fluorofentanyl 9812 Y China White, fentanyl 
Parahexyl 7374 N Synhexyl, 
Para-methoxybutyryl fentanyl 9837 Y N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide 
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-car-
boxylate) 7222 N QUPIC; PB-22 
Pentedrone  (α-methylaminovalerophenone) 1246 N 
2-(methylamino)-1-phenylpentan-1-one)(Posi-





Pentylone 7542 N 
bk-MBDP; 1-(1,3-benzodioxol-5-yl)-2-(methyl-
amino)pentan-1-one)  (Positional Isomers: 




Peyote 7415 N Cactus which contains mescaline 
Phenadoxone 9637 Y 
Phenampromide 9638 Y 
Phenomorphan 9647 Y 
Phenoperidine 9641 Y Operidine, Lealgin 
Pholcodine 9314 Y Copholco, Adaphol, Codisol, Lantuss, Pholcolin 
Piritramide 9642 Y Piridolan 
Proheptazine 9643 Y 
Properidine 9644 Y 
Propiram 9649 Y Algeril 
Psilocybin 7437 N Constituent of “Magic mushrooms” 
Psilocyn 7438 N Psilocin, constituent of “Magic mushrooms” 
Racemoramide 9645 Y 
SR-18 (Also known as RCS-8)  (1-Cyclohexy-
lethyl-3-(2-methoxyphenylacetyl) indole) 7008 N SR-18 and RCS-8 
SR-19 (Also known as RCS-4)  (1-Pen-
tyl-3-[(4-methoxy)-benzoyl] indole 7104 N SR-19 and RCS-4 
Tetrahydrocannabinols 7370 N THC, Delta-8 THC, Delta-9 THC, dronabinol and others 
Thebacon 9315 Y Acetylhydrocodone, Acedicon, Thebacetyl 
Thiofentanyl 9835 Y Chine white, fentanyl
SCHEDULE I
SUBSTANCE DEA NUMBER NARCOTIC OTHER NAMES
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THJ-2201  [1-(5-fluoropentyl)-1H-indazol-3- 
yl](naphthalen-1-yl)methanone 7024 N THJ-2201 
Tilidine 9750 Y Tilidate, Valoron, Kitadol, Lak, Tilsa 
Trimeperidine 9646 Y Promedolum 
U-47700 (3,4-dichloro-N-[2-(dimethylamino) 
cyclohexyl]-N-methylbenzamide) 9547 Y U-47700 
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-te-
tramethylcyclopropyl)metanone 7144 N UR-144 
Valeryl fentanyl 9840 Y N-(1-phenethylpiperidin-4-yl)-N-phenylpentan-amide 
SCHEDULE I
SCHEDULE II 
SUBSTANCE DEA NUMBER NARCOTIC OTHER NAMES
SUBSTANCE DEA NUMBER NARCOTIC OTHER NAMES 
1-Phenylcyclohexylamine 7460 N PCP precursor
1-Piperidinocyclohexanecarbonitrile 8603 N PCC, PCP precursor 
4-Anilino-N-phenethyl-4-piperidine (ANPP) 8333 N ANPP,  Despropionyl fentanyl 
Alfentanil 9737 Y Alfenta 
Alphaprodine 9010 Y Nisentil 
Amobarbital 2125 N Amytal, Tuinal 
Amphetamine 1100 N Dexedrine, Adderall, Obetrol 
Anileridine 9020 Y Leritine 
Bezitramide 9800 Y Burgodin 
Carfentanil 9743 Y Wildnil 
Coca Leaves 9040 Y 
Cocaine 9041 Y Methyl benzoylecgonine, Crack 
Codeine 9050 Y Morphine methyl ester, methyl morphine 
Dextropropoxyphene, bulk (non-dosage forms) 9273 Y Propoxyphene 
Dihydrocodeine 9120 Y Didrate, Parzone 
Dihydroetorphine 9334 Y DHE 
Diphenoxylate 9170 Y 
Dronabinol in an oral solution in a drug product 
approved for marketing by the U.S. Food and 
Drug Administration 
7365 N Syndros 
Ecgonine 9180 Y Cocaine precursor, in Coca leaves 
Ethylmorphine 9190 Y Dionin 
Etorphine HCl 9059 Y M 99 
Fentanyl 9801 Y Duragesic, Oralet, Actiq, Sublimaze, Innovar
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Glutethimide 2550 N Doriden, Dorimide 
Hydrocodone 9193 Y dihydrocodeinone 
Hydromorphone 9150 Y Dilaudid, dihydromorphinone 
Isomethadone 9226 Y Isoamidone 
Levo-alphacetylmethadol 9648 Y LAAM, long acting methadone, levomethadyl acetate 
Levomethorphan 9210 Y 
Levorphanol 9220 Y Levo-Dromoran 
Lisdexamfetamine 1205 N Vyvanse 
Meperidine 9230 Y Demerol, Mepergan, pethidine 
Meperidine intermediate-A 9232 Y Meperidine precursor 
Meperidine intermediate-B 9233 Y Meperidine precursor, normeperidine 
Meperidine intermediate-C 9234 Y Meperidine precursor 
Metazocine 9240 Y 
Methadone 9250 Y Dolophine, Methadose, Amidone 
Methadone intermediate 9254 Y Methadone precursor 
Methamphetamine 1105 N Desoxyn, D-desoxyephedrine, ICE, Crank, Speed 
Methylphenidate 1724 N Concerta, Ritalin, Methylin 
Metopon 9260 Y 
Moramide-intermediate 9802 Y 
Morphine 9300 Y MS Contin, Roxanol, Oramorph, RMS, MSIR 
Nabilone 7379 N Cesamet 
Noroxymorphone 9668 Y 
Opium extracts 9610 Y 
Opium fluid extract 9620 Y 
Opium poppy 9650 Y Papaver somniferum 
Opium tincture 9630 Y Laudanum 
Opium, granulated 9640 Y Granulated opium 
Opium, powdered 9639 Y Powdered opium 
Opium, raw 9600 Y Raw opium, gum opium 
Oripavine 9330 Y 
Oxycodone 9143 Y OxyContin, Percocet, Endocet, Roxicodone, Roxicet, 
Oxymorphone 9652 Y Numorphan 
Pentobarbital 2270 N Nembutal 
Phenazocine 9715 Y Narphen, Prinadol 
Phencyclidine 7471 N PCP, Sernylan 
Phenmetrazine 1631 N Preludin
SCHEDULE II
SUBSTANCE DEA NUMBER NARCOTIC OTHER NAMES
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Phenylacetone 8501 N P2P, phenyl-2-propanone, benzyl methyl ketone 
Piminodine 9730 Y 
Poppy Straw 9650 Y Opium poppy capsules, poppy heads 
Poppy Straw Concentrate 9670 Y Concentrate of Poppy Straw, CPS 
Racemethorphan 9732 Y 
Racemorphan 9733 Y Dromoran 
Remifentanil 9739 Y Ultiva 
Secobarbital 2315 N Seconal, Tuinal 
Sufentanil 9740 Y Sufenta 
Tapentadol 9780 Y 
Thebaine 9333 Y Precursor of many narcotics 
Thiafentanil 9729 Y Thianil 
SUBSTANCE DEA NUMBER NARCOTIC OTHER NAMES 
SCHEDULE III 
[3,2-c]-furazan-5α-androstan-17β-ol 4000 N 
[3,2-c]pyrazole-androst-4-en-17β-ol 4000 N 
13Beta-ethyl-17beta-hydroxygon-4-en-3-one 4000 N 
17Alpha-methyl-3alpha,17beta-dihydroxy-5al-
pha-androstane 4000 N 
17Alpha-methyl-3beta,17beta-dihydroxy-5al-
pha-androstane 4000 N 
17Alpha-methyl-3beta,17beta-dihydroxyan-








4000 N 17-Alpha-methyl-1-testosterone 
17α-Methyl-5α-androstan-17β-ol 4000 N 
17α-methyl-androst-2-ene-3,17β-diol 4000 N 
17α-methyl-androsta-1,4-diene-3,17β-diol 4000 N 
17α-Methyl-androstan-3-hydroxyimine-17β-ol 4000 N 
17β-Hydroxy-androstano[2,3-d]isoxazole 4000 N 
17β-Hydroxy-androstano[3,2-c]isoxazole 4000 N 
18a-Homo-3-hydroxy-estra-2,5(10)-dien-17-one 4000 N 
19-Nor-4,9(10)-androstadienedione 4000 N
SCHEDULE II
SUBSTANCE DEA NUMBER NARCOTIC OTHER NAMES


















dione) 4000 N 
2α,17α-dimethyl-17β-hydroxy-5β-androstan-3-
one 4000 N 
2α,3α-epithio-17α-methyl-5α-androstan-17β-ol 4000 N 
3Alpha,17beta-dihydroxy-5alpha-androstane 4000 N 
3Beta,17beta-dihydroxy-5alpha-androstane 4000 N 
3β-hydroxy-estra-4,9,11-trien-17-one 4000 N 
4-Androstenediol (3beta,17beta-dihydroxy-an-
drost-4-ene) 4000 N 4-AD 
4-Androstenedione (androst-4-en-3,17-dione) 4000 N 
4-chloro-17α-methyl-17β-hydroxy-androst-4-en-
3-one 4000 N 
4-chloro-17α-methyl-17β-hydroxy-androst-4-
ene-3,11-dione 4000 N 
4-chloro-17α-methyl-androst-4-ene-3β,17β-diol 4000 N 
4-chloro-17α-methyl-androsta-1,4-diene-3,17β-
diol 4000 N 
4-Dihydrotestosterone (17beta-hydroxyandros-
tan-3-one) 4000 N Anabolex, Andractim, Pesomax, Stanolone 
4-Hydroxy-19-nortestosterone (4,17beta-dihy-
droxyestr-4-en-3-one) 4000 N 
4-Hydroxy-androst-4-ene-3,17-dione 4000 N Listed as 4-Hydroxy-androst-4-ene-3,17-di-one[3,2-c]pyrazole-5α-androstan-17β-ol 
4-Hydroxytestosterone (4,17beta-dihydroxyan-
drost-4-en-3-one) 4000 N 
5-Androstenediol (3beta,17beta-dihydroxy-an-
drost-5-ene) 4000 N 
5-Androstenedione (androst-5-en-3,17-dione) 4000 N 
5α-Androstan-3,6,17-trione 4000 N 
6-bromo-androsta-1,4-diene-3,17-dione 4000 N 
6-bromo-androstan-3,17-dione 4000 N 
6α-Methyl-androst-4-ene-3,17-dione 4000 N 
Amobarbital & noncontrolled active ingred. 2126 N
SCHEDULE III
SUBSTANCE DEA NUMBER NARCOTIC OTHER NAMES
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Amobarbital suppository dosage form 2126 N 
Anabolic steroids 4000 N “Body Building” drugs 
Androstanedione (5alpha-androstan-3,17-dione) 4000 N 
Aprobarbital 2100 N Alurate 
Barbituric acid derivative 2100 N Barbiturates not specifically listed 
Benzphetamine 1228 N Didrex, Inapetyl 
Bolasterone (7alpha,17alpha-dimethyl-17be-
ta-hydroxyandrost-4-en-3-one) 4000 N 
Boldenone (17beta-hydroxyandrost-1,4-di-
ene-3-one) 4000 N
Equipoise, Parenabol, Vebonol, dehydrotestos-
terone 
Boldione 4000 N 
Buprenorphine 9064 Y Buprenex, Temgesic, Subutex, Suboxone 
Butabarbital (secbutabarbital) 2100 N Butisol, Butibel 
Butalbital 2100 N Fiorinal, Butalbital with aspirin 
Butobarbital (butethal) 2100 N Soneryl (UK) 
Calusterone (7beta,17alpha-dimethyl-17beta-hy-
droxyandrost-4-en-3-one) 4000 N Methosarb 
Chlorhexadol 2510 N Mechloral, Mecoral, Medodorm, Chloralodol 
Chlorphentermine 1645 N Pre-Sate, Lucofen, Apsedon, Desopimon 
Clortermine 1647 N Voranil 
Clostebol (4-chloro-17beta-hydroxyandrost-4-
en-3-one) 4000 N Alfa-Trofodermin, Clostene, 4-chlorotestosterone 
Codeine & isoquinoline alkaloid 90 mg/du 9803 Y Codeine with papaverine or noscapine 




4000 N Oral-Turinabol 
Delta1-dihydrotestosterone (17beta-hydroxy-5al-
pha-androst-1-en-3-one) 4000 N 1-Testosterone 
Desoxymethyltestosterone 4000 N 
Dihydrocodeine combination product 90 mg/du 9807 Y Synalgos-DC, Compal 
Dronabinol (synthetic) in sesame oil in soft gela-
tin capsule as approved by FDA 7369 N
Marinol, synthetic THC in sesame oil/soft gelatin 
as approved by FDA 
Drostanolone (17beta-hydroxy-2alpha-meth-
yl-5alpha-androstan-3-one) 4000 N Drolban, Masterid, Permastril 
Embutramide 2020 N Tributane 
Estra-4,9,11-triene-3,17-dione 4000 N 
Ethylestrenol (17alpha-ethyl-17beta-hydroxye-
str-4-ene) 4000 N Maxibolin, Orabolin, Durabolin-O, Duraboral 
Ethylmorphine combination product 15 mg/du 9808 Y 
Fluoxymesterone (9-fluoro-17alpha-meth-
yl-11beta,17beta-dihydroxyandrost-4-en-3-one) 4000 N Anadroid-F, Halotestin, Ora-Testryl 
Formebolone (2-formyl-17alpha-methyl-11al-
pha,17beta-dihydroxyandrost-1,4-dien-3-one) 4000 N Esiclene, Hubernol
SUBSTANCE DEA NUMBER NARCOTIC OTHER NAMES
SCHEDULE III
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Furazabol (17alpha-methyl-17beta-hydroxyan-
drostano[2,3-c]-furazan) 4000 N Frazalon, Miotolon, Qu Zhi Shu 
Gamma Hydroxybutyric Acid preparations 2012 N Xyrem 
Ketamine 7285 N Ketaset, Ketalar, Special K, K 
Lysergic acid 7300 N LSD precursor 
Lysergic acid amide 7310 N LSD precursor 
Mestanolone (17alpha-methyl-17beta-hy-
droxy-5alpha-androstan-3-one) 4000 N Assimil, Ermalone, Methybol, Tantarone 
Mesterolone (1alpha-methyl-17beta-hydroxy-5al-
pha-androstan-3-one) 4000 N Androviron, Proviron, Testiwop 
Methandienone (17alpha-methyl-17beta-hy-
droxyandrost-1,4-dien-3-one) 4000 N Dianabol, Metabolina, Nerobol, Perbolin 
Methandriol (17alpha-methyl-3beta,17beta-dihy-
droxyandrost-5-ene) 4000 N Sinesex, Stenediol, Troformone 
Methasterone (2alpha,17alpha-dimethyl-5al-
pha-androstan-17beta-ol-3-one) 4000 N
Methasterone;    2α,17α-dimethyl-17β-hydroxy-
5α-androstan-3-one 
Methenolone (1-methyl-17beta-hydroxy-5alpha-
androst-1-en-3-one) 4000 N Primobolan, Primobolan Depot, Primobolan S 
Methyldienolone (17alpha-methyl-17beta-hy-
droxyestra-4,9(10)-dien-3-one) 4000 N 
Methyltestosterone (17alpha-methyl-17beta-hy-
droxyandrost-4-en-3-one) 4000 N Android, Oreton, Testred, Virilon 
Methyltrienolone (17alpha-methyl-17beta-hy-
droxyestra-4,9,11-trien-3-one) 4000 N Metribolone 
Methyprylon 2575 N Noludar 
Mibolerone (7alpha,17alpha-dimethyl-17beta-hy-
droxyestr-4-en-3-one) 4000 N Cheque, Matenon 
Morphine combination product/50 mg/(100 ml or 
100 gm) 9810 Y 
Nalorphine 9400 Y Nalline 
Nandrolone (17beta-hydroxyestr-4-en-3-one) 4000 N Deca-Durabolin, Durabolin, Durabolin-50 
Norbolethone (13beta,17alpha-diethyl-17be-
ta-hydroxygon-4-en-3-one) 4000 N Genabol 
Norclostebol (4-chloro-17beta-hydroxyestr-4-
en-3-one 4000 N Anabol-4-19, Lentabol 
Norethandrolone (17alpha-ethyl-17beta-hy-
droxyestr-4-en-3-one) 4000 N Nilevar, Pronabol, Solevar 
Normethandrolone (17alpha-methyl-17beta-hy-
droxyestr-4-en-3-one) 4000 N Lutenin, Matronal, Orgasteron 
Opium combination product 25 mg/du 9809 Y Paregoric, other combination products 
Oxandrolone (17alpha-methyl-17beta-hydroxy-
2-oxa-5alpha-androstan-3-one) 4000 N Anavar, Lonavar, Oxandrin, Provitar, Vasorome 
Oxymesterone (17alpha-methyl-4,17beta-dihy-
droxyandrost-4-en-3-one) 4000 N Anamidol, Balnimax, Oranabol, Oranabol 10 
Oxymetholone (17alpha-methyl-2-hydroxymeth-
ylene-17beta-hydroxy-5alpha-androstan-3-one) 4000 N
Anadrol-50, Adroyd, Anapolon, Anasteron, 
Pardroyd 
Pentobarbital & noncontrolled active ingred. 2271 N FP-3 
Pentobarbital suppository dosage form 2271 N WANS
SCHEDULE III
SUBSTANCE DEA NUMBER NARCOTIC OTHER NAMES
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Perampanel 2261 N 
Fycompa, [2-(2-oxo-l-phenyl- 
5-pyridin-2-yl-l ,2-dihydropyridin-3-yl) benzonitrile 
] 
Phendimetrazine 1615 N Plegine, Prelu-2, Bontril, Melfiat, Statobex 
Prostanozol (17beta-hydroxy-5alpha-androsta-
no[3,2-c]pyrazole) 4000 N
Prostanozol;     [3,2-c]pyrazole-5α-an-
drostan-17β-ol 
Secobarbital & noncontrolled active ingred 2316 N 
Secobarbital suppository dosage form 2316 N 
Stanozolol (17alpha-methyl-17beta-hydroxy-5al-
pha-androst-2-eno[3,2-c]-pyrazole) 4000 N Winstrol, Winstrol-V 
Stenbolone (17beta-hydroxy-2-methyl--5alpha-
androst-1-en-3-one) 4000 N 
Stimulant compounds previously excepted 1405 N Mediatric 
Sulfondiethylmethane 2600 N 
Sulfonethylmethane 2605 N 
Sulfonmethane 2610 N 
Talbutal 2100 N Lotusate 
Testolactone (13-hydroxy-3-oxo-13,17-secoan-
drosta-1,4-dien-17-oic acid lactone) 4000 N Teolit, Teslac 
Testosterone (17beta-hydroxyandrost-4-en-3-
one) 4000 N Android-T, Androlan, Depotest, Delatestryl 
Tetrahydrogestrinone (13beta,17alpha-dieth-
yl-17beta-hydroxygon-4,9,11-trien-3-one) 4000 N THG 
Thiamylal 2100 N Surital 
Thiopental 2100 N Pentothal 
Tiletamine & Zolazepam Combination Product 7295 N Telazol 
Trenbolone (17beta-hydroxyestr-4,9,11-trien-3-
one) 4000 N Finaplix-S, Finajet, Parabolan 
Vinbarbital 2100 N Delvinal, vinbarbitone 
Alfaxalone 2731 N Alfaxan,  5α-pregnan-3α-ol-11,20-dione 
Alprazolam 2882 N Xanax 
Barbital 2145 N Veronal, Plexonal, barbitone 
Bromazepam 2748 N Lexotan, Lexatin, Lexotanil 
Butorphanol 9720 N Stadol, Stadol NS, Torbugesic, Torbutrol 
Camazepam 2749 N Albego, Limpidon, Paxor 
Carisoprodol 8192 N Soma
SCHEDULE IV 
SUBSTANCE DEA NUMBER NARCOTIC OTHER NAMES
SUBSTANCE DEA NUMBER NARCOTIC OTHER NAMES 
SCHEDULE III
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SCHEDULE IV
SUBSTANCE DEA NUMBER NARCOTIC OTHER NAMES
Cathine 1230 N Constituent of “Khat” plant, (+)-norpseudoephed-rine 
Chloral betaine 2460 N Beta Chlor 
Chloral hydrate 2465 N Noctec 
Chlordiazepoxide 2744 N Librium, Libritabs, Limbitrol, SK-Lygen 
Clobazam 2751 N Urbadan, Urbanyl 
Clonazepam 2737 N Klonopin, Clonopin 
Clorazepate 2768 N Tranxene
Clotiazepam 2752 N Trecalmo, Rize, Clozan, Veratran 
Cloxazolam 2753 N Akton, Lubalix, Olcadil, Sepazon 
Delorazepam 2754 N 
Dexfenfluramine 1670 N Redux 
Dextropropoxyphene dosage forms 9278 Y Darvon, propoxyphene, Darvocet, Propacet 
Diazepam 2765 N Valium, Diastat 
Dichloralphenazone 2467 N Midrin, dichloralantipyrine 
Diethylpropion 1610 N Tenuate, Tepanil 
Difenoxin 1 mg/25 ug AtSO4/du 9167 Y Motofen 
Eluxadoline 9725 N VIBERZI 
Estazolam 2756 N ProSom, Domnamid, Eurodin, Nuctalon 
Ethchlorvynol 2540 N Placidyl 
Ethinamate 2545 N Valmid, Valamin 
Ethyl loflazepate 2758 N 
Fencamfamin 1760 N Reactivan 
Fenfluramine 1670 N Pondimin, Ponderal 
Fenproporex 1575 N Gacilin, Solvolip 
Fludiazepam 2759 N 
Flunitrazepam 2763 N Rohypnol, Narcozep, Darkene, Roipnol 
Flurazepam 2767 N Dalmane 
Fospropofol 2138 N Lusedra 
Halazepam 2762 N Paxipam 
Haloxazolam 2771 N 
Ketazolam 2772 N Anxon, Loftran, Solatran, Contamex 
Loprazolam 2773 N 
Lorazepam 2885 N Ativan 
Lorcaserin 1625 N Belviq 
Lormetazepam 2774 N Noctamid 
Mazindol 1605 N Sanorex, Mazanor 
Mebutamate 2800 N Capla 
Medazepam 2836 N Nobrium
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Mefenorex 1580 N Anorexic, Amexate, Doracil, Pondinil 
Meprobamate 2820 N Miltown, Equanil, Micrainin, Equagesic, Mepro-span 
Methohexital 2264 N Brevital 
Methylphenobarbital (mephobarbital) 2250 N Mebaral, mephobarbital 
Midazolam 2884 N Versed 
Modafinil 1680 N Provigil 
Nimetazepam 2837 N Erimin 
Nitrazepam 2834 N Mogadon 
Nordiazepam 2838 N Nordazepam, Demadar, Madar 
Oxazepam 2835 N Serax, Serenid-D 
Oxazolam 2839 N Serenal, Convertal 
Paraldehyde 2585 N Paral 
Pemoline 1530 N Cylert 
Pentazocine 9709 N Talwin, Talwin NX, Talacen, Talwin Compound 
Petrichloral 2591 N Pentaerythritol chloral, Periclor 
Phenobarbital 2285 N Luminal, Bellergal-S 
Phentermine 1640 N Ionamin, Fastin, Adipex-P, Obe-Nix, Zantryl 
Pinazepam 2883 N Domar 
Pipradrol 1750 N Detaril, Stimolag Fortis 
Prazepam 2764 N Centrax 
Quazepam 2881 N Doral 
Sibutramine 1675 N Meridia 
SPA 1635 N 1-dimethylamino-1,2-diphenylethane, Lefetamine 




Temazepam 2925 N Restoril 
Tetrazepam 2886 N Myolastan, Musaril 
Tramadol (2-[(dimethylamino)methyl]-1-(3-me-
thoxyphenyl)cyclohexanol) 9752 Y Tramadol 
Triazolam 2887 N Halcion 
Zaleplon 2781 N Sonata 
Zolpidem 2783 N Ambien, Ivadal, Stilnoct, Stilnox 
Zopiclone 2784 N Lunesta
SUBSTANCE DEA NUMBER NARCOTIC OTHER NAMES
SCHEDULE IV
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SUBSTANCE DEA NUMBER NARCOTIC OTHER NAMES
Approved Cannabidiol Drugs (as defined in 21 
CFR 1308.15(f)) 7367 N 
A drug product in finished dosage formulation 
that has been approved by the U.S. Food and 
Drug Administration that contains Cannabidiol 
derived from cannabis and no more than 0.1 
percent (w/w) residual tetrahydrocannabinols. 
Brivaracetam 2710 N 
BRV, UCB-34714, Briviact, ((2S)-2-[(4R)-2-
oxo-4- 
propylpyrrolidin-1-yl] butanamide) 




Difenoxin preparations - 0.5 mg/25 ug AtSO4/du Y Motofen 
Dihydrocodeine preparations 100mg/(100 ml or 
100 gm) Y Cophene-S, various others 
Diphenoxylate preparations 2.5 mg/25 ug AtSO4 Y Lomotil, Logen 
Ethylmorphine preparations 100 mg/(100 ml or 
100 gm) Y 
Ezogabine 2779 N Potiga 
Lacosamide 2746 N Vimpat 
Opium preparations - 100 mg/(100 ml or 100 
gm) Y Parepectolin, Kapectolin PG, Kaolin Pectin P.G. 
Pregabalin 2782 N Lyrica 
Pyrovalerone 1485 N Centroton, Thymergix
SCHEDULE V
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FEDERAL TRAFFICKING PENALTIES 
DRUG/SCHEDULE QUANTITY PENALTIES QUANTITY PENALTIES 
Cocaine (Schedule II) 500–4999 grams mixture First Offense: 
Not less than 5 yrs, 
and not more than 
40 yrs. If death or 
serious injury, not 
less than 20 or more 
than life. Fine of not 
more than $5 million 
if an individual, $25 
million if not an 
individual. 
Second Offense: 
Not less than 10 
yrs, and not more 
than life. If death or 
serious injury, life 
imprisonment. 
Fine of not more 
than $8 million if an 
individual, $50 million 
if not an individual. 
5 kgs or more mixture First Offense: Not less than 
10 yrs, and not more than life. 
If death or serious injury, not 
less than 20 or more than life. 
Fine of not more than $10 mil-
lion if an individual, $50 million 
if not an individual. 
Second Offense: Not less 
than 20 yrs, and not more than 
life. If death or serious injury, 
life imprisonment. 
Fine of not more than $20 
million if an individual, $75 
million if not an individual. 
2 or More Prior 
Offenses: 
Life imprisonment. Fine of 
not more than $20 million if an 
individual, $75 million if not an 
individual. 
Cocaine Base (Schedule II) 28–279 grams mixture 280 grams or more 
mixture 




10–99 grams mixture 100 grams or more 
mixture 
Heroin (Schedule I) 100–999 grams mixture 1 kg or more mixture 
LSD (Schedule I) 1–9 grams mixture 10 grams or more 
mixture 
Methamphetamine 5–49 grams pure or 50 grams or more 
pure or 
(Schedule II) 50–499 grams mixture 500 grams or more 
mixture 
PCP (Schedule II) 10–99 grams pure 
or 100–999 grams 
mixture 
100 gm or more 
pure or 1 kg or 
more mixture 
PENALTIES 
Other Schedule I & II 
drugs (and any drug 
product containing Gamma 
Hydroxybutyric Acid) 
Any amount First Offense: Not more than 20 yrs. If death or serious injury, not less than 
20 yrs, or more than life. Fine $1 million if an individual, $5 million if not an 
individual. 
Second Offense: Not more than 30 yrs. If death or serious bodily injury, life 
imprison- ment. Fine $2 million if an individual, $10 million if not an individual.Flunitrazepam (Schedule IV) 1 gram 
Other Schedule III drugs Any amount First Offense: Not more than 10 years. If death or serious injury, not more that 
15 yrs. Fine not more than $500,000 if an individual, $2.5 million if not an individu-
al. 
Second Offense: Not more than 20 yrs. If death or serious injury, not more than 
30 yrs. Fine not more than $1 million if an individual, $5 million if not an individual. 
All other Schedule IV drugs Any amount First Offense: Not more than 5 yrs. Fine not more than $250,000 if an individ-
ual, $1 million if not an individual. 
Second Offense: Not more than 10 yrs. Fine not more than $500,000 if an individ-
ual, $2 million if other than an individual. 
Flunitrazepam (Schedule IV) Other than 1 gram or 
more 
All Schedule V drugs Any amount First Offense: Not more than 1 yr. Fine not more than $100,000 if an individual, 
$250,000 if not an individual. 
Second Offense: Not more than 4 yrs. Fine not more than $200,000 if an individ-
ual, $500,000 if not an individual.
Marijuana (Schedule I)
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*The minimum sentence for a violation after two or more prior convictions for a felony drug offense have become final is a mandatory term of life 
imprisonment without release and a fine up to $20 million if an individual and $75 million if other than an individual.
DRUG QUANTITY 1st OFFENSE 2nd OFFENSE * 
Marijuana (Schedule I) 1,000 kg or more marijuana mixture; 
or 1,000 or more marijuana plants 
Not less than 10 yrs. or more than life. 
If death or serious bodily injury, not less 
than 20 yrs., or more than life. Fine not 
more than life. Fine not more than $10 
million if an individual, $50 million if 
other than an individual. 
Not less than 20 yrs. or more than life. 
If death or serious bodily injury, life 
imprisonment. Fine not more than $20 
moillion if an individual, $75 million if 
other than an individual. 
Marijuana (Schedule I) 100 kg to 999 kg marijuana mixture; 
or 100 to 999 marijuana plants 
Not less than 5 yrs. or more than 40 
yrs. If death or serious bodily injury, not 
less than 20 yrs., or more than life. Fine 
not more than life. Fine not more than 
$5 million if an individual, $25 million if 
other than an individual. 
Not less than 10 yrs. or more than life. 
If death or serious bodily injury, life 
imprisonment. Fine not more than $20 
moillion if an individual, $75 million if 
other than an individual. 
Marijuana (Schedule I) More than 10 kgs hashish; 
50 to 99 kg marijuana mixture 
More than 1 kg of hashish oil;  
50 to 99 marijuana plants 
Not less than 20 yrs. If death or serious 
bodily injury, not less than 20 yrs., or 
more than life. Fine $1 million if an 
individual, $5 million if other than an 
individual. 
Not less than 30 yrs. If death or serious 
bodily injury, life imprisonment. Fine 
$2 million if an individual, $10 million if 
other than an individual. 
Marijuana (Schedule I) Less than 50 kilograms marijuana 
(but does not include 50 or more 
marijuana plants regardless of weight) 
marijuana plants; 
1 to 49 marijuana plants; 
Not less than 5 yrs. Fine not more than 
$250,000, $1 million if other than an 
individual 
Not less than 10 yrs. Fine $500,000 if 
an individual, $2 million if other than 
individual 
Hashish (Schedule I) 10 kg or less 
Hashish Oil (Schedule I) 1 kg or less 
FEDERAL TRAFFICKING PENALTIES MARIJUANA 
II. U.S. Chemical Control
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II. U.S. Chemical Control 
The Drug Enforcement Administration (DEA) employs a 
multifaceted approach to combat drug trafficking which 
includes enforcement, interdiction, and education. A 
lesser known approach which combines elements from all 
three of these facets is chemical control. Large quantities 
of chemicals are required to synthesize, extract, and 
purify most illicit drugs. The DEA has long recognized the 
need to monitor these chemicals as part of its overall drug 
control strategy. 
During the 1980s there was a tremendous 
increase in the clandestine production of controlled 
substances, particularly methamphetamine in 
the United States. There was also a proliferation 
of clandestine laboratories producing controlled 
substance analogues, very potent and dangerous 
variations of controlled narcotics, stimulants, 
and hallucinogens. Furthermore, DEA learned 
that U.S. firms were exporting large quantities of 
chemicals, such as acetone, methylethylketone, 
and potassium permanganate to cocaine producing 
countries. Significant amounts of these chemicals 
ultimately were diverted to clandestine cocaine 
laboratories. It became clear that mandatory 
controls were needed to control the distribution of 
these chemicals in order to have an impact on the 
clandestine laboratory problem. 
DEA embarked upon a broad chemical control 
program in 1989 that began with the Chemical 
Diversion and Trafficking Act (CDTA) of 1988. 
The CDTA regulated 12 precursor chemicals, 
eight essential chemicals, tableting machines, 
and encapsulating machines by imposing 
recordkeeping and import/export reporting 
requirements on  transactions involving these 
products. It resulted in effectively reducing the 
supply of illicit methamphetamine. The number of 
clandestine laboratories seized in the first three 
years following the law’s implementation reversed 
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the trend of the previous three decades and 
resulted in a decline. Currently, DEA regulates 42 
chemicals which are commonly used in illicit drug 
production.
 Maintaining this success requires continuous 
effort to thwart traffickers’ never-ending search 
for new methods of diversion and new precursor 
materials. 
The foundation of the government’s program to 
prevent chemical diversion is based on additional 
laws such as the Domestic Chemical Diversion 
Control Act of 1993 (DCDCA), the Comprehensive 
Methamphetamine Control Act of 1996 (MCA), 
the Methamphetamine Anti-Proliferation Act of 
2000 (MAPA), and the Combat Methamphetamine 
Epidemic Act of 2005 (CMEA). This is illustrated 
by changes in the patterns of diversion: 
• When the quantity of U.S. chemicals shipped to 
cocaine manufacturing areas declined, chemical 
suppliers from other parts of the world emerged as 
new sources of supply. The U.S. government then 
undertook an aggressive international campaign 
to educate and elicit the support of other nations 
in establishing chemical controls. Today, there is 
a broad level of international agreement regarding 
the actions that must be taken to achieve chemical 
control. Many nations have passed laws to prevent 
the diversion of chemicals. 
• As a result of government controls, ephedrine 
and other chemicals used to manufacture 
methamphetamine became more difficult to divert. 
Traffickers then began using over-the-counter 
capsules and tablets that contained these ingredients. 
As chemicals rendered into legitimate medicines 
purportedly for the commercial market, these products 
were exempted from the CDTA requirements. The 
DCDCA closed this loophole and required DEA 
registration for all manufacturers, distributors, 
importers, and exporters of List I chemicals. It also 
established recordkeeping and reporting requirements 
for transactions in single-entity ephedrine products. 
• When single-entity ephedrine products became 
regulated, drug traffickers turned to pseudoephedrine. 
This was addressed by the MCA which expanded 
regulatory control of lawfully marketed drug products 
containing ephedrine, pseudoephedrine, and 
phenylpropanolamine (PPA)1 .
• MAPA focused on the continuing retail level diversion 
by constricting retail transactions of pseudoephedrine 
and PPA drug products. It reduced the threshold for 
such transactions from 24 grams to nine grams of 
pseudoephedrine or PPA base in a single transaction 
and limited package sizes to contain no more than 
three grams of pseudoephedrine or PPA base. The 
Act also increased penalties for chemical diversion 
and provided for restitution to the government for 
cleanup costs. 
• The CMEA further restricted retail level transactions 
by redefining nonprescription products that contain 
ephedrine, pseudoephedrine, and PPA as “scheduled 
listed chemical products (SLCPs).” The Act requires 
all regulated sellers of SLCPs to complete a required 
training and self-certification process effective 
September 30, 2006. On this date, stores were 
required to keep all SLCPs behind the counter or in 
a locked cabinet. Consumers wishing to purchase 
(1)Due to concerns regarding harmful side effects that 
phenylpropanolamine (PPA) can have, on November 6, 2000, the 
Food and Drug Administration invoked a voluntary withdrawal of 
over-the counter PPA products intended for human consumption. 
 
Drugs of Abuse  | A DEA Resource Guide: 2020 EDITION   41
SLCPs are required to show identification and sign a 
logbook for each purchase. The Act also implements 
daily sales limits of 3.6 grams per purchaser and 
purchase limits of nine grams of these products in a 
30 day period to any person. 
• All of these federal laws (CDTA, DCDCA, MCA, 
MAPA, and CMEA) imposed varying degrees 
of reporting requirements on the chemical and 
pharmaceutical industries. Yet the involvement of 
private industry and the public should not be limited 
to the laws passed by Congress. The voluntary 
support by industry constitutes a powerful resource 
for protecting the health and safety of the nation. DEA 
encourages each firm to be vigilant and to become a 
partner in combating the diversion of chemicals used 
in illegal drug production. 
• It is DEA’s goal to effectively regulate while 
maintaining a positive working relationship with the 
regulated community and to educate the regulated 
community on the various laws regarding precursor 
chemicals and their implementing regulations. DEA 
understands that it can best serve the public interest 
by working in voluntary cooperation with the chemical 
industry in developing programs designed to prevent 
the diversion of regulated chemicals into the illicit  
market.
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1. N-Acetylanthranilic Acid 2 ▲ 40 40 
2. Alpha-Phenylacetoacetonitrile 3 (PAAN) ▲ 0 0 
3. Anthranilic Acid 2 ▲ 30 30 
4. Benzaldehyde ▲ ▲ 4 4 
5. Benzyl Cyanide ▲ 1 1 
6. Ephedrine 3 & 7 ▲ ▲ 0 0 
7. Ergocristine 1 ▲  
8. Ergonovine 1 ▲ 0.010 0.010 
9. Ergotamine 1 ▲ 0.020 0.020 
10. Ethylamine 1 ▲ ▲ 1 1 
11. Gamma-Butyrolactone (GBL) ▲ 0 0 
12. Hydriodic Acid ■ 1.7 1.7 
13. Hypophosphorous Acid 1 ■ ■ 0 0 
14. Iodine ■ ■ 0 0 
15. Isosafrole ▲ ▲ ▲ 4 4 
16. Methylamine 1 ▲ ▲ 1 1 
17. 3, 4-Methylenedioxyphenyl-2-Propanone ▲ ▲ ▲ 4 4 
18. N-Methylephedrine 3 ▲ 1 1 
19. N-Methylpseudoephedrine 3 ▲ 1 1 
20. N-phenethyl-4-Piperidone (NPP) ▲ 0 0 
21. Nitroethane ▲ ▲ ▲ 2.5 2.5 
22. Norpseudoephedrine 3 ▲ ▲ 2.5 2.5 
23. Phenylacetic Acid 2 ▲ 1 1 
24. Phenylpropanolamine 3 & 7 ▲ ▲ 2.5 2.5 
25. Phosphorus (red) ■ ■ 0 0 
26. Phosphorus (white or yellow) ■ ■ 0 0 
27. Piperidine 1 ▲ 0.500 0.500 
28. Piperonal (heliotropin) ▲ ▲ ▲ 4 4 
29. Propionic Anhydride ▲ 0.001 0.001 
30. Pseudoephedrine 3 & 7 ▲ ▲ 1 1 
31. Safrole ▲ ▲ ▲ 4 4 







































































































































Listed Chemicals regulated 
under the Controlled  
Substances Act 
See 21, C.F.R. §§ 1309, 1310,  
and 1314 for details 
March 2019
■  Reagent     ▲  Precursor     
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1 and its salts 
2 and its salts and esters 
3 and its salts, optical isomers, and salts of optical isomers 
4 Exports only, to all Western Hemisphere except Canada 
5 Exports to all South American countries & Panama — Domestic for HCI gas 
6 Threshold for HCI acid and sulfuric acid is 50 gallons, the equivalent weight in kilograms is shown 
7  For pseudoephedrine, phenylpropanolamine, and ephedrine drug products, see 21 USC § 802 (45)(A) and 21 C.F.R. Part 1314 
N/C = Not Controlled
KEY  

























































































































Listed Chemicals regulated 
under the Controlled  
Substances Act
See 21, C.F.R. §§ 1309, 1310,  
1313, and 1314 for details
March 2019
32. Acetic Anhydride ▲ ▲ ▲ 1,023 1,023 
33. Acetone ● ● ● ● ● ● ● 150 1,500 
34. Benzyl Chloride ▲ 1 4 
35. Ethyl Ether ● ● ● ● ● ● ● ● ● ● ● ● ● 135.8 1,364 
36. Hydrochloric Acid 5 & 6 ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ N/C 222.3 
36a. Hydrogen Chloride Gas 5 & 6 ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ 0 27 
37. Methyl Ethyl Ketone (2-Butanone) ● ● ● ● ● 145 1.455 
38. Methyl Isobutyl Ketone 4 ● ● ● ● ● N/C 1.523 
39. Potassium Permanganate ■ 55 500 
40. Sodium Permanganate ■ 55 500 
41. Sulfuric Acid 5 & 6 ■ ■ ■ ■ ■ ■ ■ N/C 347 
42. Toluene ● ● ● ● ● 159 1,591 
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III. Introduction to Drug Classes III. Introduction to Drug Classes
The Controlled Substances Act (CSA) regulates 





• Anabolic Steroids 
Each class has distinguishing properties, and 
drugs within each class often produce similar 
effects. However, all controlled substances, 
regardless of class, share a number of common 
features. This introduction will familiarize you 
with these shared features and define the terms 
frequently associated with these drugs. 
All controlled substances have abuse potential 
or are immediate precursors to substances with 
abuse potential. With the exception of anabolic 
steroids, controlled substances are abused to 
alter mood, thought, and feeling through their 
actions on the central nervous system (brain and 
spinal cord). Some of these drugs alleviate pain, 
anxiety, or depression. Some induce sleep and 
others energize. 
Though some controlled substances are 
therapeutically useful, the “feel good” effects 
of these drugs contribute to their abuse. The 
extent to which a substance is reliably capable 
of producing intensely pleasurable feelings 
(euphoria) increases the likelihood of that 
substance being abused. 
DRUG ABUSE 
When controlled substances are used in 
a manner or amount inconsistent with the 
legitimate medical use, it is called drug abuse. 
The non-sanctioned use of substances controlled 
in Schedules I through V of the CSA is considered 
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drug abuse. While legal pharmaceuticals placed 
under control in the CSA are prescribed and 
used by patients for medical treatment, the use of 
these same pharmaceuticals outside the  scope 
of sound medical practice is  drug abuse. 
DEPENDENCE 
In addition to having abuse potential, most 
controlled substances are capable of producing 
dependence, either physical or psychological. 
Physical Dependence 
Physical dependence refers to the changes 
that have occurred in the body after repeated 
use of a drug that necessitates the continued 
administration of the drug to prevent a withdrawal 
syndrome. This withdrawal syndrome can range 
from mildly unpleasant to life-threatening and is 
dependent on a number of factors, such as: 
• The drug being used 
• The dose and route of administration 
• Concurrent use of other drugs 
• Frequency and duration of drug use 
• The age, sex, health, and genetic makeup of the 
user 
Psychological Dependence 
Psychological dependence refers to the 
perceived “need” or “craving” for a drug. 
Individuals who are psychologically dependent on 
a particular substance often feel that they cannot 
function without continued use of that substance. 
While physical dependence disappears within 
days or weeks after drug use stops, psychological 
dependence can last much longer and is one of 
the primary reasons for relapse (initiation of drug 
use after a period of abstinence). 
Contrary to common belief, physical 
dependence is not addiction. While individuals 
with a substance use disorder are usually 
physically dependent on the drug they are 
abusing, physical dependence can exist 
without addiction. For example, patients who 
take narcotics for chronic pain management or 
benzodiazepines to treat anxiety are likely to be 
physically dependent on that medication. 
ADDICTION 
Addiction is defined as compulsive drug-
seeking behavior where acquiring and using 
a drug becomes the most important activity in 
the user’s life. This definition implies a loss of 
control regarding drug use, and the person with 
a substance use disorder will continue to use 
a drug despite serious medical and/or social 
consequences. In 2018, an estimated 31.9 million 
Americans aged 12 or older were current (past 
month) illicit drug users, meaning they had used 
an illicit drug during the month prior to the survey 
interview. This estimate represents 11.7% of the 
population aged 12 or older. Illicit drugs include 
marijuana, cocaine (including crack), heroin, 
hallucinogens, inhalants, methamphetamine, or 
prescription psychotherapeutics (including pain 
relievers, tranquilizers, stimulants, and sedatives) 
that were misused.1 
Drugs within a class are often compared with 
each other with terms like potency and efficacy. 
Potency refers to the amount of a drug that 
must be taken to produce a certain effect, while 
efficacy refers to whether or not a drug is capable 
of producing a given effect regardless of dose. 
(1)Results from the 2019 National Survey on Drug Use and Health: 
Detailed Tables; U.S. Department of Health and Human Services, 
Substance Abuse and Mental Health Services Administration 
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Both the strength and the ability of a substance 
to produce certain effects play a role in whether 
that drug is selected by the drug user. 
It is important to keep in mind that the effects 
produced by any drug can vary significantly and 
is largely dependent on the dose and route of 
administration. Concurrent use of other drugs 
can enhance or block an effect, and substance 
users often take more than one drug to boost the 
desired effects or counter unwanted side effects. 
The risks associated with drug abuse cannot 
be accurately predicted because each user has 
his/her own unique sensitivity to a drug. There 
are a number of theories that attempt to explain 
these differences, and it is clear that a genetic 
component may predispose an individual to 
certain toxicities or even addictive behavior. 
Youth are especially vulnerable to drug 
abuse. According to the National Institute on 
Drug Abuse, young Americans engaged in 
unprecedented levels of illicit drug use in the last 
third of the twentieth century. Today, about 47% 
of young people have used an illicit drug by the 
time they leave high school and about 8.5% of 
eighth graders, 20% of tenth graders, and 24% 
of twelfth graders are current (within the past 
month) users.2 
Substance use in youth can result in tragic 
consequences with untold harm to themselves, 
heir families, and others. The 2016 Surgeon 
General’s Report on Alcohol, Drugs, and Health 
(2)Monitoring the Future Survey, 2019; National Institute on Drug 
Abuse, National Institutes of Health, U.S. Department of Health 
and Human Services 
identified risk factors for youth which might lead 
them into substance abuse. These include being 
raised in a home where the parents or other 
relatives use drugs, living in neighborhoods and 
going to schools where drug use is common, 
and associating with peers who use substances. 
Nearly 70% of those who try an illicit drug before 
the age of 13 develop a substance use disorder 
in the next 7 years, compared with 27% of those 
who first try an illicit drug after the age of 17.3 
In the sections that follow, each of the classes 
of drugs is reviewed and various drugs within 
each class are profiled. 
Although marijuana is classified in the 
CSA as a hallucinogen, a separate section 
is dedicated to that topic. There are also a 
number of substances that are abused but not 
regulated under the CSA. Alcohol and tobacco, 
for example, are specifically exempt from 
control by the CSA. In addition, a whole group 
of substances called inhalants are commonly 
available and widely abused by children. Control 
of these substances under the CSA would not 
only impede legitimate commerce, but also 
would likely have little effect on the abuse of 
these substances by youngsters. An energetic 
campaign aimed at educating both adults and 
youth about inhalants is more likely to prevent 
their abuse. To that end, a section is dedicated to 
providing information on inhalants.
(3)Facing Addiction in America. The Surgeon General s Report on 
Alcohol, Drugs, and Health, October 2016. U.S. Department of 
Health and Human Services. 
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WHAT ARE NARCOTICS? 
Also known as “opioids,” the term “narcotic” comes from the Greek word for “stupor” and originally referred 
to a variety of substances that dulled the senses and relieved pain. Though some people still refer to 
all drugs as “narcotics,” today “narcotic” refers to opium, opium derivatives, and their semi-synthetic 
substitutes. A more current term for these drugs, with less uncertainty regarding its meaning, is “opioid.” 
Examples include the illicit drug heroin and pharmaceutical drugs like OxyContin®, Vicodin®, codeine, 
morphine, methadone, and fentanyl. 
WHAT IS THEIR ORIGIN? 
The poppy Papaver somniferum is the source for all natural opioids, whereas synthetic opioids are made 
entirely in a lab and include meperidine, fentanyl, and methadone. Semi-synthetic opioids are synthesized 
from naturally occurring opium products, such as morphine and codeine, and include heroin, oxycodone, 
hydrocodone, and hydromorphone. Teens can obtain narcotics from friends, family members, medicine 
cabinets, pharmacies, nursing homes, hospitals, hospices, doctors, and the Internet. 
What are common street names? 
Street names for various narcotics/opioids include: 
• Smack, Horse, Mud, Brown Sugar, Junk, Black Tat, Big  H, Paregoric, Dover’s Powder, MPTP (New Heroin), Hillbilly 
Heroin, Lean or Purple Drank, OC, Ox, Oxy, Oxycotton,  Sippin Syrup 
What do they look like? 
Narcotics/opioids come in various forms, including: 
• Tablets, capsules, skin patches, powder, chunks in varying 
colors (from white to shades of brown and black), liquid form for 
oral use and injection, syrups, suppositories,  and lollipops 
How are they abused? 
• Narcotics/opioids can be swallowed, smoked, sniffed, or injected. 
What is their effect on the mind? 
Besides their medical use, narcotics/opioids produce a 
general sense of well-being by reducing tension, anxiety, 
and aggression. These effects are helpful in a therapeutic 
setting but contribute to the drugs’ abuse. Narcotic/opioid 
use comes with a variety of unwanted effects, including 
drowsiness, inability to concentrate, and apathy.
Narcotics 
OxyContin 160 mg tablet 
Heroin 
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Psychological dependence 
Use can create psychological dependence. Long 
after the physical need for the drug has passed, 
the user may continue to think and talk about 
using drugs and feel overwhelmed coping with 
daily activities. Relapse is common if there are 
not changes to the physical environment or the 
behavioral motivators that prompted the abuse in 
the first place. 
What is their effect on the body? 
Narcotics/opioids are prescribed by doctors to 
treat pain, suppress cough, cure diarrhea, and 
put people to sleep. Effects depend heavily on the 
dose, how it’s taken, and previous exposure to the 
drug. Negative effects include: 
• Slowed physical activity, constriction of the pupils,
flushing of the face and neck, constipation, nausea,
vomiting, and slowed breathing
As the dose is increased, both the pain relief and 
the harmful effects become more pronounced. Some 
of these preparations are so potent that a single dose 
can be lethal to an inexperienced user. However, 
except in cases of extreme intoxication, there is no 
loss of motor coordination or slurred speech. 
Physical dependence and withdrawal 
Physical dependence is a consequence of chronic 
opioid use, and withdrawal takes place when drug 
use is discontinued. The intensity and character 
of the physical symptoms experienced during 
withdrawal are directly related to the particular 
drug used, the total daily dose, the interval 
between doses, the duration of use, and the health 
and personality of the user. These symptoms 
usually appear shortly before the time of the next 
scheduled dose. 
Early withdrawal symptoms often include: 
• Watery eyes, runny nose, yawning, and sweating
As the withdrawal worsens, symptoms can include: 
• Restlessness, irritability, loss of appetite, nausea,
tremors, drug craving, severe depression, vomiting,
increased heart rate and blood pressure, and chills
alternating with flushing and excessive sweating
However, without intervention, the withdrawal 
usually runs its course, and most physical 
symptoms disappear within days or weeks, 
depending on the particular drug. 
What are their overdose effects? 
Overdoses of narcotics are not uncommon and 
can be fatal. Physical signs of narcotics/opioid 
overdose include: 
• Constricted (pinpoint) pupils, cold clammy skin,
confusion, convulsions, extreme drowsiness, and
slowed breathing
Which drugs cause similar effects? 
With the exception of pain relief and cough 
suppression, most central nervous system 
depressants (like barbiturates, benzodiazepines, 
and alcohol) have similar effects, including slowed 
breathing, tolerance, and dependence. 
What is their legal status in the United States? 
Narcotics/opioids are controlled substances that 
vary from Schedule I to Schedule V, depending on 
their medical usefulness, abuse potential, safety, 
and drug dependence profile. Schedule I narcotics, 
like heroin, have no medical use in the U.S. and 
are illegal to distribute, purchase, or use outside of 
medical research.
WHAT IS FENTANYL? 
Fentanyl is a potent synthetic opioid drug 
approved by the Food and Drug Administration for 
use as an analgesic (pain relief) and anesthetic. 
It is approximately 100 times more potent than 
morphine and 50 times more potent than heroin 
as an analgesic. 
WHAT IS ITS ORIGIN? 
Fentanyl was first developed in 1959 and 
introduced in the 1960s as an intravenous 
anesthetic. It is legally manufactured and 
distributed in the United States. Licit fentanyl 
pharmaceutical products are diverted via theft, 
fraudulent prescriptions, and illicit distribution by 
patients, physicians, and pharmacists. 
From 2011 through 2018, both fatal overdoses 
associated with abuse of clandestinely produced 
fentanyl and fentanyl analogues, and law 
enforcement encounters increased markedly. 
According to the Centers for Disease Control 
and Prevention (CDC), fentanyl analouges were 
involved in roughly 2,600 drug overdose deaths 
each year in 2011 and 2012, but from 2012 
through 2018, the number of drug overdose 
deaths involving fentanyl and other synthetic 
opioid increased dramatically each year. More 
recently, there has been a re-emergence of 
trafficking, distribution, and abuse of illicitly 
produced fentanyl and fentanyl analogues with 
an associated dramatic increase in overdose 
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fatalities, ranging from 2,666 in 2011 to 31,335 in 
2018. 
What are common street names? 
Common street names  include: 
• Apache, China Girl, China Town, Dance Fever, Friend,
Goodfellas, Great Bear, He-Man, Jackpot, King Ivory,
Murder 8, and Tango & Cash.
What does it look like? 
Fentanyl pharmaceutical products are currently 
available in the following dosage forms: oral 
transmucosal lozenges commonly referred to as 
fentanyl “lollipops” (Actiq®), effervescent buccal 
tablets (Fentora®), sublingual tablets (Abstral®), 
sublingual sprays (Subsys®), nasal sprays 
(Lazanda®), transdermal patches (Duragesic®), 
and injectable  formulations. 
Clandestinely produced fentanyl is encountered 
either as a powder or in counterfeit tablets and is 
Fentanyl 
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sold alone or in combination with other drugs such 
as heroin or cocaine. 
How is it abused? 
Fentanyl can be injected, snorted/sniffed, smoked, 
taken orally by pill or tablet, and spiked onto 
blotter paper. Fentanyl patches are abused by 
removing its gel contents and then injecting or 
ingesting these contents. Patches have also been 
frozen, cut into pieces, and placed under the 
tongue or in the cheek cavity. Illicitly produced 
fentanyl is sold alone or in combination with heroin 
and other substances and has been identified in 
counterfeit pills, mimicking pharmaceutical drugs 
such as oxycodone. According to the National Forensic 
Laboratory Information System, reports on fentanyl 
(both pharmaceutical and clandestinely produced) 
increased from nearly  5,400 in 2014 to over 56,500 in 
2017, as reported by federal, state, and local forensic 
laboratories in the United  States. 
What is the effect on the body? 
Fentanyl, similar to other commonly used opioid 
analgesics (e.g., morphine), produces effects 
such as relaxation, euphoria, pain relief, sedation, 
confusion, drowsiness, dizziness, nausea, 
vomiting, urinary retention, pupillary constriction, 
and respiratory depression. 
What are the overdose effects? 
Overdose may result in stupor, changes in 
pupillary size, cold and clammy skin, cyanosis, 
coma, and respiratory failure leading to death. 
The presence of triad of symptoms such as coma, 
pinpoint pupils, and respiratory depression are 
strongly suggestive of opioid poisoning. 
Which drugs cause similar effects? 
Drugs that cause similar effects include other 
opioids such as morphine, hydrocodone, 
oxycodone, hydromorphone, methadone, and 
heroin. 
What is the legal status in the Federal Control 
Substances Act? 
Fentanyl is a Schedule II narcotic under the 
United States Controlled Substances Act of 1970.
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WHAT IS HEROIN? 
Heroin is a highly addictive drug and it is a rapidly 
acting opioid. 
WHAT IS ITS ORIGIN? 
Heroin is processed from morphine, a naturally 
occurring substance extracted from the seed pod 
of certain varieties of poppy plants grown in: 
• Mexico, South America, Southeast Asia (Thailand,
Laos, and Myanmar (Burma)), and Southwest Asia
(Afghanistan and Pakistan)
Heroin comes in several forms, primarily white 
powder from Mexico and South America; and 
“black tar” and brown powder from Mexico. 
What are common street names? 
Common street names for heroin include: 
• Big H, Black Tar, Chiva, Hell Dust, Horse, Negra,
Smack, and Thunder 
What does it look like? 
Heroin is typically sold as a white or brownish 
powder, or as the black sticky substance known 
on the streets as “black tar heroin.” Although 
purer heroin is becoming more common, most 
street heroin is “cut” with other drugs or with 
substances such as sugar, starch, powdered milk, 
or quinine. 
How is it abused? 
Heroin can be injected, smoked, or sniffed/ 
snorted. High purity heroin is usually snorted or 
smoked. 
What is its effect on the mind? 
Because it enters the brain so rapidly, heroin is 
particularly addictive, both psychologically and 
physically. Heroin users report feeling a surge of 
euphoria or “rush” followed by a twilight state of 
sleep and wakefulness. 
What is its effect on the body? 
One of the most significant effects of heroin use 
is addiction. With regular heroin use, tolerance to 
the drug develops. Once this happens, the person 
must use more heroin to achieve the same 
intensity. As higher doses of the drug are used 
over time, physical dependence and addiction to 
the drug develop. 
Effects of heroin use include: 
• Drowsiness, respiratory depression, constricted pupils,
nausea, a warm flushing of the skin, dry mouth, and
heavy extremities
What are its overdose effects? 
Because heroin users do not know the actual 
strength of the drug or its true contents, they are 
at a high risk of overdose or death. 
The effects of a heroin overdose are: 
• Slow and shallow breathing, blue lips and fingernails,
clammy skin, convulsions, coma, and possible death
Which drugs cause similar effects? 
Other opioids such as OxyContin®, Vicodin®, 
codeine, morphine, methadone, and fentanyl can 
cause similar effects as heroin. 
What is its legal status in the United States? 
Heroin is a Schedule I substance under the 
Controlled Substances Act meaning that it has a 
high potential for abuse, no currently accepted 
medical use in treatment in the United States, and 
a lack of accepted safety for use under medical 
supervision.
Heroin 
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Heroin liquid packets 
Brown powder heroin White powder heroin
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WHAT IS HYDROMORPHONE? 
Hydromorphone belongs to a class of drugs 
called “opioids,” which includes morphine. It 
has an analgesic potency of two to eight times 
greater than that of morphine and has a rapid 
onset of action. 
WHAT IS ITS ORIGIN? 
Hydromorphone is legally manufactured and 
distributed in the United States. However, 
users can obtain hydromorphone from 
forged prescriptions, “doctor-shopping,” 
theft from pharmacies, and from friends and 
acquaintances. 
What are the street names? 
Common street names  include: 
• D, Dillies, Dust, Footballs, Juice, and Smack
What does it look like? 
Hydromorphone comes in: 
• Tablets, capsules, oral solutions, and injectable
formulations
How is it abused? 
Users may abuse hydromorphone tablets by 
ingesting them. Injectable solutions, as well as 
tablets that have been crushed and dissolved 
in a solution may be injected as a substitute for 
heroin. 
What is its effect on the mind? 
When used as a drug of abuse, and not under 
a doctor’s supervision, hydromorphone is taken 
to produce feelings of euphoria, relaxation, 
sedation, and reduced anxiety. It may also cause 
mental clouding, changes in mood, nervousness, 
and restlessness. It works centrally (in the 
brain) to reduce pain and suppress cough. 
Hydromorphone use is associated with both 
physiological and psychological dependence. 
What is its effect on the body? 
Hydromorphone may cause: 
• Constipation, pupillary constriction, urinary retention,
nausea, vomiting, respiratory depression, dizziness,
impaired coordination, loss of appetite, rash, slow or
rapid heartbeat, and changes in blood pressure
What are its overdose effects? 
Acute overdose of hydromorphone can produce: 
Severe  respiratory  depression,  drowsiness  
progressing to stupor or coma, lack of skeletal 
muscle tone, cold and clammy skin, constricted 
pupils, and reduction in blood pressure and heart 
rate 
Severe overdose may result in death due to 
respiratory depression. 
Which drugs cause similar effects? 
Drugs that have similar effects include: 
• Heroin, morphine, hydrocodone, fentanyl, and
oxycodone
What is its legal status in the United States? 
Hydromorphone is a Schedule II drug under the 
Controlled Substances Act with an accepted 
medical use as a pain reliever. Hydromorphone 
has a high potential for abuse and use may lead 
to severe psychological or physical dependence.
Hydromorphone 
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WHAT IS METHADONE? 
Methadone is a synthetic (man-made) narcotic. 
WHAT IS ITS ORIGIN? 
German scientists synthesized methadone during 
World War II because of a shortage of morphine. 
Methadone was introduced into the United States 
in 1947 as an analgesic (Dolophine®). 
What are common street names? 
Common street names include: 
• Amidone, Chocolate Chip Cookies, Fizzies with MDMA,
and Wafer
What does it look like? 
Methadone is available as a tablet, oral solution, 
or injectable liquid. Tablets are available in 5 mg 
and 10 mg formulations. As of January 1, 2008, 
manufacturers of methadone hydrochloride 
tablets 40 mg (dispersible) have voluntarily 
agreed to restrict distribution of this formulation to 
only those facilities authorized for detoxification 
and maintenance treatment of opioid addiction, 
and hospitals. Manufacturers will instruct their 
wholesale distributors to discontinue supplying this 
formulation to any facility not meeting the above 
criteria. 
How is it abused? 
Methadone can be swallowed or injected. 
What is its effect on the mind? 
Abuse of methadone can lead to psychological 
dependence. 
What is its effect on the body? 
When an individual uses methadone, he/she may 
experience physical symptoms like sweating, 
itchy skin, or sleepiness. Individuals who abuse 
methadone risk becoming tolerant of and 
physically dependent on the drug. 
When use is stopped, individuals may 
experience withdrawal symptoms including: 
• Anxiety, muscle tremors, nausea, diarrhea, vomiting, and
abdominal cramps
What are its overdose effects? 
The effects of a methadone overdose are: 
• Slow and shallow breathing, blue fingernails and lips,
stomach spasms, clammy skin, convulsions, weak pulse,
coma, and possible death
Which drugs cause similar effects? 
Although chemically unlike morphine or heroin, 
methadone produces many of the same effects. 
What is its legal status in the United States? 
Methadone is a Schedule II drug under the 
Controlled Substances Act. While it may legally be 
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WHAT IS MORPHINE? 
Morphine is a non-synthetic narcotic with a high 
potential for abuse and is derived from opium. It is 
used for the treatment of pain. 
WHAT IS ITS ORIGIN? 
In the United States, a small percentage of the 
morphine obtained from opium is used directly for 
pharmaceutical products. The remaining morphine 
is processed into codeine and other derivatives. 
What are common street names? 
Common street names  include: 
• Dreamer, Emsel, First Line, God’s Drug, Hows, M.S.,
Mister Blue, Morf, Morpho, and Unkie
What does it look like? 
Morphine is marketed under generic and brand 
name products, including: 
• MS-Contin®, Oramorph SR®, MSIR®, Roxanol®,
Kadian®, and RMS®
How is it abused? 
Traditionally, morphine was almost exclusively 
used by injection, but the variety of pharmaceutical 
forms that it is marketed as today support its use 
by oral and other routes of administration. 
Forms include: 
• Oral solutions, immediate-and extended-release tablets
and capsules, and injectable preparations
Those dependent on morphine prefer injection 
because the drug enters the bloodstream more 
quickly. 
What is its effect on the mind? 
Morphine’s effects include euphoria and relief of 
pain. Chronic use of morphine results in tolerance, 
and physical and psychological dependence. 
What is its effect on the body? 
Morphine use results in relief from physical pain, 
decrease in hunger, and inhibition of the cough 
reflex. 
What are its overdose effects? 
Overdose effects include: 
• Cold and clammy skin, lowered blood pressure,
sleepiness, slowed breathing, slow pulse rate, coma, and
possible death
Which drugs cause similar effects? 
Drugs causing similar effects as morphine include: 
• Opium, codeine, heroin, methadone, hydrocodone,
fentanyl, and oxycodone
What is its legal status in the United States? 
Morphine is a Schedule II narcotic under the 
Controlled Substances Act. 
Morphine 
Morphine
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WHAT IS OPIUM? 
Opium is a highly addictive non-synthetic narcotic that 
is extracted from the poppy plant, Papaver somniferum. 
The opium poppy is the key source for many narcotics, 
including morphine, codeine, and heroin. 
WHAT IS ITS ORIGIN? 
The poppy plant, Papaver somniferum, is the source 
of opium. It was grown in the Mediterranean region as 
early as 5000 B.C., and has since been cultivated in a 
number of countries throughout the world. The milky 
fluid that seeps from its incisions in the unripe seedpod 
of this poppy has been scraped by hand and air-dried 
to produce what is known as opium. 
A more modern method of harvesting for 
pharmaceutical use is by the industrial poppy straw 
process of extracting alkaloids from the mature dried 
plant (concentrate of poppy straw). All opium and 
poppy straw used for pharmaceutical products are 
imported into the United States from legitimate sources 
in regulated countries. 
What are common street names? 
Common street names include: 
• Ah-pen-yen, Aunti, Aunti Emma, Big O, Black Pill, Chandoo, 
Chandu, Chinese Molasses, Chinese Tobacco, Dopium, 
Dover’s Powder, Dream Gun, Dream Stick, Dreams, Easing 
Powder, Fi-do-nie, Gee, God’s Medicine, Gondola, Goric, 
Great Tobacco, Guma, Hop/hops, Joy Plant, Midnight Oil, 
Mira, O, O.P., Ope, Pen Yan, Pin Gon, Pox, Skee, Toxy, 
Toys, When-shee, Ze, and Zero 
What does it look like? 
Opium can be a liquid, solid, or powder, but most 
poppy straw concentrate is available commercially as 
a fine brownish powder. 
How is it abused? 
Opium can be smoked, intravenously injected, or taken 
in pill form. Opium is also abused in combination with 
other drugs. For example, “Black” is a combination 
of marijuana, opium, and methamphetamine, and 
“Buddha” is potent marijuana spiked with opium. 
What is its effect on the mind? 
The intensity of opium’s euphoric effects on the brain 
depends on the dose and route of administration. It works 
quickly when smoked because the opiate chemicals 
pass into the lungs, where they are quickly absorbed and 
then sent to the brain. An opium “high” is very similar to a 
heroin “high”; users experience a euphoric rush, followed 
by relaxation and the relief of physical pain. 
What is its effect on the body? 
Opium inhibits muscle movement in the bowels leading 
to constipation. It also can dry out the mouth and 
mucous membranes in the nose. Opium use leads to 
physical and psychological dependence, and can lead 
to overdose. 
What are its overdose effects? 
Overdose effects include: 
• Slow breathing, seizures, dizziness, weakness, loss of 
consciousness, coma, and possible death 
Which drugs cause similar effects? 
Drugs that cause similar effects include: 
• Morphine, codeine, heroin, methadone, hydroquinone, 
fentanyl, and oxycodone
What is its legal status in the United States? 
Opium is a Schedule II drug under the Controlled 
Substances Act. Most opioids are Schedule II, III, IV, 
or V drugs. Some drugs that are derived from opium, 
such as heroin, are Schedule I drugs.
Opium 
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WHAT IS OXYCODONE? 
Oxycodone is a semi-synthetic narcotic analgesic 
and historically has been a popular drug of abuse 
among the narcotic abusing population. 
WHAT IS ITS ORIGIN? 
Oxycodone is synthesized from thebaine, a 
constituent of the poppy plant. 
What are common street names? 
Common street names include: 
• Hillbilly Heroin, Kicker, OC, Ox, Roxy, Perc, and Oxy
What does it look like? 
Oxycodone is marketed alone as OxyContin® in 
10, 20, 40 and 80 mg extended-release tablets 
and other immediate-release capsules like 5 
mg OxyIR®. It is also marketed in combination 
products with aspirin such as Percodan® or 
acetaminophen such as Roxicet®. 
How is it abused? 
Oxycodone is abused orally or intravenously. 
The tablets are crushed and sniffed or dissolved 
in water and injected. Others heat a tablet that 
has been placed on a piece of foil then inhale the 
vapors. 
What is its effect on the mind? 
Euphoria and feelings of relaxation are the most 
common effects of oxycodone on the brain, which 
explains its high potential for abuse. 
What is its effect on the body? 
Physiological effects of oxycodone include: 
• Pain relief, sedation, respiratory depression,
constipation, papillary constriction, and cough
suppression. Extended or chronic use of oxycodone
containing acetaminophen may cause severe liver
damage
What are its overdose effects? 
Overdose effects include: 
• Extreme drowsiness, muscle weakness, confusion, cold
and clammy skin, pinpoint pupils, shallow breathing,
slow heart rate, fainting, coma, and possible  death
Which drugs cause similar effects? 
Drugs that cause similar effects to Oxycodone 
include: 
• Opium, codeine, heroin, methadone, hydrocodone,
fentanyl, and morphine
What is its legal status in the United States? 
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WHAT ARE STIMULANTS? 
Stimulants speed up the body’s systems. This 
class of drugs includes: 
• Prescription drugs such as amphetamines [Adder- 
all® and Dexedrine®], methylphenidate [Concerta®
and Ritalin®], diet aids [such as Didrex®, Bontril®,
Preludin®, Fastin®, Adipex P®, Ionomin®, and
Meridia®] and other illicitly used drugs such as
methamphetamine, cocaine, methcathinone, and other
synthetic cathinones that are commonly sold under the
guise of “bath salts.”
WHAT IS THEIR ORIGIN? 
Stimulants are diverted from legitimate 
channels and clandestinely manufactured 
exclusively for the illicit market. 
What are common street names? 
Common street names for stimulants include: 
• Bennies, Black Beauties, Cat, Coke, Crank, Crystal,
Flake, Ice, Pellets, R-Ball, Skippy, Snow, Speed,
Uppers, and Vitamin R
What do they look like? 
Stimulants come in the form of: 
• Pills, powder, rocks, and injectable  liquids
How are they abused? 
Stimulants can be pills or capsules that are 
swallowed. Smoking, snorting, or injecting 
stimulants produces a sudden sensation known 
as a “rush” or a “flash.” 
Abuse is often associated with a pattern of 
binge use — sporadically consuming large doses 
of stimulants over a short  period of time. Heavy 
users may inject themselves every few hours, 
continuing until they have depleted their drug 
supply or reached a point of delirium, psychosis, 
and physical exhaustion. During heavy use, all 
other interests become secondary to recreating 
the initial euphoric rush. 
What is their effect on the mind? 
When used as drugs of abuse and not under a 
doctor’s supervision, stimulants are frequently 
taken to: 
• Produce a sense of exhilaration, enhance self-
esteem, improve mental and physical performance,
increase activity, reduce appetite, extend wakefulness
for prolonged period, and “get high”
Chronic, high-dose use is frequently associated 
with agitation, hostility, panic, aggression, and 
suicidal or homicidal tendencies.
Stimulants 
Ritalin SR 20mg tablet 
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Paranoia, sometimes accompanied by both 
auditory and visual hallucinations, may also occur. 
Tolerance, in which more and more drug is 
needed to produce the usual effects, can develop 
rapidly, and psychological dependence occurs. 
In fact, the strongest psychological dependence 
observed occurs with the more potent stimulants, 
such as amphetamine, methylphenidate, 
methamphetamine, cocaine, and methcathinone. 
Abrupt cessation is commonly followed by 
depression, anxiety, drug craving, and extreme 
fatigue, known as a “crash.” 
What is their effect on the body? 
Stimulants are sometimes referred to as uppers 
and reverse the effects of fatigue on both mental 
and physical tasks. 
Therapeutic levels of stimulants can produce 
exhilaration, extended wakefulness, and loss of 
appetite. These effects are greatly intensified 
when large doses of stimulants are taken. 
Taking too large a dose at one time or taking 
large doses over an extended period of time may 
cause such physical side effects as: 
• Dizziness, tremors, headache, flushed skin, chest
pain with palpitations, excessive sweating, vomiting,
and abdominal cramps.
What are their overdose effects? 
In overdose, unless there is medical intervention, 
high fever, convulsions, and cardiovascular 
collapse may precede death. Because accidental 
death is partially due to the effects of stimulants 
on the body’s cardiovascular and temperature- 
regulating systems, physical exertion increases 
the hazards of stimulant use. 
Which drugs cause similar effects? 
Some hallucinogenic substances, such as 
ecstasy, have a stimulant component to their 
activity. 
What is their legal status in the United States? 
A number of stimulants have no medical use 
in the United States but have a high potential 
for abuse. These stimulants are controlled in 
Schedule I. Some prescription stimulants are not 
controlled, and some stimulants like tobacco and 
caffeine don’t require a prescription — though 
society’s recognition of their adverse effects has 
resulted in a proliferation of caffeine-free products 
and efforts to discourage cigarette smoking. 
Stimulant chemicals in over-the-counter products, 
such as ephedrine and pseudoephedrine, can be 
found in allergy and cold medicine. As required by 
The Combat Methamphetamine Epidemic Act of 
2005, a retail outlet must store these products out 
of reach of customers, either behind the counter 
or in a locked cabinet. Regulated sellers are 
required to maintain a written or electronic form 
of a logbook to record sales of these products. 
In order to purchase these products, customers 
must now show a photo identification issued by 
a state or federal government. They are also 
required to write or enter into the logbook: their 
name, signature, address, date, and time of 
sale. In addition to the above, there are daily and 
monthly sales limits set for customers.
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WHAT ARE AMPHETAMINES? 
Amphetamines are stimulants that speed up the 
body’s system. Some are legally prescribed and used 
to treat attention-deficit hyperactivity disorder (ADHD). 
WHAT IS THEIR ORIGIN? 
Amphetamines were first marketed in the 1930s as 
Benzedrine in an over-the-counter inhaler to treat 
nasal congestion. 
By 1937 amphetamines were available by 
prescription in tablet form and were used in the 
treatment of the sleeping disorder narcolepsy and 
ADHD. 
Over the years, the use and abuse of clandestinely 
produced amphetamines have spread. Today, 
clandestine laboratory production of amphetamines 
has mushroomed, and the abuse of the drug has 
increased dramatically. 
What are common street names? 
Common street names include: 
• Bennies, Black Beauties, Crank, Ice, Speed, and Uppers
What do they look like? 
Amphetamines can look like pills or powder. 
Common prescription amphetamines include 
amphetamine and dextroamphetamine 
(Adderall®), dextroamphetamine (Dexedrine®), 
lisdexamphetamine (Vyvanse™) and 
methamphetamine (Desoxyn®). 
How are they abused? 
Amphetamines are generally taken orally or injected. 
However, the addition of “ice,” the slang name 
of crystallized methamphetamine hydrochloride, 
has promoted smoking as another mode of 
administration. Just as “crack” is smokable cocaine, 
“ice” is smokable methamphetamine. 
What is their effect on the mind? 
The effects of amphetamines are similar to cocaine, 
but their onset is slower and their duration is longer. 
In contrast to cocaine, which is quickly removed 
from the brain and is almost completely metabolized, 
methamphetamine remains in the central nervous 
system longer, and a larger percentage of the drug 
remains unchanged in the body, producing prolonged 
stimulant effects. 
Chronic abuse produces a psychosis that 
resembles schizophrenia and is characterized by 
paranoia, picking at the skin, preoccupation with one’s 
own thoughts, and auditory and visual hallucinations. 
Violent and erratic behavior is frequently seen among 
chronic users of amphetamines. 
What is their effect on the body? 
Physical effects of amphetamine use include: 
• Increased blood pressure and pulse rates, insomnia, loss
of appetite, and physical exhaustion
What are their overdose effects? 
Overdose effects include: 
• Agitation, increased body temperature, hallucinations,
convulsions, and possible death
Which drugs cause similar effects? 
Drugs that cause similar effects include: 
• Dexmethylphendiate, phendimetrazine, cocaine, crack,
and khat
What is their legal status in the United States? 
Many amphetamines are Schedule II stimulants, 
which means that they have a high potential for 
abuse and a currently acceptable medical use (in 
FDA-approved products). Pharmaceutical products 
are available only through a prescription that cannot 
be refilled.
Amphetamines 
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WHAT IS COCAINE? 
Cocaine is an intense, euphoria-producing 
stimulant drug with strong addictive potential. 
WHAT IS ITS ORIGIN? 
Cocaine is derived from coca leaves grown 
in Bolivia, Peru, and Colombia. The cocaine 
manufacturing process takes place in remote 
jungle labs where the raw product undergoes 
a series of chemical transformations. Colombia 
produces about 90 percent of the cocaine powder 
reaching the United States. Most of the cocaine 
entering the United States comes through Mexico. 
What are common street names? 
Common street names include: 
• Blow, Coca, Coke, Crack, Flake, Snow, and Soda Cot
What does it look like? 
Cocaine is usually distributed as a white, 
crystalline powder. Cocaine is often diluted (“cut”) 
with a variety of substances, the most common of 
which are sugars and local anesthetics. It is “cut” 
to stretch the amount of the product and increase 
profits for dealers. In contrast, cocaine base 
(crack) looks like small, irregularly shaped chunks 
(or “rocks”) of a whitish solid. 
How is it abused? 
Powdered cocaine can be snorted or injected into 
the veins after dissolving in water. Cocaine base 
(crack) is smoked, either alone or on marijuana 
or tobacco. Cocaine is also used in combination 
with an opiate, like heroin, a practice known as 
“speedballing.” Although injecting into veins or 
muscles, snorting, and smoking are the common 
ways of using cocaine, all mucous membranes 
readily absorb cocaine. Cocaine users often binge 
on the drug until they are exhausted or run out of 
cocaine. 
What is its effect on the mind? 
The intensity of cocaine’s euphoric effects 
depends on how quickly the drug reaches the 
brain, which depends on the dose and method 
of abuse. Following smoking or intravenous 
injection, cocaine reaches the brain in seconds, 
with a rapid buildup in levels. This results in a 
rapid-onset, intense euphoric effect known as a 
“rush.” 
By contrast, the euphoria caused by snorting 
cocaine is less intense and does not happen as 
quickly due to the slower build-up of the drug 
in the brain. Other effects include increased 
alertness and excitation, as well as restlessness, 
irritability, and anxiety. 
Tolerance to cocaine’s effects develops rapidly, 
causing users to take higher and higher doses. 
Taking high doses of cocaine or prolonged use, 
such as binging, usually causes paranoia. The 
Cocaine 
Cocaine powder
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crash that follows euphoria is characterized 
by mental and physical exhaustion, sleep, and 
depression lasting several days. Following the 
crash, users experience a craving to use cocaine 
again. 
What is its effect on the body? 
Physiological effects of cocaine include increased 
blood pressure and heart rate, dilated pupils, 
insomnia, and loss of appetite. The widespread 
abuse of highly pure street cocaine has led to many 
severe adverse health consequences such as: 
• Irregular heartbeat, ischemic heart conditions, sudden
cardiac arrest, convulsions, strokes, and death
In some users, the long-term use of inhaled 
cocaine has led to a unique respiratory syndrome, 
and chronic snorting of cocaine has led to the 
erosion of the upper nasal cavity. 
Which drugs cause similar effects? 
Other stimulants, such as amphetamine and 
methamphetamine, cause effects similar to 
cocaine that vary mainly in degree. 
What is its legal status in the United States? 
Cocaine is a Schedule II drug under the 
Controlled Substances Act, meaning it has a high 
potential for abuse and has an accepted medical 
use for treatment in the United States. Cocaine 
hydrochloride solution (4 percent and 10 percent) 
is used primarily as a topical local anesthetic 
for the upper respiratory tract. It also is used to 
reduce bleeding of the mucous membranes in 
the mouth, throat, and nasal cavities. However, 
more effective products have been developed for 
these purposes, and cocaine is now rarely used 
medically in the United States.
Cocaine bricks, seized by DEA
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WHAT IS KHAT? 
Khat is a flowering evergreen shrub that is abused 
for its stimulant-like effect. Khat has two active 
ingredients, cathine and cathinone. 
WHAT IS ITS ORIGIN? 
Khat is native to East Africa and the Arabian 
Peninsula, where the use of it is an established 
cultural tradition for many social situations. 
What are common street names? 
Common street names for khat include: 
• Abyssinian Tea,  African Salad, Catha, Chat, Kat, and Oat
What are its overdose effects? 
The dose needed to constitute an overdose is not 
known, however it has been historically associated 
with those who are long-term chewers of the 
leaves. Symptoms of toxicity include: 
• Delusions, loss of appetite, difficulty with breathing, and
increases in both blood pressure and heart  rate
Additionally, there are reports of liver damage
(chemical hepatitis) and of cardiac complications, 
specifically myocardial infarctions. This mostly 
occurs among long-term chewers of khat or those 
who have chewed too large a dose. 
What does it look like? 
Khat is a flowering evergreen shrub. Khat that is 
sold and abused is usually just the leaves, twigs, 
and shoots of the khat shrub. 
How is it abused? 
Khat is typically chewed like tobacco, then retained 
in the cheek and chewed intermittently to release 
the active drug, which produces a stimulant-like 
effect. Dried khat leaves can be made into tea or a 
chewable paste, and khat can also be smoked and 
even sprinkled on food. 
What is its effect on the mind? 
Khat can induce manic behavior with: 
• Grandiose delusions, paranoia, nightmares, hallucinations,
and hyperactivity 
• Chronic khat abuse can result in violence and suicidal
depression.
What is its effect on the body? 
Khat causes an immediate increase in blood 
pressure and heart rate. Khat can also cause a 
brown staining of the teeth, insomnia, and gastric 
disorders. Chronic abuse of khat can cause 
physical exhaustion.
Which drugs cause similar effects? 
Khat’s effects are similar to other stimulants, such 
as cocaine, amphetamine, and methamphetamine. 
What is its legal status in the United States? 
The chemicals found in khat are controlled under 
the Controlled Substances Act. Cathine is a 
Schedule IV stimulant, and cathinone is a Schedule 
I stimulant under the Controlled Substances Act, 
meaning that it has a high potential for abuse, no 
currently accepted medical use in treatment in the 
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WHAT IS METHAMPHETAMINE? 
Methamphetamine (meth) is a stimulant. The FDA- 
approved brand-name medication is Desoxyn®. 
WHAT IS ITS ORIGIN? 
Mexican drug trafficking organizations have 
become the primary manufacturers and distributors 
of methamphetamine to cities throughout the 
United States, including in Hawaii. Domestic 
clandestine laboratory operators also produce 
and distribute meth but usually on a smaller scale. 
The methods used depend on the availability of 
precursor chemicals. 
Currently, this domestic clandestinely produced 
meth is mainly made with diverted products 
that contain pseudoephedrine. Mexican 
methamphetamine is made with different precursor 
chemicals. The Combat Methamphetamine 
Epidemic Act of 2005 requires retailers of non-
prescription products containing pseudoephedrine, 
ephedrine, or phenylpropanolamine to place these 
products behind the counter or in a locked cabinet. 
Consumers must show identification and sign a 
logbook for each purchase. 
What are common street names? 
Common street names include: 
• Batu, Bikers Coffee, Black Beauties, Chalk, Chicken
Feed, Crank, Crystal, Glass, Go-Fast, Hiropon, Ice,
Meth, Methlies Quick, Poor Man’s Cocaine, Shabu,
Shards, Speed, Stove Top, Tina, Trash, Tweak, Uppers,
Ventana, Vidrio, Yaba, and Yellow Bam
What does it look like? 
Regular meth is a pill or powder. Crystal meth 
resembles glass fragments or shiny blue-white 
“rocks” of various sizes. 
How is it abused? 
Meth is swallowed, snorted, injected, or smoked. To 
intensify the effects, users may take higher doses 
of the drug, take it more frequently, or change their 
method of intake. 
What is its effect on the mind? 
Meth is a highly addictive drug with potent central 
nervous system (CNS)  stimulant properties. 
Those who smoke or inject it report a brief, intense 
sensation, or rush. Oral ingestion or snorting 
produces a long-lasting high instead of a rush, 
which reportedly can continue for as long as half 
a day. Both the rush and the high are believed to 
result from the release of very high levels of the 
neurotransmitter dopamine into areas of the brain 
that regulate feelings of pleasure. Long-term meth 
use results in many damaging effects, including 
addiction.
Methamphetamine 
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Chronic meth users can exhibit violent behavior, 
anxiety, confusion, insomnia, and psychotic 
features including paranoia, aggression, visual 
and auditory hallucinations, mood disturbances, 
and delusions — such as the sensation of insects 
creeping on or under the skin.
 Such paranoia can result in homicidal or 
suicidal thoughts. Researchers have reported 
that as much as 50 percent of the dopamine-
producing cells in the brain can be damaged 
after prolonged exposure to relatively low levels 
of meth. Some studies suggested that the use of 
methamphetamine may also result in serotonergic 
neurotoxicity. 
What is its effect on the body? 
Taking even small amounts of meth can result in: 
• Increased wakefulness, increased physical activity,
decreased appetite, rapid breathing and heart rate,
irregular heartbeat, increased blood pressure, and
hyperthermia (overheating)
High doses can elevate body temperature to 
dangerous, sometimes lethal, levels, and cause 
convulsions and even cardiovascular collapse and 
death. Meth use may also cause extreme anorexia, 
memory loss, and severe dental problems. 
What are its overdose effects? 
High doses may result in death from stroke, heart 
attack, or multiple organ problems caused by 
overheating. 
Which drugs cause similar effects? 
Cocaine and potent stimulant pharmaceuticals, 
such as amphetamines and methylphenidate, 
produce similar effects. 
What is its legal status in the United States? 
Methamphetamine is a Schedule II stimulant under 
the Controlled Substances Act, which means that 
it has a high potential for abuse and a currently 
accepted medical use (in FDA-approved products). 
It is available only through a prescription that 
cannot be refilled. Today there is only one legal 
meth product, Desoxyn®. It is currently marketed in 
5, 10, and 15-milligram tablets (immediate release 
and extended release formulations) and has very 
limited use in the treatment of obesity and attention 
deficit hyperactivity disorder (ADHD).
Methamphetamine in finished form
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WHAT ARE DEPRESSANTS? 
Depressants will induce sleep, relieve anxiety and 
muscle spasms, and prevent seizures. 
Barbiturates are older drugs and include 
butalbital (Fiorina®), phenobarbital, Pentothal®, 
Seconal®, and Nembutal®. A person can 
rapidly develop dependence on and tolerance to 
barbiturates, meaning a person needs more and 
more of them to feel and function normally. This 
makes them unsafe, increasing the likelihood of 
coma or death. 
Benzodiazepines were developed to replace 
barbiturates, though they still share many of 
the undesirable side effects including tolerance 
and dependence. Some examples are Valium®, 
Xanax®, Halcion®, Ativan®, Klonopin®, and 
Restoril®. Rohypnol® is a benzodiazepine that 
is not manufactured or legally marketed in the 
United States, but it is used illegally. 
Lunesta®, Ambien®, and Sonata® are 
sedative-hypnotic medications approved for the 
short-term treatment of insomnia that share many 
of the properties of benzodiazepines. Other CNS 
depressants include meprobamate, methaqualone 
(Quaalude®), and the illicit drug GHB. 
WHAT IS THEIR ORIGIN? 
Generally, legitimate pharmaceutical products 
are diverted to the illicit market. Teens can obtain 
depressants from the family medicine cabinet, 
friends, family members, the Internet, doctors, 
and hospitals. 
What are common street names? 
Common street names for depressants include: 
• Barbs, Benzos, Downers, Georgia Home Boy,
GHB, Grievous Bodily Harm, Liquid X, Nerve Pills,
Phennies, R2, Reds, Roofies, Rophies, Tranks, and
Yellows
What do they look like? 
Depressants come in the form of pills, syrups, and 
injectable liquids. 
How are they abused? 
Individuals abuse depressants to experience 
euphoria. Depressants are also used with 
other drugs to add to the other drugs’ high or to 
deal with their side effects. Users take higher 
doses than people taking the drugs under a 
doctor’s supervision for therapeutic purposes. 
Depressants like GHB and Rohypnol are also 
misused to facilitate sexual assault.
Depressants 
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What is their effect on the mind? 
Depressants used therapeutically do what they 
are prescribed for: 
• To induce sleep, relieve anxiety and muscle spasms,
and prevent seizures
They also: 
• Cause amnesia (leaving no memory of events that occur
while under the influence), reduce reaction time, impair
mental functioning and judgment, and cause confusion
Long-term use of depressants produces 
psychological dependence and tolerance. 
What is their effect on the body? 
Some depressants can relax the muscles. 
Unwanted physical effects include: 
• Slurred speech, loss of motor coordination, weakness,
headache, lightheadedness, blurred vision, dizziness,
nausea, vomiting, low blood pressure, and slowed
breathing
Prolonged use of depressants can lead 
to physical dependence even at doses 
recommended for medical treatment. Unlike 
barbiturates, large doses of benzodiazepines are 
rarely fatal unless combined with other drugs or 
alcohol. But unlike the withdrawal syndrome seen 
with most other drugs of abuse, withdrawal from 
depressants can be life threatening. 
What is their legal status in the United States? 
Most depressants are controlled substances that 
range from Schedule I to Schedule IV under the 
Controlled Substances Act, depending on their 
risk for abuse and whether they currently have an 
accepted medical use. Many of the depressants 
have FDA-approved medical uses. Rohypnol® 
and Quaaludes® are not manufactured, legally 
marketed, and have no accepted medical use in 
the United States.
Klonopin 5mg tablet
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WHAT ARE BARBITURATES? 
Barbiturates are depressants that produce a wide 
spectrum of central nervous system depression 
from mild sedation to coma. They also have been 
used as sedatives, hypnotics, anesthetics, and 
anticonvulsants. 
Barbiturates are classified as: 
• Ultrashort, Short, Intermediate, Long-acting
WHAT IS THEIR ORIGIN? 
Barbiturates were first introduced for medical use 
in the 1900s, and today, few substances are in 
medical use. 
What are common street names? 
Common street names  include: 
• Barbs, Block Busters, Christmas Trees, Goof Balls,
Pinks, Red Devils, Reds & Blues, and Yellow Jackets
What do they look like? 
Barbiturates come in a variety of multicolored pills 
and tablets. Users prefer the short-acting and 
intermediate barbiturates such as Amytal® and 
Seconal®. 
How are they abused? 
Barbiturates are abused by swallowing a pill or 
injecting a liquid form. Barbiturates are generally 
abused to reduce anxiety, decrease inhibitions, 
and treat unwanted effects of illicit drugs. 
Barbiturates can be extremely dangerous 
because overdoses can occur easily and lead to 
death. 
What is their effect on the mind? 
Barbiturates cause: 
• Mild euphoria, lack of restraint, relief of anxiety, and
sleepiness
Higher doses cause: 
• Impairment of memory, judgment, and coordination;
irritability; and paranoid and suicidal ideation
• Tolerance develops quickly and larger doses are then
needed to produce the same effect, increasing the
danger of an overdose.
What is their effect on the body? 
Barbiturates slow down the central nervous 
system and cause sleepiness. 
What are their overdose effects? 
Effects of overdose include: 
• Central nervous system depression, decreased
respiration, increased heart rate, decreased blood 
pressure, decreased urine production, decreased body 
temperature, coma, and possible death 
Which drugs cause similar effects? 
Drugs with similar effects include: 
• Alcohol, benzodiazepines like Valium® and Xanax®,
tranquilizers, sleeping pills, Rohypnol®, and GHB
What is their legal status in the United States? 
Barbiturates are Schedule II, III, and IV 
depressants under the Controlled Substances 
Act.
Barbiturates 
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WHAT ARE BENZODIAZEPINES? 
Benzodiazepines are depressants that produce 
sedation and hypnosis, relieve anxiety and muscle 
spasms, and reduce seizures. 
WHAT IS THEIR ORIGIN? 
Benzodiazepines are only legally available through 
prescription. Many users maintain their drug supply 
by getting prescriptions from several doctors, 
forging prescriptions, or buying them illicitly. 
Alprazolam and clonazepam are the two most 
frequently encountered benzodiazepines on the 
illicit market. 
What are common street names? 
Common street names include Benzos and 
Downers. 
What do they look like? 
The most common benzodiazepines are the 
prescription drugs Valium®, Xanax®, Halcion®, 
Ativan®, and Klonopin®. Tolerance can develop, 
although at variable rates and to different degrees. 
Shorter-acting benzodiazepines used to 
manage insomnia include estazolam (ProSom®), 
flurazepam (Dalmane®), temazepam (Restoril®), 
and triazolam (Halcion®). Midazolam (Versed®), 
a short-acting benzodiazepine, is utilized for 
sedation, anxiety, and amnesia in critical care 
settings and prior to anesthesia. It is available in 
the United States as an injectable preparation and 
as a syrup (primarily for pediatric patients). 
Benzodiazepines with a longer duration of 
action are utilized to treat insomnia in patients 
with daytime anxiety. These benzodiazepines 
include alprazolam (Xanax®), chlordiazepoxide 
(Librium®), clorazepate (Tranxene®), diazepam 
(Valium®), halazepam (Paxipam®), lorzepam 
(Ativan®), oxazepam (Serax®), prazepam 
(Centrax®), and quazepam (Doral®). Clonazepam 
(Klonopin®), diazepam, and clorazepate are also 
used as anticonvulsants. 
How are they abused? 
Abuse is frequently associated with adolescents 
and young adults who take the drug orally or crush 
it up and snort it to get high. 
Abuse is particularly high among heroin and 
cocaine users. Additionally, opioid users often co-
abuse benzodiazepines to enhance euphoria. 
What is their effect on the mind? 
Benzodiazepines are associated with amnesia, 
hostility, irritability, and vivid or disturbing dreams. 
What is their effect on the body? 
Benzodiazepines slow down the central nervous 
system and may cause sleepiness and relaxed 
mood. 
What are their overdose effects? 
Effects of overdose include: 
• Extreme drowsiness, confusion, impaired coordination,
decreased reflexes, respiratory depression, coma, and
possible death. Overdose effects of concomitant use of
benzodiazepines and opioids include: Profound sedation,
respiratory depression, coma, and death.
Which drugs cause similar effects? 
Drugs that cause similar effects include: 
• Alcohol, barbiturates, sleeping pills, and GHB
What is their legal status in the United States? 
Benzodiazepines are controlled in Schedule IV of 
the Controlled Substances Act.
Benzodiazepines 
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WHAT IS GHB? 
Gamma-Hydroxybutyric acid (GHB) is another 
name for the generic drug sodium oxybate. Xyrem® 
(which is sodium oxybate) is the trade name of the 
Food and Drug Administration (FDA)-approved 
prescription medication. Xyrem® is approved as 
a treatment to improve daytime sleepiness and 
muscle weakness with narcolepsy (a disorder 
marked by sudden, unexplained, spontaneous 
fatigue, napping, or falling asleep throughout the 
day). 
Analogues that are often substituted for GHB 
include  GBL  (gamma  butyrolactone) and 1,4 BD  
(also called just “BD”), which is 1,4-butanediol. 
These analogues are available legally as industrial 
solvents used to produce polyurethane, pesticides, 
elastic fibers, pharmaceuticals, coatings on metal 
or plastic, and other products. They are also sold 
illicitly as supplements for bodybuilding, fat loss, 
reversal of baldness, improved eyesight, and to 
combat aging, depression, drug addiction, and  
insomnia. 
GBL and BD are sold as “fish tank cleaner,” 
“ink stain remover,” “ink cartridge cleaner,” and 
“nail enamel remover” for approximately $100 per 
bottle — much more expensive than comparable 
products. Attempts to identify the abuse of GHB 
analogues are hampered by the fact that routine 
toxicological screens do not detect the presence of 
these analogues. 
WHAT IS ITS ORIGIN? 
GHB is produced illegally in both domestic and 
foreign clandestine laboratories. The major source 
of GHB on the street is through clandestine 
synthesis by local operators. At bars or “rave” 
parties, GHB is typically sold in liquid form 
by the capful or “swig” for $5 to $25 per cap. 
Xyrem® has the potential for diversion and 
abuse like any other pharmaceutical containing a 
controlled substance. 
GHB has been encountered in nearly every 
region of the country. 
What are common street names? 
Common street names include: 
• Easy Lay, G, Georgia Home Boy, GHB, Goop, Grievous
Bodily Harm, Liquid Ecstasy, Liquid X, and Scoop
What does it look like? 
GHB is usually sold as a liquid or as a white 
powder that is dissolved in a liquid, such as water, 
juice, or alcohol. GHB dissolved in liquid has been 
packaged in small vials or small water bottles. In 
liquid form, GHB is clear and colorless and slightly 
salty in taste. 
How is it abused? 
GHB and its analogues are misused for their 
euphoric and calming effects and because some 
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GHB and its analogues are also misused for their 
ability to increase libido, suggestibility, passivity, 
and to cause amnesia (no memory of events while 
under the influence of the substance) — traits that 
make victims vulnerable to sexual assault and other 
criminal acts. 
GHB misuse became popular among teens and 
young adults at dance clubs and “raves” in the 1990s 
and gained notoriety as a date rape drug. GHB is 
taken alone or in combination with other drugs, such 
as alcohol (primarily), other depressants, stimulants, 
hallucinogens, and marijuana. 
The average dose ranges from 1 to 5 grams 
(depending on the purity of the compound, this can 
be 1-2 teaspoons mixed in a beverage). However, 
the concentrations of these “home-brews” have 
varied so much that users are usually unaware of 
the actual dose they are drinking. 
What is its effect on the mind? 
GHB occurs naturally in the central nervous system 
in very small amounts. Use of GHB produces 
Central Nervous System (CNS) depressant effects 
including: 
• Euphoria, drowsiness, decreased anxiety, confusion,
and memory impairment
GHB can also produce both visual hallucinations and 
— paradoxically — excited and aggressive behavior. 
GHB greatly increases the CNS depressant effects 
of alcohol and other depressants. 
What is its effect on the body? 
GHB takes effect in 15 to 30 minutes, and the 
effects last 3 to 6 hours. Low doses of GHB produce 
nausea. 
At high doses, GHB overdose can result in: 
• Unconsciousness, seizures, slowed heart rate, greatly
slowed breathing, lower body temperature, vomiting, 
nausea, coma, and death. 
Regular use of GHB can lead to addiction and 
withdrawal that includes: 
• Insomnia, anxiety, tremors, increased heart rate and
blood pressure, and occasional psychotic thoughts.
Currently, there is no antidote available for GHB
intoxication. GHB analogues are known to produce side
effects such as:
• Topical irritation to the skin and eyes, nausea, vomiting,
incontinence, loss of consciousness, seizures, liver
damage, kidney failure, respiratory depression, and
death
What are its overdose effects? 
GHB overdose can cause coma and death. 
Which drugs cause similar effects? 
• GHB analogues are often abused in place of GHB.
Both GBL and BD metabolize to GHB when taken and
produce effects similar to GHB.
• CNS depressants such as barbiturates and
methaqualone also produce effects similar to GHB.
What is its legal status in the United States? 
GHB is a Schedule I controlled substance, meaning 
that it has a high potential for abuse, no currently 
accepted medical use in treatment in the United 
States, and a lack of accepted safety for use under 
medical supervision. FDA-approved GHB products 
are Schedule III substances under the Controlled 
Substances Act. In addition, GBL is a List I chemical. 
GHB was placed on Schedule I of the Controlled 
Substances Act in March 2000. However, when sold 
as FDA-approved GHB products (such as Xyrem®), 
it is considered Schedule III, one of several drugs 
that are listed in multiple schedules.
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WHAT IS ROHYPNOL? 
Rohypnol® is a trade name for flunitrazepam, 
a central nervous system (CNS) depressant 
that belongs to a class of drugs known as 
benzodiazepines. Flunitrazepam is also marketed 
as generic preparations and other trade name 
products outside of the United States. 
Like other benzodiazepines, Rohypnol® 
produces sedative-hypnotic, anti-anxiety, and 
muscle relaxant effects. This drug has never been 
approved for medical use in the United States 
by the Food and Drug Administration. Outside 
the United States, Rohypnol® is commonly 
prescribed to treat insomnia. Rohypnol® is also 
referred to as a “date rape” drug. 
WHAT IS ITS ORIGIN? 
Rohypnol® is smuggled into the United States 
from other countries, such as  Mexico. 
What are common street names? 
Common street names include: 
• Circles, Forget Pill, Forget-Me-Pill, La Rocha, Lunch
Money Drug, Mexican Valium, Pingus, R2, Reynolds,
Roach, Roach 2, Roaches, Roachies, Roapies, Robutal,
Rochas Dos, Rohypnol, Roofies, Rophies, Ropies,
Roples, Row-Shay, Ruffies, and Wolfies
What does it look like? 
Prior to 1997, Rohypnol® was manufactured as 
a white tablet (0.5-2 milligrams per tablet), and 
when mixed in drinks, was colorless, tasteless, 
and odorless. In 1997, the manufacturer 
responded to concerns about the drug’s role in 
sexual assaults by reformulating the drug. 
Rohypnol® is now manufactured as an oblong 
olive green tablet with a speckled blue core that 
when dissolved in light-colored drinks will dye the 
liquid blue. However, generic versions of the drug 
may not contain the blue dye. 
How is it abused? 
The tablet can be swallowed whole, crushed 
and snorted, or dissolved in liquid. Adolescents 
may abuse Rohypnol® to produce a euphoric 
effect often described as a “high.” While high, 
they experience reduced inhibitions and impaired 
judgment. 
Rohypnol is also used in combination with 
alcohol to produce an exaggerated intoxication. 
In addition, abuse of Rohypnol® may be 
associated with multiple-substance abuse. 
For example, cocaine users may use 
benzodiazepines such as Rohypnol® to relieve 
the side effects (e.g., irritability and agitation) 
associated with cocaine binges. 
Rohypnol is also misused to physically and 
psychologically incapacitate victims targeted 
for sexual assault. The drug is usually placed 
Rohypnol ®
Rohypnol® tablets
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in the alcoholic drink of an unsuspecting victim 
to incapacitate them and prevent resistance 
to sexual assault. The drug leaves the victim 
unaware of what has happened to them. 
What is its effect on the mind? 
Like other benzodiazepines, Rohypnol® slows 
down the functioning of the CNS producing: 
• Drowsiness (sedation), sleep (pharmacological
hypnosis), decreased anxiety, and amnesia (no memory
of events while under the influence of the substance)
Rohypnol® can also cause: 
• Increased or decreased reaction time, impaired mental
functioning and judgment, confusion, aggression, and
excitability
What is its effect on the body? 
Rohypnol® causes muscle relaxation. Adverse 
physical effects include: 
• Slurred speech, loss of motor coordination, weakness,
headache, and respiratory depression
Rohypnol® also can produce physical 
dependence when taken regularly over a period 
of time. 
What are its overdose effects? 
High doses of Rohypnol®, particularly when 
combined with CNS depressant drugs such 
as alcohol and heroin, can cause severe 
sedation, unconsciousness, slow heart rate, and 
suppression of respiration that may be sufficient 
to result in death. 
Which drugs cause similar effects? 
Drugs that cause similar effects include 
GHB (gamma hydroxybutyrate) and other 
benzodiazepines such as alprazolam (e.g., 
Xanax®), clonazepam (e.g., Klonopin®), and 
diazepam (e.g., Valium®). 
What is its legal status in the United States? 
Rohypnol® is a Schedule IV substance under 
the Controlled Substances Act. Rohypnol® is 
not approved for manufacture, sale, use, or 
importation to the United States. However, it 
is legally manufactured and marketed in other 
countries. Penalties for possession, trafficking, 
and distribution involving one gram or more are 
the same as those of a Schedule I drug.
Blister pack of Rohypnol® tablets
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WHAT ARE HALLUCINOGENS? 
Hallucinogens are found in plants and fungi or are 
synthetically produced and are among the oldest 
known group of drugs used for their ability to alter 
human perception and mood. 
WHAT IS THEIR ORIGIN? 
Hallucinogens can be synthetically produced in 
illicit laboratories or are found in plants. 
What are common street names? 
Common street names include: 
• Acid, Blotter, Cubes, Fry, Mind Candy, Mushrooms, 
Shrooms, Special K, STP, X,  and XTC 
What do they look like? 
Hallucinogens come in a variety of forms. MDMA 
or ecstasy tablets are sold in many colors with a 
variety of logos to attract youth. LSD is sold in the 
form of saturated paper (blotter paper), typically 
imprinted with colorful  graphic designs. 
How are they abused? 
The most commonly abused hallucinogens 
among junior and senior high school students 
are hallucinogenic mushrooms, LSD, and MDMA 
(ecstasy). Hallucinogens are typically taken orally 
or can be smoked. 
What is their effect on the mind? 
Sensory effects include perceptual distortions that 
vary with dose, setting, and mood. Psychic effects 
include distortions of thought associated with time 
and space. Time may appear to stand still, and 
forms and LSD powder and capsules colors seem 
to change and take on new significance. Weeks    
or even months after some hallucinogens have 
been taken, the user may develop an uncommon 
disorder called Hallucinogen Persisting 
Perception Disorder (HPPD) or experience 
“flashbacks.” HPPD can include fragmentary 
recurrences of certain aspects of the drug 
experience in the absence of actually taking the 
drug. The occurrence of HPPD is unpredictable, 
but may be more likely to occur during times of 
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What is their effect on the body? 
Physiological effects include elevated heart rate, 
increased blood pressure, dilated pupils, and 
often can induce nausea and vomiting. 
What are their overdose effects? 
Deaths exclusively from acute overdose of LSD, 
magic mushrooms, and mescaline are extremely 
rare. Deaths generally occur due to suicide, 
accidents, and dangerous behavior, or due to 
the person inadvertently eating poisonous plant 
material. 
A severe overdose of PCP or ketamine can 
result in: 
• Respiratory depression, coma, convulsions, seizures,
and death due to respiratory arrest
What is their legal status in the United States? 
Many hallucinogens are Schedule I under the 
Controlled Substances Act, meaning that they 
have a high potential for abuse, no currently 
accepted medical use in treatment in the United 
States, and a lack of accepted safety for use 
under medical supervision.
LSD powder and capsules
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WHAT IS ECSTASY/MDMA? 
MDMA acts as both a stimulant and psychedelic, 
producing an energizing effect, distortions in 
time and perception, and enhanced enjoyment of 
tactile experiences. 
Adolescents and young adults use it to reduce 
inhibitions and to promote: 
• Euphoria, feelings of closeness, empathy, and sexuality
Although MDMA is known among users as 
ecstasy, researchers have determined that many 
ecstasy tablets contain not only MDMA but also a 
number of other drugs or drug combinations that 
can be harmful, such as: 
• Methamphetamine, ketamine, cocaine, cathinones, and
caffeine
In addition, other drugs similar to MDMA, such 
as MDA or PMA, are often sold as ecstasy, which 
can lead to overdose and death when the user 
takes additional doses to obtain the desired effect. 
WHAT IS ITS ORIGIN? 
MDMA is a synthetic chemical made in 
labs. Seized MDMA in the U.S. is primarily 
manufactured in, and smuggled across U.S. 
borders from, clandestine laboratories in Canada 
and, to a lesser extent, the Netherlands. A small 
number of MDMA clandestine laboratories have 
also been identified operating in the U.S. 
What are common street names? 
Common street names include: 
• Adam, Beans, Clarity, Disco Biscuit, E, Ecstasy, Eve,
Go, Hug Drug, Lover’s Speed, MDMA, Peace, STP, X,
and XTC
What does it look like? 
MDMA is mainly distributed in tablet form. MDMA 
tablets are often sold with logos, creating brand 
names for users to seek out. The colorful pills are 
often hidden among colorful candies. MDMA is 
also distributed in capsules, powder, and liquid  
forms. 
How is it abused? 
MDMA use mainly involves swallowing tablets 
(50-150 mg), which are sometimes crushed and 
snorted, occasionally smoked, but rarely injected. 
MDMA is also available as a powder. 
MDMA users usually take MDMA by “stacking” 
(taking three or more tablets at once) or by 
“piggy-backing” (taking a series of tablets over 
a short period of time). One trend among young 
adults is “candy flipping,” which is the co-abuse of 
MDMA and LSD. 
MDMA is considered a “party drug.” As with 
many other drugs of abuse, MDMA is rarely used 
alone. It is common for users to mix MDMA with 
other substances, such as alcohol and marijuana. 
What is its effect on the mind? 
MDMA mainly affects brain cells that use 
the chemical serotonin to communicate with 
each other. Serotonin helps to regulate mood, 
aggression, sexual activity, sleep, and sensitivity 
to pain. Clinical studies suggest that MDMA 
may increase the risk of long-term, perhaps 
permanent, problems with memory and learning. 
MDMA causes changes in perception, including 
euphoria and increased sensitivity to touch, 
energy, sensual and sexual arousal, need to be 
touched, and need for stimulation.
Ecstasy/MDMA 
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Some unwanted psychological effects include: 
• Confusion, anxiety, depression, paranoia, sleep
problems, and drug craving
All these effects usually occur within 30 to 45
minutes of swallowing the drug and usually last 4 
to 6 hours, but they may occur or last weeks after 
ingestion. 
What is its effect on the body? 
Users of MDMA experience many of the same 
effects and face many of the same risks as 
users of other stimulants such as cocaine and 
amphetamines. These include increased motor 
activity, alertness, heart rate, and blood pressure. 
Some unwanted physical effects include: 
• Muscle tension, tremors, involuntary teeth clenching,
muscle cramps, nausea, faintness, chills, sweating, and
blurred vision
Severe dehydration can result from the
combination of the drug’s effects and the crowded 
and hot conditions in which the drug is often taken. 
Studies suggest chronic use of MDMA can 
produce damage to the serotonin system. It is 
ironic that a drug that is taken to increase pleasure 
may cause damage that reduces a person’s ability 
to feel pleasure. 
What are its overdose effects? 
In high doses, MDMA can interfere with the 
body’s ability to regulate temperature. On 
occasions, this can lead to a sharp increase in 
body temperature (hyperthermia), resulting in 
liver, kidney, and cardiovascular system failure, 
and death. Because MDMA can interfere with its 
own metabolism (that is, its breakdown within the 
body), potentially harmful levels can be reached 
by repeated drug use within short intervals. 
Which drugs cause similar effects? 
MDMA produces both amphetamine-like 
stimulation and mild mescaline-like hallucinations. 
What is its legal status in the United States? 
MDMA is a Schedule I drug under the Controlled 
Substances Act, meaning it has a high potential 
for abuse, no currently accepted medical use 
in treatment in the United States, and a lack 
of accepted safety for use under medical 
supervision.
MDMA/Ecstacy pills
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WHAT IS KETAMINE? 
Ketamine is a dissociative anesthetic that has some 
hallucinogenic effects. It distorts perceptions of sight 
and sound and makes the user feel disconnected 
and not in control. It is an injectable, short-acting 
anesthetic for use in humans and animals. It is 
referred to as a “dissociative anesthetic” because 
it makes patients feel detached from their pain and 
environment. 
Ketamine can induce a state of sedation (feeling 
calm and relaxed), immobility, relief from pain, and 
amnesia (no memory of events while under the 
influence of the drug). 
It is abused for its ability to produce dissociative 
sensations and hallucinations. Ketamine has also 
been used to facilitate sexual assault. 
WHAT IS ITS ORIGIN? 
Ketamine is produced commercially in a number 
of countries, including the United States. Most 
of the ketamine illegally distributed in the United 
States is diverted or stolen from legitimate sources, 
particularly veterinary clinics, or smuggled into the 
United States from Mexico. 
Distribution of ketamine typically occurs among 
friends  and acquaintances, most often at raves, 
nightclubs, and at private parties; street sales of 
ketamine are rare. 
How is it abused? 
Ketamine, along with the other “club drugs,” has 
become  popular among teens and young adults at 
dance clubs and “raves.” Ketamine is manufactured 
commercially as a powder or liquid. Powdered 
ketamine is also formed from pharmaceutical 
ketamine by evaporating the liquid using hot plates, 
warming trays, or microwave ovens, a process that 
results in the formation of crystals, which are then 
ground into powder. 
What are common street names? 
Common street names include: 
• Cat Tranquilizer, Cat Valium, Jet K, Kit Kat, Purple, 
Special K, Special La Coke, Super Acid, Super K, and 
Vitamin K 
What does it look like? 
Ketamine comes in a clear liquid and a white 
or off-white powder. Powdered ketamine (100 
milligrams to 200 milligrams) typically is packaged 
in small glass vials, small plastic bags, and 
capsules as well as paper, glassine, or aluminum 
foil folds. 
Powdered ketamine is cut into lines known as 
bumps and snorted, or it is smoked, typically in 
marijuana or tobacco cigarettes. Liquid ketamine 
is injected or mixed into drinks. Ketamine is found 
by itself or often in combination with MDMA, 
amphetamine, methamphetamine, or cocaine.
Ketamine 
Vials containing liquid ketamine 
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What is its effect on the mind? 
Ketamine produces hallucinations. It distorts 
perceptions of sight and sound and makes the user 
feel disconnected and not in control. A “Special K” trip 
is touted as better than that of LSD or PCP because 
its hallucinatory effects are relatively short in duration, 
lasting approximately 30 to 60 minutes as opposed to 
several hours.
 Slang for experiences related to Ketamine or 
effects of ketamine include: 
• “K-land” (refers to a mellow & colorful experience)
• “K-hole” (refers to the out-of-body, near death
experience)
• “Baby food” (users sink in to blissful, infantile inertia)
• “God” (users are convinced that they have met their
maker)
The onset of effects is rapid and often occurs within 
a few minutes of taking the drug, though taking it 
orally results in a slightly slower onset of effects. 
Hallucinogen Persisting Perception Disorder (HPPD) 
has been reported several weeks after ketamine is 
used and may include experiencing the negative side 
effects that occurred while taking the drug initially. 
Ketamine may also cause agitation, depression, 
cognitive difficulties, unconsciousness, and amnesia. 
What is its effect on the body? 
A couple of minutes after taking the drug, the user 
may experience an increase in heart rate and blood 
pressure that gradually decreases over the next 10 to 
20 minutes. Ketamine can make users unresponsive 
to stimuli. When in this state, users experience: 
• Involuntarily rapid eye movement, dilated pupils,
salivation, tear secretions, and stiffening of the muscles
This drug can also cause nausea. 
What are its overdose effects? 
An overdose can cause unconsciousness and 
dangerously slowed breathing. 
Which drugs cause similar effects? 
Other hallucinogenic drugs such as LSD, PCP, and 
mescaline can cause hallucinations. There are also 
several drugs such as GHB, Rohypnol®, and other 
depressants that are misused for their amnesiac or 
sedative properties to facilitate sexual assault. 
What is its legal status in the United States? 
Since the 1970s, ketamine has been marketed 
in the United States as an injectable, short-acting 
anesthetic for use in humans and animals. In 1999, 
ketamine, including its salts, isomers and salts 
of isomers, became a Schedule III non-narcotic 
substance under the Controlled Substances Act. 
It currently has accepted medical uses for short-
term sedation and anesthesia. In addition, in 2019, 
FDA approved the S(+) enantiomer of ketamine 
(esketamine) nasal spray version (Spravato®) for 
treatment-resistant depression that is only available 
at a certified doctor’s office or clinic. Ketamine has 
the potential for abuse, which may lead to moderate 
or low physical dependence or high psychological 
dependence.
Ketamine in various forms
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WHAT IS LSD? 
LSD is a potent hallucinogen that has a high 
potential for abuse and currently has no accepted 
medical use in treatment in the United States. 
WHAT IS ITS ORIGIN? 
LSD is produced in clandestine laboratories in the 
United States. 
What are common street names? 
Common names for LSD include: 
• Acid, Dots, Mellow Yellow, and Window Pane
What does it look like? 
LSD is an odorless and colorless substance with 
a slightly bitter taste. LSD is available in saturated 
absorbent paper (e.g., blotter paper, divided 
into small, decorated squares, with each square 
representing one dose), tablets or “micro dots,” 
saturated sugar cubes, or in a liquid form. 
What is its effect on the body? 
The physical effects include: 
• Dilated pupils, higher body temperature, increased heart
rate and blood pressure, sweating, loss of appetite,
sleeplessness, dry mouth, and  tremors
How is it abused? 
LSD is abused orally. 
What is its effect on the mind? 
During the first hour after ingestion, users may 
experience visual changes with extreme changes 
in mood. While hallucinating, the user may suffer 
impaired depth and time perception accompanied 
by distorted perception of the shape and size  of  
objects,  movements,  colors,  sound,  touch, and 
the user’s own body  image. 
The ability to make sound judgments and see 
common dangers is impaired, making the user 
susceptible to personal injury. It is possible for 
users to suffer acute anxiety and depression after 
an LSD “trip.” Hallucinogen Persisting Perception 
Disorder, which may include fragmentary 
recurrences of certain aspects of the drug 
experience or “flashbacks” have been reported 
days, and even months, after taking the last dose. 
What are its overdose effects? 
Longer, more intense “trip” episodes, psychosis, 
and possible death 
Which drugs cause similar effects? 
LSD’s effects are similar to other hallucinogens, 
such as PCP, mescaline, and peyote. 
What is its legal status in the United States? 
LSD is a Schedule I substance under the 
Controlled Substances Act. Schedule I 
substances have a high potential for abuse, no 
currently accepted medical use in treatment in the 
United States, and a lack of accepted safety for 
use under  medical supervision.
LSD Peyote & Mescaline
LSD blotter paper with match for size comparison
Image by Erik Fenderson
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WHAT ARE PEYOTE AND 
MESCALINE? 
Peyote is a small, spineless cactus. The 
active ingredient in peyote is the hallucinogen 
mescaline. 
WHAT IS ITS ORIGIN? 
From earliest recorded time, peyote has been 
used by indigenous peoples in northern Mexico 
and the southwestern United States as a part of 
their religious rites. Mescaline can be extracted 
from peyote or produced synthetically. 
What is its effect on the body? 
Following the consumption of peyote and 
mescaline, users may experience: 
• Intense nausea, vomiting, dilation of the pupils,
increased heart rate, increased blood pressure, a rise
in body temperature that causes heavy perspiration,
headaches, muscle weakness, and impaired motor
coordination
Which drugs cause similar effects? 
Other hallucinogens like LSD, psilocybin 
(mushrooms), and PCP 
What are common street names? 
Common street names include: 
• Buttons, Cactus, Mesc, and Peyoto
What does it look like? 
The top of the peyote cactus is referred to as the 
“crown” and consists of disc-shaped buttons that 
are cut off. 
How is it abused? 
The fresh or dried buttons are chewed or soaked 
in water to produce an intoxicating liquid. Peyote 
buttons may also be ground into a powder that 
can be placed inside gelatin capsules to be 
swallowed, or smoked with a leaf material such as 
cannabis or tobacco. 
What is its effect on the mind? 
Abuse of peyote and mescaline will cause varying 
degrees of: 
• Illusions, hallucinations, altered perception of space and
time, and altered body image
Users may also experience euphoria, which is 
sometimes followed by feelings of anxiety. 
What is its legal status in the United States? 
Peyote and mescaline are Schedule I substances 
under the Controlled Substances Act, meaning 
that they have a high potential for abuse, no 
currently accepted medical use in treatment in the 
United States, and a lack of accepted safety for 
use under medical supervision.
Peyote & Mescaline 
Peyote cactus
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WHAT IS PSILOCYBIN? 
Psilocybin is a chemical obtained from certain 
types of fresh or dried mushrooms. 
WHAT IS ITS ORIGIN? 
Psilocybin mushrooms are found in Mexico, 
Central America, and the United States. 
What are common street names? 
Common street names include: 
• Magic Mushrooms, Mushrooms, and Shrooms
What does it look like? 
Mushrooms containing psilocybin are available 
fresh or dried and have long, slender stems 
topped by caps with dark gills on the underside. 
Fresh mushrooms have white or whitish-gray 
stems; the caps are dark brown around the edges 
and light brown or white in the center. Dried 
mushrooms are usually rusty brown with isolated 
areas of off-white. 
How is it abused? 
Psilocybin mushrooms are ingested orally. They 
may also be brewed as a tea or added to other 
foods to mask their bitter flavor. 
What is its effect on the body? 
The physical effects include: 
• Nausea, vomiting, muscle weakness, and lack of
coordination
What is its effect on the mind? 
The psychological consequences of psilocybin 
use include hallucinations and an inability to 
discern fantasy from reality. Panic reactions and a 
psychotic-like episode also may occur, particularly 
if a user ingests a high dose. 
What are its overdose effects? 
Effects of overdose include: 
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Abuse of psilocybin mushrooms could also lead to poisoning if one of the many varieties of poisonous 
mushrooms is incorrectly identified as a psilocybin mushroom. 
Which drugs cause similar effects? 
Psilocybin effects are similar to other hallucinogens, such as mescaline and peyote. 
What is its legal status in the United States? 
Psilocybin is a Schedule I substance under the Controlled Substances Act, meaning that it has a high 
potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of 
accepted safety for use under medical supervision.
Image by Erik Fenderson
Psilocybin mushrooms
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WHAT ARE STEROIDS? 
Anabolic steroids are synthetically produced variants of the naturally occurring male hormone 
testosterone  that are abused in an attempt to promote muscle growth, enhance athletic or other physical 
performance, and improve physical appearance. 
Testosterone, trenbolone, oxymetholone, methandrostenolone, nandrolone, stanozolol, boldenone, and 
oxandrolone are some of the anabolic steroids that are most commonly encountered by United States 
law enforcement. 
WHAT IS THEIR ORIGIN? 
Most illicit steroids are smuggled into the U.S. from abroad. Steroids are also illegally diverted from 
legitimate sources (theft or inappropriate prescribing). The Internet is the most widely used means 
of buying and selling anabolic steroids. Steroids are also bought and sold at gyms, bodybuilding 
competitions, and schools from teammates, coaches, and  trainers. 
What are common street names? 
Common street names  include: 
• Arnolds, Juice, Pumpers, Roids, Stackers, and Weight Gainers 
What do they look like? 
Steroids are available in: 
• Tablets and capsules, sublingual-tablets, liquid drops, gels, creams, 
transdermal patches, subdermal implant pellets, and water-based and oil-
based injectable solutions 
The appearance of these products varies depending on the type 
and manufacturer. 
How are they abused? 
Steroids are ingested orally, injected intramuscularly, or applied to 
the skin. The doses abused are often 10 to 100 times higher than 
the approved therapeutic and medical treatment dosages. Users 
typically take two or more anabolic steroids at the same time in a 
cyclic manner, believing that this will improve their effectiveness 
and minimize the adverse effects.
Steroids 
Depo-Testosterone
Testosterone Cypionate Injection, USP
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What is their effect on the mind? 
Case studies and scientific research indicate that 
high doses of anabolic steroids may cause mood 
and behavioral effects. 
In some individuals, anabolic steroid use can 
cause dramatic mood swings, increased feelings 
of hostility, impaired judgment, and increased 
levels of aggression (often referred to as “roid 
rage”). 
When users stop taking steroids, they may 
experience depression that may be severe 
enough to lead one to commit suicide. 
Anabolic steroid use may also cause 
psychological dependence and addiction. 
What is their effect on the body? 
A wide range of adverse effects is associated 
with the use or abuse of anabolic steroids. These 
effects depend on several factors including: 
• Age, sex, the anabolic steroid used, amount used, and
duration of use
In adolescents, anabolic steroid use can stunt the 
ultimate height that an individual might otherwise 
achieve. 
In boys, anabolic steroid use can cause early 
sexual development, acne, and stunted growth. 
In adolescent girls and women, anabolic steroid 
use can induce permanent physical changes, such 
as deepening of the voice, increased facial and 
body hair growth, menstrual irregularities, male 
pattern baldness, and lengthening of the clitoris. 
In men, anabolic steroid use can cause 
shrinkage of the testicles, reduced sperm count, 
enlargement of the male breast tissue, sterility, 
and an increased risk of prostate cancer. 
In both men and women, anabolic steroid use 
can cause high cholesterol levels, which may 
increase the risk of coronary artery disease, 
strokes, and heart attacks. Anabolic steroid use 
can also cause acne and fluid retention. Oral 
preparations of anabolic steroids, in particular, can 
damage the liver. 
Users who inject anabolic steroids run the risk 
of contracting various infections due to non-sterile 
injection techniques, sharing of contaminated 
needles, and the use of steroid preparations 
manufactured in non-sterile environments. All 
these factors put users at risk for contracting viral 
infections such as HIV/AIDS or hepatitis B or C, 
and bacterial infections at the sight of injection. 
Users may also develop endocarditis, a 
bacterial infection that causes a potentially fatal 
inflammation of the heart lining. 
What are their overdose effects? 
Anabolic steroids are not associated with 
overdoses. The adverse effects a user would 
experience develop from the use of steroids over 
time. 
Which drugs cause similar effects? 
There are several substances that produce effects 
similar to those of anabolic steroids. These include 
human growth hormone (hHG), clenbuterol, 
gonadotropins, and erythropoietin. 
What is their legal status in the United States? 
Anabolic steroids are Schedule III substances 
under the Controlled Substances Act. Only a small 
number of anabolic steroids are approved for 
either human or veterinary use. Anabolic steroids 
may be prescribed by a licensed physician for 
the treatment of testosterone deficiency, delayed 
puberty, low red blood cell count, breast cancer,  
and tissue wasting resulting from AIDS.
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WHAT IS MARIJUANA? 
Marijuana is a mind-altering (psychoactive) 
drug, produced by the Cannabis sativa plant. 
Marijuana has over 480 constituents. THC (delta-
9-tetrahydrocannabinol) is believed to be the main
ingredient that produces the psychoactive effect.
WHAT IS ITS ORIGIN? 
Marijuana is grown in the United States, Canada, 
Mexico, South America, Caribbean, and Asia. 
It can be cultivated in both outdoor and indoor 
settings. 
What are common street names? 
Common street names include: 
• Aunt Mary, BC Bud, Blunts, Boom, Chronic, Dope,
Gangster, Ganja, Grass, Hash, Herb, Hydro, Indo, Joint,
Kif, Mary Jane, Mota, Pot, Reefer, Sinsemilla, Skunk,
Smoke, Weed, and Yerba
What does it look like? 
Marijuana is a dry, shredded green/brown mix 
of flowers, stems, seeds, and leaves from the 
Cannabis sativa plant. The mixture typically is 
green, brown, or gray in color and may resemble 
tobacco. 
How is it abused? 
Marijuana is usually smoked as a cigarette (called 
a joint) or in a pipe or bong. It is also smoked in 
blunts, which are cigars that have been emptied 
of tobacco and refilled with marijuana, sometimes 
in combination with another drug. Marijuana is 
also mixed with foods or brewed as a tea. 
What is its effect on the mind? 
When marijuana is smoked, the active ingredient 
THC passes from the lungs and into the 
bloodstream, which carries the chemical to the 
organs throughout the body, including the brain. 
In the brain, THC connects to specific sites 
called cannabinoid receptors on nerve cells and 
influences the activity of those cells.
 Many of these receptors are found in the parts 
of the brain that influence: 
• Pleasure, memory, thought, concentration, sensory and
time perception, and coordinated movement
The short-term effects of marijuana include:
• Problems with memory and learning, distorted
perception, difficulty in thinking and problem-solving,
and loss of coordination
The effect of marijuana on perception and
coordination are responsible for serious 
impairments in learning, associative processes, 
and psychomotor behavior (driving abilities). 
Long term, regular use can lead to physical 
dependence and withdrawal following 
discontinuation, as well as psychological addiction 
or dependence. 
Clinical studies show that the physiological, 
psychological, and behavioral effects of 
marijuana vary among individuals and present 
a list of common responses to cannabinoids, as 
described in the scientific literature: 
• Dizziness, nausea, tachycardia, facial flushing, dry
mouth, and tremor initially
• Merriment, happiness, and even exhilaration at high
doses
Marijuana/Cannabis 
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• Disinhibition, relaxation, increased sociability, and
talkativeness
• Enhanced sensory perception, giving rise to increased
appreciation of music, art, and touch
• Heightened imagination leading to a subjective sense of
increased creativity
• Time distortions
• Illusions, delusions, and hallucinations are rare except
at high doses
• Impaired judgment, reduced coordination, and ataxia,
which can impede driving ability or lead to an increase in
risk-taking behavior
• Emotional lability, incongruity of affect, dysphoria,
disorganized thinking, inability to converse logically,
agitation, paranoia, confusion, restlessness, anxiety,
drowsiness, and panic attacks may occur, especially in
inexperienced users or in those who have taken a large
dose
• Increased appetite and short-term memory impairment
are common
What is its effect on the body? 
Short-term physical effects from marijuana use 
may include: 
• Sedation, bloodshot eyes, increased heart rate,
coughing from lung irritation, increased appetite, and
increased blood pressure (although prolonged use may
cause a decrease in blood pressure).
Marijuana smokers experience serious health 
problems such as bronchitis, emphysema, and 
bronchial asthma. Extended use may cause 
suppression of the immune system. Withdrawal 
from chronic use of high doses of marijuana 
causes physical signs including headache, 
shakiness, sweating, and stomach pains and 
nausea. 
Withdrawal symptoms also include behavioral 
signs such as: 
• Restlessness, irritability, sleep difficulties, and
decreased appetite
Marijuana Leaves
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Marijuana Concentrates
What are its overdose effects? 
No deaths from overdose of marijuana have been 
reported. 
Which drugs cause similar effects? 
Hashish and hashish oil are drugs made from 
the cannabis plant that are like marijuana, only 
stronger. 
Hashish (hash) consists of the THC-rich 
resinous material of the cannabis plant, which 
is collected, dried, and then compressed into a 
variety of forms, such as balls, cakes, or cookie 
like sheets. Pieces are then broken off, placed in 
pipes or mixed with tobacco and placed in pipes 
or cigarettes, and smoked. 
The main sources of hashish are the Middle 
East, North Africa, Pakistan, and Afghanistan. 
Hashish oil (hash oil, liquid hash, cannabis 
oil) is produced by extracting the cannabinoids 
from the plant material with a solvent. The color 
and odor of the extract will vary, depending on 
the solvent used. A drop or two of this liquid on 
a cigarette is equal to a single marijuana joint. 
Like marijuana, hashish and hashish oil are both 
Schedule I drugs. 
What is its legal status in the United States? 
Marijuana is a Schedule I substance under the 
Controlled Substances Act, meaning that it has 
a high potential for abuse, no currently accepted 
medical use in treatment in the United States, and 
a lack of accepted safety for use under medical 
supervision. 
Although some states within the United 
States have allowed the use of marijuana for 
medicinal purpose, it is the U.S. Food and Drug 
Administration that has the federal authority to 
approve drugs for medicinal use in the U.S. To 
date, the FDA has not approved a marketing 
application for any marijuana product for any 
clinical indication. Consistent therewith, the FDA 
and DEA have concluded that marijuana has no 
federally approved medical use for treatment 
in the U.S. and thus it remains as a Schedule I 
controlled substance under federal law. 
Marinol is a synthetic version of THC in 
a capsule (also referred to as dronabinol, 
the generic or International Nonproprietary 
Name given to THC), prescribed for the 
control of nausea and vomiting caused by 
chemotherapeutic agents used in the treatment 
of cancer and to stimulate appetite in acquired 
immune deficiency syndrome (AIDS) patients. 
Marinol is a Schedule III drug under the 
Controlled  Substances Act. 
Syndros is an oral dronabinol (THC) solution 
that is used for the treatment of anorexia 
associated with weight loss in patients who have 
failed to respond adequately to conventional 
antiemetic treatments. Syndros is a Schedule II 
drug under the Controlled Substances Act. 
Epidoloex is an oral solution of cannabidiol 
(CBd) that has no more that 0.1% THC, used to 
treat two epilepsy conditions, Dravet syndrome 
and Lennox-Gestaut syndrome. Epidoloex 
is a Schedule V drug under the Controlled 
Substances Act.
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Marijuana Concentrates 
WHAT ARE MARIJUANA 
CONCENTRATES? 
A marijuana concentrate is a highly potent 
concentrated form of THC (tetrahydrocannabinol) 
that is most similar in appearance to either honey 
or butter, and commonly referred to or known on 
the street as “honey oil” or “budder.” 
WHAT IS ITS ORIGIN? 
Marijuana concentrates contain extraordinarily 
high THC levels that could range from 40 to 80 
percent. This form of marijuana can be up to four 
times higher in THC content than high grade or 
top shelf marijuana, which normally measures 
around 20 percent THC levels. 
Many methods are utilized to convert or 
“manufacture” marijuana into marijuana 
concentrates. One method is the butane 
extraction process. This process is particularly 
dangerous because it uses highly flammable 
butane to extract the THC from the cannabis 
plant. Given the flammable nature of butane, this 
process has resulted in violent explosions. THC 
extraction labs are being reported nationwide, 
particularly in the western states and in states 
where local and state marijuana laws are more 
relaxed. 
What are common street names? 
Common street names include: 
• 710 (the word “OIL” flipped and spelled backwards),
wax, ear wax, honey oil, budder, butane hash oil, butane
honey oil (BHO), shatter, dabs (dabbing), black glass,
and errl.
What does it look like? 
Marijuana concentrates are similar in appearance 
to honey or butter and are either brown or gold in 
color 
How is it used? 
Marijuana concentrates can be mixed with various 
food or drink products to be consumed orally; 
however, smoking remains the most popular route 
of administration by use of water or oil pipes. A 
disturbing aspect of this emerging threat is the 
inhalation of concentrates via electronic cigarettes 
(also known as e-cigarettes) or vaporizers. 
Many marijuana concentrate users prefer the 
e-cigarette/vaporizer because it is smokeless,
sometimes odorless, and easy to hide or conceal.
The user takes a small amount of marijuana
concentrate, referred to as a “dab,” then heats
the substance using the e-cigarette/vaporizer
producing vapors that ensures an instant “high”
effect upon the user. Using an e-cigarette/
vaporizer to inhale marijuana concentrates is
commonly referred to as “dabbing” or “vaping.”
Marijuana concentrate
Image by Erik Fenderson
92   Drugs of Abuse | A DEA Resource Guide: 2020 EDITION
What is Vaping? 
Vaping is the act of inhaling and exhaling an 
aerosol or vapor made from a liquid or dry material 
that is heated in an electronic powered device, 
called an electronic cigarette, or e-cigarette.  The 
liquid can contain flavoring, nicotine, or marijuana 
concentrates. Dry herb vape devices can heat 
dry marijuana without combusting it and without 
using additional liquid. Generally, the vaping device 
consists of a battery, a cartridge for containing the 
e-liquid or dry marijuana, and a heating component. 
Vaping devices come in a variety of shapes and 
sizes, with some resembling USB flash drives, pens, 
or other everyday objects that are often difficult for 
parents and teachers to recognize. 
What are common street names? 
• Common street names include: E-cigs, e-hookahs, mods,
vape pens, vapes, tank systems, and Juuls or Juuling
(after the Juul brand of vaping devices).
What are the effects of vaping? 
Vaping is not considered safe, especially for teens 
and young adults, since the adolescent brain is still 
developing and inhaling any substance through 
these devices may be harmful. Additionally, some 
devices might explode, resulting in burns and other 
injuries. Most vaping devices contain and release 
a number of potentially toxic substances including 
metals and volatile organic compounds from the 
devices and solvents used. Some of these have 
been linked to cell and DNA damage. 
Vaping 
Source: National Academies of Sciences, Engineering, and Medicine, 2018. Public Health Consequences of E-Cigarettes.
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What are the Effects of Using Marijuana Concentrates? 
Being a highly concentrated form of marijuana, the effects upon the user may be more psychologically 
and physically intense than plant marijuana use. To date, long term effects of marijuana concentrate use 
are not yet fully known; but, the effects of marijuana use are known. 
These effects include: 
• paranoia, anxiety, panic attacks, and hallucinations. Additionally, the use of plant marijuana increases one’s heart rate and
blood pressure, although prolonged use can produce hypotension. Plant marijuana users may also experience withdrawal
and addiction problems.
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WHAT ARE INHALANTS? 
Inhalants are invisible, volatile substances found 
in common household products that produce 
chemical vapors that are inhaled to induce 
psychoactive or mind altering effects. 
WHAT IS THEIR ORIGIN? 
There are more than 1,000 products that are very 
dangerous when inhaled — things like typewriter 
correction fluid, air conditioning refrigerant, felt 
tip markers, spray paint, air freshener, butane, 
and even cooking spray. See products abused 
as inhalants at www.inhalants.org/product.htm 
(National Inhalant Prevention Coalition). 
What are common street names? 
Common street names include: 
• Gluey, Huff, Rush, and Whippets
What do they look like? 
Common household products such as glue, 
lighter fluid, cleaning fluids, and paint all produce 
chemical vapors that can be inhaled. 
How are they abused? 
Although other abused substances can be 
inhaled, the term “inhalants” is used to describe 
a variety of substances whose main common 
characteristic is that they are rarely, if ever, taken 
by any route other than inhalation. 
Inhalants are breathed in through the nose or 
the mouth in a variety of ways, such as: 
• “Sniffing” or “snorting”
• “Bagging”— sniffing or inhaling fumes from
substances sprayed or deposited inside a plastic or
paper bag
• “Huffing” from an inhalant-soaked rag stuffed in the
mouth, or inhaling from balloons filled with nitrous
oxide
Inhalants are often among the first drugs that
young children use. About 1 in 5 kids report having 
used inhalants by the eighth grade. Inhalants are 
also one of the few substances abused more by 
younger children than by older ones. 
What is their effect on the mind? 
Inhalant abuse can cause damage to the parts of 
the brain that control thinking, moving, vision, and 
hearing. Cognitive abnormalities can range from 
mild impairment to severe dementia. 
What is their effect on the body? 
Inhaled chemicals are rapidly absorbed 
through the lungs into the bloodstream and 
quickly distributed to the brain and other organs. 
Nearly all inhalants produce effects similar to 
anesthetics, which slow down the body’s function. 
Depending on the degree of abuse, the user 
can experience slight stimulation, feeling of less 
inhibition, or loss of consciousness. 
Within minutes of inhalation, the user 
Inhalants 
Paint thinner
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experiences intoxication along with other effects 
similar to those produced by alcohol. These 
effects may include slurred speech, an inability to 
coordinate movements, euphoria, and dizziness. 
After heavy use of inhalants, users may feel 
drowsy for several hours and experience a 
lingering headache. 
Additional symptoms exhibited by long-term 
inhalant users include: 
• Weight loss, muscle weakness, disorientation, inat- 
tentiveness, lack of coordination, irritability, depression,
and damage to the nervous system and other organs
Some of the damaging effects to the body may
be at least partially reversible when inhalant 
abuse is stopped; however, many of the effects 
from prolonged abuse are irreversible. 
Prolonged sniffing of the highly concentrated 
chemicals in solvents or aerosol sprays can 
induce irregular and rapid heart rhythms and 
lead to heart failure and death within minutes. 
There is a common link between inhalant use 
and problems in school — failing grades, chronic 
absences, and general apathy. 
Other signs include: 
• Paint or stains on body or clothing; spots or sores
around the mouth; red or runny eyes or nose;
chemical breath odor; drunk, dazed, or dizzy
appearance; nausea; loss of appetite; anxiety;
excitability; and irritability
What are their overdose effects? 
Because intoxication lasts only a few minutes, 
users try to prolong the high by continuing to 
inhale repeatedly over the course of several 
hours, which is a very dangerous practice. With 
successive inhalations, users may suffer loss of 
consciousness and/or death. 
“Sudden sniffing death” can result from a 
single session of inhalant use by an otherwise 
healthy young person. Sudden sniffing death is 
particularly associated with the abuse of butane, 
propane, and chemicals in aerosols. 
Inhalant abuse can also cause death by 
asphyxiation from repeated inhalations, which 
lead to high concentrations of inhaled fumes 
displacing the available oxygen in the lungs, 
suffocation by blocking air from entering the lungs 
when inhaling fumes from a plastic bag placed 
over the head, and choking from swallowing vomit 
after inhaling substances. 
Which drugs cause similar effects? 
Most inhalants produce a rapid high that is 
similar to the effects of alcohol intoxication. 
What is their legal status in the United States? 
The common household products that are 
misused as inhalants are legally available for 
their intended and legitimate uses. Many state 
legislatures have attempted to deter youth 
who buy legal products to get high by placing 
restriction on the sale of these products to minors. 
Even though some substances are not currently 
controlled by  the Controlled Substances Act, 
they pose risks to individuals who abuse them. 
The following section describes these drugs and 
their associated risks.
Highlighter markers
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WHAT ARE “BATH SALTS?” 
Synthetic stimulants often referred to as “bath  
salts” are from the synthetic cathinone class 
of drugs. Synthetic cathinones are central 
nervous stimulants and are designed to mimic 
effects similar to those produced by cocaine, 
methamphetamine, and MDMA (ecstasy). These 
substances are often marketed as “bath salts,” 
“research chemicals,” “plant food,” “glass cleaner,” 
and labeled “not for human consumption,” in 
order to circumvent application of the Controlled 
Substance Analogue Enforcement Act. Marketing 
in this manner attempts to hide the true reason 
for the products’ existence—the distribution of a 
psychoactive/stimulant substance for abuse. 
WHAT IS THEIR ORIGIN? 
Synthetic cathinones are manufactured in East 
Asia and have been distributed at wholesale 
levels throughout Europe, North America, 
Australia, and other parts of the world. 
What are common street names? 
• Bliss, Blue Silk, Cloud Nine, Drone, Energy-1, Ivory
Wave, Lunar Wave, Meow Meow, Ocean Burst, Pure
Ivory, Purple Wave, Red Dove, Snow Leopard, Stardust,
Vanilla Sky, White Dove, White Knight, White Lightning
What does it look like? 
Websites have listed products containing these 
synthetic stimulants as “plant food” or “bath salts,” 
however, the powdered form is also compressed 
in gelatin capsules. The synthetic stimulants are 
sold at smoke shops, head shops, convenience 
stores, adult book stores, gas stations, and on 
Internet sites and often labeled “not for human 
consumption.”
Designer Drugs 
Recently, the abuse of clandestinely synthesized drugs has 
re-emerged as a major worldwide problem.  These drugs are 
illicitly produced with the intent of developing substances 
that differ slightly from controlled substances in their 
chemical structure while retaining their pharmacological 
effects. These substances are commonly known as designer 
drugs and fall under several drug categories. The following 
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How are they abused? 
“Bath salts” are usually ingested by sniffing/ 
snorting. They can also be taken orally, smoked, or 
put into a solution and injected into veins. 
What is their effect on the mind? 
These synthetic substances are abused for their 
desired effects, such as euphoria and alertness. 
Other effects that have been reported from the 
use of these drugs include psychological effects 
such as confusion, acute psychosis, agitation, 
combativeness, aggressive, violent, and self-
destructive  behavior. 
What is their effect on the body? 
Adverse or toxic effects associated with the 
abuse of cathinones, including synthetic 
cathinones, include rapid heartbeat; hypertension; 
hyperthermia; prolonged dilation of the pupil of 
the eye; breakdown of muscle fibers that leads to 
release of muscle fiber contents into bloodstream; 
teeth grinding; sweating; headaches; palpitations; 
seizures; as well as paranoia, hallucinations, and 
delusions. 
What are their overdose effects? 
In addition to effects above, reports of death from 
individuals abusing drugs in this class indicate 
the seriousness of the risk users are taking when 
ingesting these products. 
Which drugs cause similar effects? 
They cause effects similar to those of other 
stimulants such as methamphetamine, MDMA, 
and cocaine. 
What is their legal status in the United States? 
In July 2012, the U.S. Government passed Pub.L. 
112- 144, the Synthetic Drug Abuse Prevention 
Act (SDAPA), that classified a number of synthetic 
substances under Schedule I of the Controlled 
Substances Act. SDAPA placed these substances 
in the most restrictive category of controlled 
substances. Cannabimimetic agents, including 
15 synthetic cannabinoid compounds identified 
by name, two synthetic cathinone compounds 
(mephedrone and MDPV), and nine synthetic 
hallucinogens known as the 2C family, were 
restricted by this law. In addition, methylone and 
ten (10) synthetic cathinones that were subject to 
temporary control were permanently controlled by 
DEA through the administrative process. Another 
synthetic cathinone, N-ethylbentylone, was 
temporarily controlled in 2018. 
Other synthetic cathinones may be subject 
to prosecution under the Controlled Substance 
Analogue Enforcement Act which allows these 
dangerous substances to be treated as Schedule I 
controlled substances if certain criteria can be met.
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WHAT IS K2? 
K2 and Spice are just two of the many trade names 
or brands for synthetic designer drugs that are 
intended to mimic THC, the main psychoactive 
ingredient of marijuana. These designer synthetic 
drugs are from the synthetic cannabinoid class of 
drugs that are often marketed and sold under the 
guise of “herbal incense” or “potpourri.” 
Synthetic cannabinoids are not organic, but are 
chemical compounds created in a laboratory. Since 
2009, law enforcement has encountered hundreds 
of different synthetic cannabinoids that are being 
sold as “legal” alternatives to marijuana. These 
products are being abused for their psychoactive 
properties and are packaged without information as 
to their health and safety risks. 
Synthetic cannabinoids are sold as “herbal 
incense” and “potpourri” under names like K2 
and Spice, as well as many other names, at small 
convenience stores, head shops, gas stations, 
and via the Internet from both domestic and 
international sources. These products are labeled 
“not for human consumption” in an attempt to shield 
the manufacturers, distributors, and retail sellers 
from criminal prosecution. This type of marketing 
is nothing more than a means to make dangerous, 
psychoactive substances widely available to the 
public. 
WHAT IS ITS ORIGIN? 
The vast majority of synthetic cannabinoids are 
manufactured in Asia without manufacturing 
requirements or quality control standards. The 
bulk products are smuggled into the United States 
typically as misbranded imports and have no 
legitimate medical or industrial use. 
What are common street names? 
There are numerous and various street names of 
synthetic cannabinoids as drug manufacturers try 
to appeal and entice youth and young adults by 
labeling these products with exotic and extravagant 
names. Some of the many street names of K2/Spice 
synthetic marijuana are: 
•  “Spice, K2, Blaze, RedX Dawn, Paradise, Demon, 
Black Magic, Spike, Mr. Nice Guy, Ninja, Zohai, Dream, 
Genie, Sence, Smoke, Skunk, Serenity, Yucatan, Fire, 
and Crazy Clown. 
What does it look like? 
These chemical compounds are generally found in 
bulk powder form, and then dissolved in solvents, 
such as acetone, before being applied to dry plant 
material to make the “herbal incense” products. 
After local distributors apply the drug to the dry 
plant material, they package it for retail distribution, 
again without pharmaceutical-grade chemical purity 
standards, as these have no accepted medical use, 
and ignoring any control mechanisms to prevent 
contamination or to ensure a consistent, uniform 
concentration of the powerful and dangerous 
drug in each package. The bulk powder can also 
be dissolved in solution intended to be used in 
e-cigarette or other vaping devices.
K2/Spice 
K2/Spice
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How is it abused? 
Spraying or mixing the synthetic cannabinoids 
on plant material provides a vehicle for the most 
common route of administration - smoking (using 
a pipe, a water pipe, or rolling the drug-laced plant 
material in cigarette papers). In addition to the 
cannabinoids laced on plant material and sold as 
potpourri and incense, liquid cannabinoids have 
been designed to be vaporized through both 
disposable and reusable electronic cigarettes. 
What are its overdose effects? 
Severe adverse effects have been attributed to 
the abuse of synthetic cannabinoids, including 
agitation, anxiety, seizures, stroke, coma, and 
death by heart attack or organ failure. Acute 
kidney injury requiring hospitalization and dialysis 
in several patients reportedly having smoked 
synthetic cannabinoids has also been reported by 
the Centers for Disease Control and Prevention. 
Which drugs cause similar effects? 
Synthetic cannabinoids are marketed as an 
alternative to THC, the main psychoactive 
constituent of marijuana, however they are much 
more potent and have been shown to cause side 
effects that are more severe than those reported 
from THC. 
What is its effect on the mind? 
Acute psychotic episodes, dependence, and 
withdrawal are associated with use of these 
synthetic cannabinoids. Some individuals have 
suffered from intense hallucinations. Other effects 
include severe agitation, disorganized thoughts, 
paranoid delusions, and violence after smoking 
products laced with these substances. 
What is its effect on the body? 
State public health and poison centers have issued 
warnings in response to adverse health effects 
associated with abuse of herbal incense products 
containing these synthetic  cannabinoids. These 
adverse effects included tachycardia (elevated heart 
rate), elevated blood pressure, unconsciousness, 
tremors, seizures, vomiting, hallucinations, 
agitation, anxiety, pallor, numbness, and tingling. 
This is in addition to the numerous public health 
and poison centers which have similarly issued 
warnings regarding the abuse of these synthetic 
cannabinoids. 
What is its legal status in the United States? 
These substances have no accepted medical 
use in the United States and have been reported 
to produce adverse health effects. Currently, 43 
substances are specifically listed as Schedule I 
substances under the Controlled Substances Act 
either through legislation or regulatory action. In 
addition there are many other synthetic cannabinoids 
that meet the definition for “cannabimimetic agent” 
under the Controlled Substances Act and thus are 
Schedule I substances. 
There are many synthetic cannabinoid substances 
that are being sold as “incense,” “potpourri,” and 
other products that are not controlled substances. 
However, synthetic cannabinoids may be subject 
to prosecution under the Controlled Substance 
Analogue Enforcement Act which allows non-
controlled drugs to be treated as Schedule I 
controlled substances if certain criteria can be 
met. The DEA has successfully investigated and 
prosecuted individuals trafficking and selling 
these dangerous substances using the Controlled 
Substance Analogue Enforcement Act.
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WHAT ARE SYNTHETIC OPIOIDS? 
Synthetic opioids are substances that are 
synthesized in a laboratory and that act on the 
same targets in the brain as natural opioids (e.g., 
morphine and codeine) to produce analgesic 
(pain relief) effects. In contrast, natural opioids are 
naturally occurring substances extracted from the 
seed pod of certain varieties of poppy plants. Some 
synthetic opioids, such as fentanyl and methadone, 
have been approved for medical use. 
Clandestinely produced synthetic opioids 
structurally related to the Schedule II opioid 
analgesic fentanyl were trafficked and abused 
on the West Coast in the late 1970s and 1980s. 
In the 1980s, DEA controlled several of these 




hydroxyfentanyl, para-fluorofentanyl, and 
3-methylfentanyl. 
As of 2013, there has been a re-emergence in 
the trafficking and abuse of various clandestinely 
produced synthetic opioids, including several 
substances related to fentanyl. Some common 
illicitly produced synthetic opioids that are currently 
encountered by law enforcement include, but are 
not limited to, acetyl fentanyl, butyryl fentanyl, 
beta- hydroxythiofentanyl, furanyl fentanyl, 
4-fluoroisobutyryl fentanyl, acryl fentanyl, and 
U-47700. 
WHAT IS THEIR ORIGIN? 
Synthetic opioids are believed to be synthesized 
abroad and then imported into the United States. 
What do they look like? 
Clandestinely produced synthetic opioids have 
been encountered in powder form and were 
identified on bottle caps and spoons, detected 
within glassine bags, on digital scales, and on 
sifters which demonstrates the abuse of these 
substances as replacements for heroin or other 
opioids. These drugs are also encountered as 
tablets, mimicking pharmaceutical opioid products. 
Clandestinely produced synthetic opioids are 
encountered as a single substance in combination 
with other opioids (fentanyl, heroin, U-47700) or 
other substances. 
How are they abused? 
Abuse of clandestinely produced synthetic 
opioids parallels that of heroin and prescription 
opioid analgesics. Many of these illicitly produced 
synthetic opioids are more potent than morphine 
and heroin and thus have the potential to result in a 
fatal overdose.
Synthetic Opioids 
Clandestinely produced counterfeit oxycodone tablets 
that contain fentanyl. 
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What are their effects? 
Some effects of clandestinely produced 
synthetic opioids, similar to other commonly 
used opioid analgesics (e.g., morphine), may 
include relaxation, euphoria, pain relief, sedation, 
confusion, drowsiness, dizziness, nausea, 
vomiting, urinary retention, pupillary constriction, 
and respiratory depression. 
What are their overdose effects? 
Overdose effects of clandestinely produced 
synthetic opioids are similar to other opioid 
analgesics. These effects may include stupor, 
changes in pupillary size, cold and clammy skin, 
cyanosis, coma, and respiratory failure leading to 
death. The presence of triad of symptoms such as 
coma, pinpoint pupils, and respiratory depression 
are strongly suggestive of opioid poisoning. 
Which drugs cause similar effects? 
Some drugs that cause similar effects include 
other opioids such as morphine, hydrocodone, 
oxycodone, hydromorphone, methadone, and 
heroin. 
What is their legal status in the United States? 
Many synthetic opioids are currently controlled 
under the Controlled Substances Act. The 
DEA temporarily placed U-47700 and several 
other substances that are structurally related to 
fentanyl, such as acetyl fentanyl, butyryl fentanyl, 
beta-hydroxythiofentanyl, and furanyl fentanyl, 
in Schedule I of the Controlled Substances Act. 
In February 2018, the DEA temporarily placed 
fentanyl-related substances in Schedule I of the 
CSA. Other synthetic opioid substances may 
be subject to prosecution under the Controlled 
Substance Analogue Enforcement Act which 
allows non-controlled substances to be treated 
as Schedule I substances if certain criteria are 
met. The DEA has successfully investigated and 
prosecuted individuals trafficking and selling 
these dangerous substances using the Controlled 
Substances Analogue Enforcement Act.
Synthetic Opioid powder U-47700.
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WHAT IS DXM? 
Dextromethorphan (DXM) is a cough 
suppressor found in more than 120 over-the-
counter (OTC) cold medications, either alone 
or in combination with other drugs such as 
analgesics (e.g., acetaminophen), antihistamines 
(e.g., chlorpheniramine), decongestants (e.g., 
pseudoephedrine),  and/ or expectorants (e.g., 
guaifenesin). The typical adult dose for cough is 15 
to 30 mg taken three to four times daily. The cough-
suppressing effects of DXM persist for 5 to 6 hours 
after ingestion. When taken as directed, side effects 
are rarely observed. 
WHAT IS ITS ORIGIN? 
DXM users can obtain the drug at almost any 
pharmacy or supermarket, seeking out the products 
with the highest concentration of the drug from 
among all the OTC cough and cold remedies that 
contain it. DXM products and powder can also be 
purchased on the  Internet. 
What are common street names? 
Common street names include: 
• CCC, Dex, DXM, Poor Man’s PCP, Robo, Rojo, Skittles, 
Triple C, and Velvet 
What does it look like? 
DXM can come in the form  of: 
• Cough syrup, tablets, capsules, or powder 
How is it abused? 
DXM is abused in high doses to experience euphoria 
and visual and auditory hallucinations. Users take 
various amounts depending on their body weight 
and the effect they are attempting to achieve. Some 
users ingest 250 to 1,500 milligrams in a single 
dosage, far more than the recommended therapeutic 
dosages described above. 
Illicit use of DXM is referred to on the street as 
“Robo-tripping,” “skittling,” or “dexing,” derived from 
the products that are most commonly abused, 
Robitussin and Coricidin HBP. DXM abuse has 
traditionally involved drinking large volumes 
of the OTC liquid cough preparations. More 
recently, however, abuse of tablet and gel capsule 
preparations has increased. 
These newer, high-dose DXM products have 
particular appeal for users. They are much easier to 
consume, eliminate the need to drink large volumes 
of unpleasant-tasting syrup, and are easily portable 
and concealed, allowing an abuser to continue to 
abuse DXM throughout the day, whether at school or 
work. 
DXM powder, sold over the Internet, is also a 
source of DXM for abuse. (The powdered form of 
DXM poses additional risks to the user due to the 
uncertainty of composition and dose.) 
DXM is also distributed in illicitly manufactured 
tablets containing only DXM or mixed with 
Drugs of Concern 
Even though some substances are not currently controlled 
by the Controlled Substances Act, they pose risks to 
individuals who abuse them. The following section describes 
these drugs of concern and their associated risks. 
DXM 
Drugs of Abuse  | A DEA Resource Guide: 2020 EDITION   103
other drugs such as pseudoephedrine and/ or 
methamphetamine. 
DXM is abused by individuals of all ages, but its 
abuse by teenagers and young adults is of particular 
concern. This abuse is fueled by DXM’s OTC 
availability and extensive “how to” abuse information 
on various websites. 
What is its effect on the mind? 
Some of the many psychoactive effects associated 
with high-dose DXM include: 
• Confusion, inappropriate laughter, agitation, paranoia, 
euphoria, and hallucinations 
• Other sensory changes, including the feeling of floating 
and changes in hearing and touch 
Long-term abuse of DXM is associated with severe 
psychological dependence. Abusers of DXM describe 
the following three dose-dependent “plateaus”: 
What is its effect on the body? 
DXM intoxication involves: 
• Over-excitability, lethargy, loss of coordination, slurred 
speech, sweating, hypertension, nausea, vomiting, and 
involuntary spasmodic movement of the eyeballs 
The use of high doses of DXM in combination with 
alcohol or other drugs is particularly dangerous, and 
deaths have been reported. Approximately 5-10 
percent of Caucasians are poor DXM metabolizers 
and at increased risk for overdoses and deaths. DXM 
taken with antidepressants can be life threatening. 
OTC products that contain DXM often contain 
other ingredients such as acetaminophen, 
chlorpheniramine, and guaifenesin that have their 
own effects, such as: 
• Liver damage, rapid heart rate, lack of coordination, 
vomiting, seizures, and coma 
To circumvent the many side effects associated with 
these other ingredients, a simple chemical extraction 
procedure has been developed and published on the 
Internet that removes most of these other ingredients 
in cough syrup. 
What are its overdose effects? 
DXM overdose can be treated in an emergency 
room setting and generally does not result in severe 
medical consequences or death. Most DXM-
related deaths are caused by ingesting the drug in 
combination with other drugs. DXM-related deaths 
also occur from impairment of the senses, which can 
lead to accidents. 
In 2003, a 14-year-old boy in Colorado who 
abused DXM died when he was hit by two cars as he 
attempted to cross a highway. State law enforcement 
investigators suspect that the drug affected the boy’s 
depth perception and caused him to misjudge the 
distance and speed of the oncoming vehicles. 
Which drugs cause similar effects? 
Depending on the dose, DXM can have effects 
similar to marijuana or ecstasy. In moderate to high 
doses its out-of-body effects are similar to those of 
ketamine or PCP. 
What is its legal status in the United States? 
DXM is a legally marketed cough suppressant that 
is neither a controlled substance nor a regulated 
chemical under the Controlled  Substances Act.
DOSE (MG) BEHAVIORAL EFFECTS 
100-200 Mild Stimulation 
200-400 Euphoria and hallucinations 
300-1500 Distorted visual perceptions 
Loss of motor coordination 
Out of body sensations 
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WHAT IS KRATOM? 
Kratom is a tropical tree native to Southeast Asia. Consumption 
of its leaves produces both stimulant effects (in low doses) and 
sedative effects (in high doses), and can lead to psychotic symptoms, 
and psychological and physiological dependence. Kratom leaves 
contain two major psychoactive ingredients (mitragynine and 
7-hydroxymytragynine). These leaves are crushed and then smoked, 
brewed with tea, or placed into gel capsules. Kratom has a long history 
of use in Southeast Asia, where it is commonly known as thang, 
kakuam, thom, ketum, and biak. In the U.S., the abuse of kratom has 
increased markedly in recent years. 
How is it abused? 
Mostly abused by oral ingestion in the form of a tablet, capsule, or 
extract. Kratom leaves may also be dried or powdered and ingested as 
a tea, or the kratom leaf may be chewed. 
What are the effects? 
At low doses, kratom produces stimulant effects with users reporting 
increased alertness, physical energy, and talkativeness. At high doses, 
users experience sedative effects. Kratom consumption can lead to  
addiction. 
Several cases of psychosis resulting from use of kratom have been 
reported, where individuals addicted to kratom exhibited psychotic  
symptoms, including hallucinations, delusion, and confusion. 
What does it do to the body? 
Kratom’s effects on the body include nausea, itching, sweating, dry 
mouth, constipation, increased urination, tachycardia, vomiting, 
drowsiness, and loss of appetite. Users of kratom have also 
experienced anorexia, weight loss, insomnia, hepatotoxicity, seizure, 
and hallucinations. 
What is its legal status? 
Kratom is not controlled under the Controlled Substances Act; however, there may be some state 
regulations or prohibitions against the possession and use of kratom. The FDA has not approved Kratom 
for any medical use. In addition, DEA has listed kratom as a Drug and Chemical of Concern.
Kratom 
Leaf of kratom tree
Kratom capsules
Kratom tree
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WHAT IS SALVIA DIVINORUM? 
Salvia divinorum is a perennial herb in the mint 
family that is abused for its hallucinogenic effects. 
WHAT IS ITS ORIGIN? 
Salvia divinorum is native to certain areas of the 
Sierra Mazaleca region of Oaxaca, Mexico. It is 
one of several plants that are used by Mazatec 
Indians for ritual divination. Salvia divinorum 
plants can be grown successfully outside of this 
region. They can be grown indoors and outdoors, 
especially in humid semitropical climates. 
What are common street names? 
Common street names include: 
• Maria Pastora, Sally-D, and Salvia 
What does it look like? 
The plant has spade-shaped variegated green 
leaves that look similar to mint. The plants 
themselves grow to more than three feet high, 
have large green leaves, hollow square stems, 
and white flowers with purple calyces. 
How is it abused? 
Salvia can be chewed, smoked, or vaporized. 
What is its effect on the mind? 
Psychic effects include perceptions of bright 
lights, vivid colors, shapes, and body movement, 
as well as body or object distortions. Salvia 
divinorum may also cause fear and panic, 
uncontrollable laughter, a sense of overlapping 
realities, paranoia, and hallucinations. 
Users typically experience rapid onset of 
intense hallucinations that can impair judgment 
and disrupt sensory and cognitive functions. 
Salvinorin A is the principal ingredient 
responsible for the psychoactive effects of Salvia 
divinorum. 
What is its effect on the body? 
Adverse physical effects may include: 
• Loss of coordination, dizziness, and slurred speech 
Which drugs cause similar effects? 
When Salvia divinorum is chewed or smoked, the 
hallucinogenic effects elicited are similar to those 
induced by Scheduled hallucinogenic substances. 
What is its legal status in the United States? 
Neither Salvia divinorum nor its active constituent 
Salvinorin A has an approved medical use in the 
United States. Salvia divinorum is not controlled 
under the Controlled Substances Act. Salvia 
divinorum is, however, controlled by a number of 
states. Since Salvia divinorum is not controlled by 
the CSA, some online botanical companies and 
drug promotional sites have advertised Salvia as 
a legal alternative to other plant hallucinogens like 
mescaline. 
Salvia Divinorum 
Leaves of the Salvia divinorum plant
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IV. Resources 
DRUG USE PREVENTION 
RESOURCES 
Drug prevention programs are designed and 
implemented on many levels. The federal 
government has instituted a number of 
national drug prevention programs which reach 
targeted populations through public service 
announcements, grant programs, educational 
programs, and the sharing of expertise. State 
and local governments also have a significant 
number of prevention programs that are tailored 
to address particular problems and needs. Law 
enforcement and the military have brought 
drug prevention expertise into classrooms and 
communities; businesses have also contributed 
significantly to drug prevention through sponsored 
programs, drug-free policies, and corporate 
support for community initiatives. Other segments 
of society, including faith-based institutions, civic 
organizations, and private foundations are also 
active forces in drug prevention. 
On the next page is a partial list of drug 
prevention agencies and programs. There are 
many other outstanding efforts which are ongoing 
across the nation; it is impossible to include 
them all. Some programs are aimed at particular 
populations or specific drugs. Within a given 
agency, there may be many prevention programs 
which are aimed at different audiences.
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Centers for Disease Control and 
Prevention  (CDC): 
CDC’s National Center for Injury Prevention and 
Control helps protect America’s health by tracking 
injuries and deaths to look for dangerous trends, 
researching the best ways to prevent injuries 
and violence, developing prevention strategies, 
evaluating effectiveness of prevention strategies, 
and supporting states in implementing programs. 
www.cdc.gov/injury 
Drug Enforcement Administration  (DEA): 
In addition to dismantling major drug trafficking 
organizations, DEA is committed to reducing the 
demand for drugs in America. DEA’s community 
outreach and prevention support is carried out by 
employees across the United States who work in 
communities to share expertise and information 
on drug trends, emerging problems, the dangers 







National Institute on Drug Abuse (NIDA): 
NIDA conducts and disseminates the results of 
research about the effects of drugs on the body 
and the brain. NIDA is an excellent source of 
information on drug addiction. 
www.nida.nih.gov 
Office of National Drug Control Policy (ONDCP): 
ONDCP works to reduce drug use and its 
consequences by leading and coordinating the 
development, implementation, and assessment of 
U.S. drug policy. 
www.whitehousedrugpolicy.gov 
Substance Abuse and Mental Health Services 
Administration (SAMHSA): 
This agency is responsible for overseeing 
and administering mental health, drug misuse 
prevention, and drug addiction treatment 
programs around the nation. The Center for 
Substance Abuse Prevention and the Center for 
Substance Abuse Treatment are part of SAMHSA. 
www.samhsa.gov 
www.samhsa.gov/prevention 
U.S. Department of Education (ED): 
ED’s Office of Safe and Healthy Students serves 
states and school communities by providing 
resources, direct support, and technical 
assistance on topics that affect the well-being, 
health, and safety of the nation’s young people 
www.ed.gov
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Community Anti-Drug Coalitions of America 
(CADCA) 
www.cadca.org 
National Association of State Alcohol and Drug 
Abuse Directors (NASADAD) 
www.nasadad.org 
National Crime Prevention Council (NCPC) 
www.ncpc.org 
National Families in Action (NFIA) 
www.nationalfamilies.org 
American Council for Drug Education (ACDE) 
www.acde.org 
Elks Drug Awareness Program 
www.elks.org/dap 
Center on Addiction 
www.centeronaddiction.org 
Partnership for Drug-Free Kids 
www.drugfree.org 
DEA Educational Foundation Youth 
Dance Program 
www.deaeducationalfoundation.org 
Drug Abuse Resistance Education (DARE) 
www.dare.com 
Law Enforcement Exploring 
exploring.learningforlife.org/services/career-
exploring/law-enforcement/ 




National Prevention Network 
www.nasadad.org/npn-4 
Mentor Foundation USA 
www.mentorfoundation.org 
Drug Free America Foundation 
www.dfaf.org 
National Family Partnership 
www.nfp.org 
Other Anti-Drug Organizations: 

Drug Enforcement Administration 
Community Outreach and Prevention Support Section 
8701 Morrissette Drive 
Springfield, VA  22152 
202-307-7936 
community.outreach@usdoj.gov

